<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/_common/xslt/rss.xslt"?>
<rss version="2.0">
<channel>
<title>Drug Discovery Today - Events</title>
<link>http://www.drugdiscoverytoday.com/</link>
<description></description>
<copyright>Copyright Elsevier Ltd</copyright>
<generator>Intuitiv Ltd (www.intuitiv.net)</generator>
<lastBuildDate>2012-02-04T09:02Z</lastBuildDate>
<image>
<title>Drug Discovery Today</title>
<link>http://www.drugdiscoverytoday.com/</link>
<url>http://www.drugdiscoverytoday.com/_common/img/template/ddt/site-logo.gif</url>
</image>
<item>
<title>Gordon Research Conference on Computer Aided Drug Design</title>
<link>http://www.drugdiscoverytoday.com/view/539/gordon-research-conference-on-computer-aided-drug-design/</link>
<description><![CDATA[<strong>From:</strong> 19 July 2009<br /><strong>To:</strong> 24 July 2009<br /><br />Tilton School, Tilton, NH, USA. ]]></description>
<guid>539</guid>
</item>
<item>
<title>Gordon Research Conference on Medicinal Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/540/gordon-research-conference-on-medicinal-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 02 August 2009<br /><strong>To:</strong> 07 August 2009<br /><br />Colby-Sawyer College, New London, NH, USA. ]]></description>
<guid>540</guid>
</item>
<item>
<title>DDT World Congress</title>
<link>http://www.drugdiscoverytoday.com/view/541/ddt-world-congress/</link>
<description><![CDATA[<strong>From:</strong> 03 August 2009<br /><strong>To:</strong> 06 August 2009<br /><br />Boston, USA. ]]></description>
<guid>541</guid>
</item>
<item>
<title>Drug Discovery and Development Week</title>
<link>http://www.drugdiscoverytoday.com/view/542/drug-discovery-and-development-week/</link>
<description><![CDATA[<strong>From:</strong> 03 August 2009<br /><strong>To:</strong> 06 August 2009<br /><br />The World Trade Center and Seaport Hotel, Boston, MA, USA. ]]></description>
<guid>542</guid>
</item>
<item>
<title>Third International Symposium on Advances In Synthetic and Medicinal Chemistry </title>
<link>http://www.drugdiscoverytoday.com/view/543/third-international-symposium-on-advances-in-synthetic-and-medicinal-chemistry-/</link>
<description><![CDATA[<strong>From:</strong> 23 August 2009<br /><strong>To:</strong> 27 August 2009<br /><br />Kiev, Ukraine . (Tel: +32 10 45 47 77)
(Fax: +32 10 45 97 19)
E-mail: info@ldorganisation.com]]></description>
<guid>543</guid>
</item>
<item>
<title>SBS Symposium Screening Stem Cells: From Reprogramming to Regenerative Medicine </title>
<link>http://www.drugdiscoverytoday.com/view/544/sbs-symposium-screening-stem-cells-from-reprogramming-to-regenerative-medicine-/</link>
<description><![CDATA[<strong>From:</strong> 02 September 2009<br /><strong>To:</strong> 03 September 2009<br /><br />Boston Park Plaza Hotel, Boston, MA, USA. (Tel: +1 20 37 43 13 36)
(Fax: +1 20 37 48 58 46)
E-mail: email@sbsonline.org]]></description>
<guid>544</guid>
</item>
<item>
<title>Drug Discovery: 2009</title>
<link>http://www.drugdiscoverytoday.com/view/545/drug-discovery-2009/</link>
<description><![CDATA[<strong>From:</strong> 07 September 2009<br /><strong>To:</strong> 08 September 2009<br /><br />BT Convention Centre, Liverpool, UK. A joint SBS/ELRIG symposium.
E-mail: jackie.howard@lab-robotics.org]]></description>
<guid>545</guid>
</item>
<item>
<title>Science @ The British Pharmaceutical Conference 2009</title>
<link>http://www.drugdiscoverytoday.com/view/586/science-the-british-pharmaceutical-conference-2009/</link>
<description><![CDATA[<strong>From:</strong> 07 September 2009<br /><strong>To:</strong> 09 September 2009<br /><br />Manchester Central, Manchester, UK. ]]></description>
<guid>586</guid>
</item>
<item>
<title>Immunogenicity for Biologics 2009</title>
<link>http://www.drugdiscoverytoday.com/view/546/immunogenicity-for-biologics-2009/</link>
<description><![CDATA[<strong>From:</strong> 08 September 2009<br /><strong>To:</strong> 09 September 2009<br /><br />Andel’s Hotel, Prague, Czech Republic. (Tel: +44 20 70 17 74 81)
(Fax: +44 20 70 17 78 23)
E-mail: registrations@informa-ls.com]]></description>
<guid>546</guid>
</item>
<item>
<title>Pathology Visions Conference</title>
<link>http://www.drugdiscoverytoday.com/view/547/pathology-visions-conference/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2009<br /><strong>To:</strong> 15 September 2009<br /><br />San Diego Marriott Hotel and Marina, San Diego, CA, US. (Tel: +1 76 05 39 11 93)
E-mail: info@pathologyvisions.com]]></description>
<guid>547</guid>
</item>
<item>
<title>Biological Production 2009</title>
<link>http://www.drugdiscoverytoday.com/view/548/biological-production-2009/</link>
<description><![CDATA[<strong>From:</strong> 21 September 2009<br /><strong>To:</strong> 22 September 2009<br /><br />Copthorne Tara Hotel, London, UK. (Tel: +44  87 09 09 07 12)
(Fax:  +44  87 09 09 07 11)
E-mail: enquire@ipqc.co.uk]]></description>
<guid>548</guid>
</item>
<item>
<title>Frontiers of Retrovirology</title>
<link>http://www.drugdiscoverytoday.com/view/549/frontiers-of-retrovirology/</link>
<description><![CDATA[<strong>From:</strong> 21 September 2009<br /><strong>To:</strong> 23 September 2009<br /><br />Le Corum, Montpellier, France. (Tel: +44 20 31 92 20 00)
E-mail: info@biomedcentral.com]]></description>
<guid>549</guid>
</item>
<item>
<title>Americas Antibody Congress 2009</title>
<link>http://www.drugdiscoverytoday.com/view/550/americas-antibody-congress-2009/</link>
<description><![CDATA[<strong>From:</strong> 21 September 2009<br /><strong>To:</strong> 23 September 2009<br /><br />Hamilton Crowne Plaza, Washington, DC, USA. (Tel: +1 212 379 6320)
(Fax: +1 212 379 6319)
E-mail stefanie.baronoff@terrapinn.com ]]></description>
<guid>550</guid>
</item>
<item>
<title>First World Conference on Physico-Chemical Methods in Drug Discovery and Development</title>
<link>http://www.drugdiscoverytoday.com/view/551/first-world-conference-on-physicochemical-methods-in-drug-discovery-and-development/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2009<br /><strong>To:</strong> 01 October 2009<br /><br />Hotel Park, Rovinj, Croatia. E-mail: office@iapchem.org]]></description>
<guid>551</guid>
</item>
<item>
<title>The China Clinical Trials Outsourcing Congress</title>
<link>http://www.drugdiscoverytoday.com/view/553/the-china-clinical-trials-outsourcing-congress/</link>
<description><![CDATA[<strong>From:</strong> 28 September 2009<br /><strong>To:</strong> 29 September 2009<br /><br />The Midland Hotel, Manchester, UK. (Tel: +44  18 65 79 43 62)
E-mail: steve.hambrook@ebaoxford.co.uk]]></description>
<guid>553</guid>
</item>
<item>
<title>KOL Knowledge Leaders</title>
<link>http://www.drugdiscoverytoday.com/view/805/kol-knowledge-leaders/</link>
<description><![CDATA[<strong>From:</strong> 30 September 2009<br /><strong>To:</strong> 01 October 2009<br /><br />Copthorne Tara Hotel, London, United Kingdom. ]]></description>
<guid>805</guid>
</item>
<item>
<title>III InterAmerican Oncology Conference Current Status and Future of Anti-Cancer Targeted Therapies </title>
<link>http://www.drugdiscoverytoday.com/view/554/iii-interamerican-oncology-conference-current-status-and-future-of-anticancer-targeted-therapies-/</link>
<description><![CDATA[<strong>From:</strong> 01 October 2009<br /><strong>To:</strong> 02 October 2009<br /><br />Buenos Aires, Argentina . E-mail: secretariat@oncologyconferences.com.ar]]></description>
<guid>554</guid>
</item>
<item>
<title>Third Annual Collaborative Drug Discovery–UCSF Community Meeting for Catalysing Humanitarian and Commercial Research</title>
<link>http://www.drugdiscoverytoday.com/view/578/third-annual-collaborative-drug-discoveryucsf-community-meeting-for-catalysing-humanitarian-and-commercial-research/</link>
<description><![CDATA[<strong>From:</strong> 01 October 2009<br /><strong>To:</strong> 01 January 1800<br /><br />The J. David Gladstone Institutes, San Francisco, CA, USA. E-mail: info@collaborativedrug.com]]></description>
<guid>578</guid>
</item>
<item>
<title>EMBO Conference Series on Morphogenesis and Dynamics of Multicellular Systems</title>
<link>http://www.drugdiscoverytoday.com/view/555/embo-conference-series-on-morphogenesis-and-dynamics-of-multicellular-systems/</link>
<description><![CDATA[<strong>From:</strong> 02 October 2009<br /><strong>To:</strong> 06 October 2009<br /><br />EMBL Heidelberg, Germany. ]]></description>
<guid>555</guid>
</item>
<item>
<title>BioNetwork 2009 The 7th Annual Pharmaceutical-Biotech Partnering Conference </title>
<link>http://www.drugdiscoverytoday.com/view/556/bionetwork-2009-the-7th-annual-pharmaceuticalbiotech-partnering-conference-/</link>
<description><![CDATA[<strong>From:</strong> 05 October 2009<br /><strong>To:</strong> 07 October 2009<br /><br />The Ritz Carlton, Laguna Niguel, CA, USA. (Tel: +1 88 84 82 60 12)
(Fax: +1 64 62 00 75 35)
E-mail: bionetwork@wbresearch.com]]></description>
<guid>556</guid>
</item>
<item>
<title>Managing Partnerships with CROs</title>
<link>http://www.drugdiscoverytoday.com/view/800/managing-partnerships-with-cros/</link>
<description><![CDATA[<strong>From:</strong> 05 October 2009<br /><strong>To:</strong> 06 October 2009<br /><br />Crowne Plaza Hotel, London - St. James, UK. ]]></description>
<guid>800</guid>
</item>
<item>
<title>PEGS Europe</title>
<link>http://www.drugdiscoverytoday.com/view/821/pegs-europe/</link>
<description><![CDATA[<strong>From:</strong> 06 October 2009<br /><strong>To:</strong> 08 October 2009<br /><br />Exhibition Grounds, Hannover, Germany. PEGS Europe is the premier Cambridge Healthtech Institute Conference Event covering all aspects of protein engineering. From discovery to bedside delegates will hear the latest information on methods and technologies for protein expression and production, phage display, and antibody engineering. The meeting combines the 3rd Annual Protein Expression - Europe and Antibodies - Europe meetings with 2 new meetings: Antibodies from Bench to Bedside and Phage Display to Develop Therapeutics. The event is also co-located with the largest Biotechnology event in Europe, BIOTECHNICA.]]></description>
<guid>821</guid>
</item>
<item>
<title>EMBO Practical Course on Current Methods in Cell Biology</title>
<link>http://www.drugdiscoverytoday.com/view/557/embo-practical-course-on-current-methods-in-cell-biology/</link>
<description><![CDATA[<strong>From:</strong> 08 October 2009<br /><strong>To:</strong> 16 October 2009<br /><br />EMBL Heidelberg, Germany. (Tel: +49 62 21 38 78 39 7)
(Fax: +49 62 21 38 78 15 8)
E-mail: conferences@embl.de]]></description>
<guid>557</guid>
</item>
<item>
<title>Advances in BioDetection Technologies</title>
<link>http://www.drugdiscoverytoday.com/view/757/advances-in-biodetection-technologies/</link>
<description><![CDATA[<strong>From:</strong> 09 October 2009<br /><strong>To:</strong> 01 January 1800<br /><br />London, UK. ]]></description>
<guid>757</guid>
</item>
<item>
<title>BioPartnering Europe &amp; BioPartnering China</title>
<link>http://www.drugdiscoverytoday.com/view/729/biopartnering-europe-biopartnering-china/</link>
<description><![CDATA[<strong>From:</strong> 11 October 2009<br /><strong>To:</strong> 14 October 2009<br /><br />QEII Conference Centre | London, United Kingdom . QEII Conference Centre | London, United Kingdom ]]></description>
<guid>729</guid>
</item>
<item>
<title>17th Annual BioPartnering Europe</title>
<link>http://www.drugdiscoverytoday.com/view/558/17th-annual-biopartnering-europe/</link>
<description><![CDATA[<strong>From:</strong> 11 October 2009<br /><strong>To:</strong> 13 October 2009<br /><br />QEII Conference Centre, London, UK. (Tel: +44  20 76 38 95 71)
(Fax: +44 20 76 28 00 46)
E-mail: amber.bielecka@citigatedr.co.uk]]></description>
<guid>558</guid>
</item>
<item>
<title>PBA 2009. 21st International Symposium on Pharmaceutical &amp; Biomedical Analysis</title>
<link>http://www.drugdiscoverytoday.com/view/814/pba-2009-21st-international-symposium-on-pharmaceutical-biomedical-analysis/</link>
<description><![CDATA[<strong>From:</strong> 11 October 2009<br /><strong>To:</strong> 14 October 2009<br /><br />Hilton Walt Disney, Orlando, FL, USA . The 2009 conference will provide an opportunity to discuss all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as the omics, high-throughput analysis and microfluidic technologies, as well as the more traditional topics. 
]]></description>
<guid>814</guid>
</item>
<item>
<title>Conducting Clinical Trials in Europe</title>
<link>http://www.drugdiscoverytoday.com/view/807/conducting-clinical-trials-in-europe/</link>
<description><![CDATA[<strong>From:</strong> 12 October 2009<br /><strong>To:</strong> 13 October 2009<br /><br />Crowne Plaza Hotel - St James, London, UK. ]]></description>
<guid>807</guid>
</item>
<item>
<title>Conducting Clinical Trials in Europe</title>
<link>http://www.drugdiscoverytoday.com/view/801/conducting-clinical-trials-in-europe/</link>
<description><![CDATA[<strong>From:</strong> 12 October 2009<br /><strong>To:</strong> 13 October 2009<br /><br />Crowne Plaza Hotel, London - St. James, UK. ]]></description>
<guid>801</guid>
</item>
<item>
<title>MipTec</title>
<link>http://www.drugdiscoverytoday.com/view/559/miptec/</link>
<description><![CDATA[<strong>From:</strong> 13 October 2009<br /><strong>To:</strong> 15 October 2009<br /><br />Congress Centre, Basel, Switzerland. (Tel: +41  61 68 67 77 7)
(Fax: +41  61 68 67 78 8)
E-mail: amber.bielecka@citigatedr.co.uk, friederike.gutmann@congrex.com]]></description>
<guid>559</guid>
</item>
<item>
<title>Ubiquitin Drug Discovery &amp; Diagnostics 2009</title>
<link>http://www.drugdiscoverytoday.com/view/813/ubiquitin-drug-discovery-diagnostics-2009/</link>
<description><![CDATA[<strong>From:</strong> 13 October 2009<br /><strong>To:</strong> 14 October 2009<br /><br />Park Hyatt at the Bellevue, Philadelphia, PA, USA. ]]></description>
<guid>813</guid>
</item>
<item>
<title>RNAi Asia</title>
<link>http://www.drugdiscoverytoday.com/view/751/rnai-asia/</link>
<description><![CDATA[<strong>From:</strong> 14 October 2009<br /><strong>To:</strong> 16 October 2009<br /><br />Kunshan, China. The Chinese government has recently announced the establishment of the country’s biggest siRNA R&amp;D complex in Kunshan (near Shanghai) which will house both basic research and commercial startup companies.
In partnership with local organizers, Select Biosciences has been asked to host this inaugural international conference (circa. 500 expected). Attendance represents a major opportunity to forge brand new links and collaborations as this area will be the centre of RNAi activities in China going forwards.

]]></description>
<guid>751</guid>
</item>
<item>
<title>5th Annual Biosimilars Conference</title>
<link>http://www.drugdiscoverytoday.com/view/845/5th-annual-biosimilars-conference/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2009<br /><strong>To:</strong> 21 October 2009<br /><br />BSG Conference Centre, London, UK. The biological drug market is one of the fastest growing sectors of the pharmaceutical industry which corresponds to over 15% of the total pharmaceutical market. However, due to the patent expiry of many drugs, and increasing pressure from government, insurers and patient advocacy groups to reduce expenditure a number of opportunities for biosimilars have been created.
]]></description>
<guid>845</guid>
</item>
<item>
<title>Exploratory Clinical Development World</title>
<link>http://www.drugdiscoverytoday.com/view/844/exploratory-clinical-development-world/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2009<br /><strong>To:</strong> 23 October 2009<br /><br />Hyatt Regency, Boston, MA, USA. ]]></description>
<guid>844</guid>
</item>
<item>
<title>Nutraceuticals and Functional Foods</title>
<link>http://www.drugdiscoverytoday.com/view/808/nutraceuticals-and-functional-foods/</link>
<description><![CDATA[<strong>From:</strong> 21 October 2009<br /><strong>To:</strong> 22 October 2009<br /><br />Crowne Plaza Hotel - St James, London, UK. ]]></description>
<guid>808</guid>
</item>
<item>
<title>Point of Care Diagnostics - Market Adoption and Technology Trends</title>
<link>http://www.drugdiscoverytoday.com/view/809/point-of-care-diagnostics-market-adoption-and-technology-trends/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2009<br /><strong>To:</strong> 27 October 2009<br /><br />Crowne Plaza Hotel – St James’, London, UK. ]]></description>
<guid>809</guid>
</item>
<item>
<title>8th Polymorphism &amp; Crystallization Scientific Forum</title>
<link>http://www.drugdiscoverytoday.com/view/871/8th-polymorphism-crystallization-scientific-forum/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2009<br /><strong>To:</strong> 28 October 2009<br /><br />Hub Cira Center, Philadelphia, PA, USA. ]]></description>
<guid>871</guid>
</item>
<item>
<title>5th Forum on Laboratory Informatics 2009</title>
<link>http://www.drugdiscoverytoday.com/view/872/5th-forum-on-laboratory-informatics-2009/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2009<br /><strong>To:</strong> 28 October 2009<br /><br />The Ritz-Carlton San Francisco, San Francisco, CA, USA. ]]></description>
<guid>872</guid>
</item>
<item>
<title>Drug Discovery Partnership: Filling the Pipeline</title>
<link>http://www.drugdiscoverytoday.com/view/579/drug-discovery-partnership-filling-the-pipeline/</link>
<description><![CDATA[<strong>From:</strong> 28 October 2009<br /><strong>To:</strong> 30 October 2009<br /><br />Hyatt Regency Boston, Boston, MA, USA. (Tel: +1 21 25 32 98 98) 
(Fax: +1 21 25 32 71 51) 
E-mail: feedback@opalgroup.net
]]></description>
<guid>579</guid>
</item>
<item>
<title>European Pharmaceutical Pricing &amp; Reimbursement </title>
<link>http://www.drugdiscoverytoday.com/view/810/european-pharmaceutical-pricing-reimbursement-/</link>
<description><![CDATA[<strong>From:</strong> 28 October 2009<br /><strong>To:</strong> 29 October 2009<br /><br />Courtyard by Marriott - Munich City Centre, Germany. ]]></description>
<guid>810</guid>
</item>
<item>
<title>RNAi for Screening Cellular Pathways and Targets</title>
<link>http://www.drugdiscoverytoday.com/view/842/rnai-for-screening-cellular-pathways-and-targets/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2009<br /><strong>To:</strong> 03 November 2009<br /><br />InterContinental Hotel, Boston, MA, USA. ]]></description>
<guid>842</guid>
</item>
<item>
<title>Third Annual HDAC Inhibitors</title>
<link>http://www.drugdiscoverytoday.com/view/904/third-annual-hdac-inhibitors/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2009<br /><strong>To:</strong> 03 November 2009<br /><br />InterContinental Hotel, Boston MA, USA. ]]></description>
<guid>904</guid>
</item>
<item>
<title>SBS Symposium Advances &amp; Challenges in Label-Free Technologies for Drug Discovery </title>
<link>http://www.drugdiscoverytoday.com/view/561/sbs-symposium-advances-challenges-in-labelfree-technologies-for-drug-discovery-/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2009<br /><strong>To:</strong> 03 November 2009<br /><br />San Diego, CA, USA . (Tel: +1 20 37 43 13 36)
(Fax: +1 20 37 48 58 46)
E-mail: email@sbsonline.org]]></description>
<guid>561</guid>
</item>
<item>
<title>BIO-Europe 2009</title>
<link>http://www.drugdiscoverytoday.com/view/714/bioeurope-2009/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2009<br /><strong>To:</strong> 04 November 2009<br /><br />Messe Vien Exhibition &amp; Conference Center, Vienna, Austria. ]]></description>
<guid>714</guid>
</item>
<item>
<title>Kinase Inhibitors</title>
<link>http://www.drugdiscoverytoday.com/view/715/kinase-inhibitors/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 04 November 2009<br /><br />InterContinental Hotel, Boston, MA, USA. ]]></description>
<guid>715</guid>
</item>
<item>
<title>Targeting Diabetes with Novel Therapeutics </title>
<link>http://www.drugdiscoverytoday.com/view/716/targeting-diabetes-with-novel-therapeutics-/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 04 November 2009<br /><br />InterContinental Hotel, Boston, MA, USA. ]]></description>
<guid>716</guid>
</item>
<item>
<title>Third Annual Kinase Inhibitors</title>
<link>http://www.drugdiscoverytoday.com/view/905/third-annual-kinase-inhibitors/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 04 November 2009<br /><br />InterContinental Hotel, Boston, MA, USA. ]]></description>
<guid>905</guid>
</item>
<item>
<title>Next Generation Protein Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/889/next-generation-protein-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 05 November 2009<br /><br />Danubius Regents Park, London, United Kingdom . ]]></description>
<guid>889</guid>
</item>
<item>
<title>RNAi for Developing Targeted Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/843/rnai-for-developing-targeted-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 04 November 2009<br /><br />InterContinental Hotel, Boston, MA, USA. ]]></description>
<guid>843</guid>
</item>
<item>
<title>The 2009 JIB Congress</title>
<link>http://www.drugdiscoverytoday.com/view/870/the-2009-jib-congress/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2009<br /><strong>To:</strong> 06 November 2009<br /><br />CNIT, Paris La Defense, France. ]]></description>
<guid>870</guid>
</item>
<item>
<title>Advances in Metabolic Profiling</title>
<link>http://www.drugdiscoverytoday.com/view/752/advances-in-metabolic-profiling/</link>
<description><![CDATA[<strong>From:</strong> 05 November 2009<br /><strong>To:</strong> 06 November 2009<br /><br />Barcelona, Spain. ]]></description>
<guid>752</guid>
</item>
<item>
<title>European Biomarkers Summit</title>
<link>http://www.drugdiscoverytoday.com/view/753/european-biomarkers-summit/</link>
<description><![CDATA[<strong>From:</strong> 05 November 2009<br /><strong>To:</strong> 06 November 2009<br /><br />Barcelona, Spain. ]]></description>
<guid>753</guid>
</item>
<item>
<title>Proteomics Europe</title>
<link>http://www.drugdiscoverytoday.com/view/754/proteomics-europe/</link>
<description><![CDATA[<strong>From:</strong> 05 November 2009<br /><strong>To:</strong> 06 November 2009<br /><br />Barcelona, Spain. ]]></description>
<guid>754</guid>
</item>
<item>
<title>Mass Spec Europe</title>
<link>http://www.drugdiscoverytoday.com/view/755/mass-spec-europe/</link>
<description><![CDATA[<strong>From:</strong> 05 November 2009<br /><strong>To:</strong> 06 November 2009<br /><br />Barcelona, Spain. ]]></description>
<guid>755</guid>
</item>
<item>
<title>High Throughput Microscopy for Systems Biology</title>
<link>http://www.drugdiscoverytoday.com/view/562/high-throughput-microscopy-for-systems-biology/</link>
<description><![CDATA[<strong>From:</strong> 08 November 2009<br /><strong>To:</strong> 13 November 2009<br /><br />EMBL Heidelberg, Germany. (Tel: +49 62 21 38 78 83 6)
(Fax: +49 62 21 38 78 15 8)
E-mail: courses@embl.de ]]></description>
<guid>562</guid>
</item>
<item>
<title>Protein Science Forum 2009</title>
<link>http://www.drugdiscoverytoday.com/view/563/protein-science-forum-2009/</link>
<description><![CDATA[<strong>From:</strong> 09 November 2009<br /><strong>To:</strong> 10 November 2009<br /><br />De Vere, Wokefield Park, Reading, UK. (Tel: +44 12 35 44 12 11)
E-mail: psf2009@evotec.com]]></description>
<guid>563</guid>
</item>
<item>
<title>R&amp;D Leaders’ Forum/Oncology Leaders’ Forum 2009</title>
<link>http://www.drugdiscoverytoday.com/view/564/rd-leaders-forumoncology-leaders-forum-2009/</link>
<description><![CDATA[<strong>From:</strong> 09 November 2009<br /><strong>To:</strong> 11 November 2009<br /><br />The Marriott Long Wharf, Boston, MA, USA. (Tel: +44  20 78 39 61 37)
(Fax: +44  20 78 39 65 33)
E-mail: team@phacilitate.co.uk]]></description>
<guid>564</guid>
</item>
<item>
<title>Human and Veterinary Vaccinology</title>
<link>http://www.drugdiscoverytoday.com/view/771/human-and-veterinary-vaccinology/</link>
<description><![CDATA[<strong>From:</strong> 09 November 2009<br /><strong>To:</strong> 13 November 2009<br /><br />Department for Continuing Education, University of Oxford, UK. The Human and Veterinary Vaccinology course is a one-week Master’s level course designed to stand alone and cover all aspects of vaccinology. This training course will provide students with: 

An overview of the field of human and veterinary vaccinology, from Edward Jenner to modern day vaccines. 

An understanding of the immune system and immune mechanisms needed to provide protection from disease. 

An understanding of the recent advances that have been made in the vaccine field and appreciation of the impact of molecular immunology and pathogen genomics on vaccine development. 

An overview of the molecular methods used for the design and construction of vaccines. 

An appreciation of the importance of pre-clinical testing and the many factors involved in the selection of animal models. 

The ability to understand and interpret the bioassays used to measure vaccine immunogenicity and to understand how immunogenicity correlates with protection. 
An understanding of the role of veterinary vaccines in animal heath, animal welfare, environmental protection and public health. 

An understanding of the vaccine development pathway - from bench to market. 

An overview of the ethical issues surrounding vaccine development and deployment]]></description>
<guid>771</guid>
</item>
<item>
<title>5th Annual Developing IP Strategies for Crystalline Forms</title>
<link>http://www.drugdiscoverytoday.com/view/876/5th-annual-developing-ip-strategies-for-crystalline-forms/</link>
<description><![CDATA[<strong>From:</strong> 09 November 2009<br /><strong>To:</strong> 11 October 2009<br /><br />Regus Conference Centre, 1 Broadgate Circus, London. ]]></description>
<guid>876</guid>
</item>
<item>
<title>Translational Medicine Initiative // 2009 Meeting</title>
<link>http://www.drugdiscoverytoday.com/view/815/translational-medicine-initiative-2009-meeting/</link>
<description><![CDATA[<strong>From:</strong> 11 November 2009<br /><strong>To:</strong> 12 November 2009<br /><br />M&#246;venpick Hotel Z&#252;rich-Regensdorf, Zurich, Switzerland. This meeting will not be a best practice conference with standard speaking slots and power point presentations. Yes, we have leading thinkers in this space on our speaker panel – but delegates in attendance will be as much a part of the meeting as these speakers. Discussion, debate and scrutiny will be the order of the meeting. This is your chance to be part of an Initiative to test theories, discuss successful models and collaborations and ultimately use the take-aways from these discussions to take your Discovery and Development process to the next level. 

]]></description>
<guid>815</guid>
</item>
<item>
<title>The 10th Annual Pharmaceutical Regulatory and Compliance Congress</title>
<link>http://www.drugdiscoverytoday.com/view/792/the-10th-annual-pharmaceutical-regulatory-and-compliance-congress/</link>
<description><![CDATA[<strong>From:</strong> 11 November 2009<br /><strong>To:</strong> 13 November 2009<br /><br />JW Marriott Hotel, Washington, DC. ]]></description>
<guid>792</guid>
</item>
<item>
<title>De-Risking Next Generation Biologics</title>
<link>http://www.drugdiscoverytoday.com/view/841/derisking-next-generation-biologics/</link>
<description><![CDATA[<strong>From:</strong> 12 November 2009<br /><strong>To:</strong> 13 November 2009<br /><br />Hyatt Regency Bethesda, Bethesda, MD, USA. ]]></description>
<guid>841</guid>
</item>
<item>
<title>Meeting the Needs of Patients – Pharmacy and Mental Health Care</title>
<link>http://www.drugdiscoverytoday.com/view/717/meeting-the-needs-of-patients-pharmacy-and-mental-health-care/</link>
<description><![CDATA[<strong>From:</strong> 12 November 2009<br /><strong>To:</strong> 01 January 1800<br /><br />The Royal Pharmaceutical Society of Great Britain, London, UK . ]]></description>
<guid>717</guid>
</item>
<item>
<title>Translating Behaviour Bridging Clinical and Animal Model Research </title>
<link>http://www.drugdiscoverytoday.com/view/565/translating-behaviour-bridging-clinical-and-animal-model-research-/</link>
<description><![CDATA[<strong>From:</strong> 14 November 2009<br /><strong>To:</strong> 16 November 2009<br /><br />EMBL Heidelberg, Germany. (Tel: +49 62 21 38 78 83 6)
(Fax: +49 62 21 38 78 15 8)
E-mail: conferences@embl.de ]]></description>
<guid>565</guid>
</item>
<item>
<title>COPD: Novel Therapeutics and Management Strategies </title>
<link>http://www.drugdiscoverytoday.com/view/566/copd-novel-therapeutics-and-management-strategies-/</link>
<description><![CDATA[<strong>From:</strong> 16 November 2009<br /><strong>To:</strong> 17 November 2009<br /><br />Le M&#233;ridien , Munich, Germany. (Tel: +44  87 09 09 07 12)
(Fax: +44  87 09 09 07 11)
E-mail: enquire@ipqc.co.uk ]]></description>
<guid>566</guid>
</item>
<item>
<title>Stem Cells USA &amp; Regenerative Medicine Congress 2009</title>
<link>http://www.drugdiscoverytoday.com/view/587/stem-cells-usa-regenerative-medicine-congress-2009/</link>
<description><![CDATA[<strong>From:</strong> 16 November 2009<br /><strong>To:</strong> 18 November 2009<br /><br />Westin City Center, Washington D.C.. (Tel: +1 212 379 6320)
(Fax: +1 212 379 6319)
E-mail stefanie.baronoff@terrapinn.com ]]></description>
<guid>587</guid>
</item>
<item>
<title>Cell Based Assays </title>
<link>http://www.drugdiscoverytoday.com/view/567/cell-based-assays-/</link>
<description><![CDATA[<strong>From:</strong> 18 November 2009<br /><strong>To:</strong> 19 November 2009<br /><br />Crowne Plaza Hotel, St James, London, United Kingdom. (Tel: +44  87 09 09 07 11)
(Fax: +44  87 09 09 07 12)
E-mail: eclient_services@smi-online.co.uk]]></description>
<guid>567</guid>
</item>
<item>
<title>Influenza Congress USA 2009</title>
<link>http://www.drugdiscoverytoday.com/view/580/influenza-congress-usa-2009/</link>
<description><![CDATA[<strong>From:</strong> 18 November 2009<br /><strong>To:</strong> 20 November 2009<br /><br />Westin Washington DC City Center, Washington DC, USA. (Tel: +1 212 379 6320)
(Fax: +1 212 379 6319)
E-mail stefanie.baronoff@terrapinn.com ]]></description>
<guid>580</guid>
</item>
<item>
<title>Probe Discovery</title>
<link>http://www.drugdiscoverytoday.com/view/756/probe-discovery/</link>
<description><![CDATA[<strong>From:</strong> 19 November 2009<br /><strong>To:</strong> 20 November 2009<br /><br />La Jolla, CA, USA. ]]></description>
<guid>756</guid>
</item>
<item>
<title>Tableting Technology for the Pharmaceutical Industry</title>
<link>http://www.drugdiscoverytoday.com/view/568/tableting-technology-for-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 23 November 2009<br /><strong>To:</strong> 25 November 2009<br /><br />The Moller Centre, Cambridge, UK. (Tel: +44  20 75 72 26 40)
E-mail: events@rpsgb.org]]></description>
<guid>568</guid>
</item>
<item>
<title>Novel enzyme targets and pathways</title>
<link>http://www.drugdiscoverytoday.com/view/791/novel-enzyme-targets-and-pathways/</link>
<description><![CDATA[<strong>From:</strong> 25 November 2009<br /><strong>To:</strong> 26 November 2009<br /><br />Danubius Hotel Regents Park, London, UK. ]]></description>
<guid>791</guid>
</item>
<item>
<title>Clinical Trials in CNS</title>
<link>http://www.drugdiscoverytoday.com/view/811/clinical-trials-in-cns/</link>
<description><![CDATA[<strong>From:</strong> 25 November 2009<br /><strong>To:</strong> 26 November 2009<br /><br />Crowne Plaza Hotel – St James’, London, UK. ]]></description>
<guid>811</guid>
</item>
<item>
<title>European Antibody Congress 2009</title>
<link>http://www.drugdiscoverytoday.com/view/892/european-antibody-congress-2009/</link>
<description><![CDATA[<strong>From:</strong> 30 November 2009<br /><strong>To:</strong> 02 December 2009<br /><br />Crowne Plaza Hotel, Geneva, Switzerland. ]]></description>
<guid>892</guid>
</item>
<item>
<title>Clinically relevant Drug Transporters</title>
<link>http://www.drugdiscoverytoday.com/view/875/clinically-relevant-drug-transporters/</link>
<description><![CDATA[<strong>From:</strong> 30 November 2009<br /><strong>To:</strong> 02 December 2009<br /><br />M&#246;venpick Hotel Berlin, Berlin, Germany. ]]></description>
<guid>875</guid>
</item>
<item>
<title>CPhi India 2009</title>
<link>http://www.drugdiscoverytoday.com/view/888/cphi-india-2009/</link>
<description><![CDATA[<strong>From:</strong> 01 December 2009<br /><strong>To:</strong> 03 December 2009<br /><br />Bombay Exhibition Centre, Mumbai, India. ]]></description>
<guid>888</guid>
</item>
<item>
<title>Biosimilars India 2009</title>
<link>http://www.drugdiscoverytoday.com/view/891/biosimilars-india-2009/</link>
<description><![CDATA[<strong>From:</strong> 01 December 2009<br /><strong>To:</strong> 02 December 2009<br /><br />Bombay Exhibition Centre, Mumbai, India. ]]></description>
<guid>891</guid>
</item>
<item>
<title>EMEA Joint Meeting with TOPRA: Evolution to the next Step– The Needs of the Future?</title>
<link>http://www.drugdiscoverytoday.com/view/996/emea-joint-meeting-with-topra-evolution-to-the-next-step-the-needs-of-the-future/</link>
<description><![CDATA[<strong>From:</strong> 01 December 2009<br /><strong>To:</strong> 02 December 2009<br /><br />East Wintergarden, Canary Wharf, London, UK . The 4th annual EMEA round-up of the year and look towards the next year - a firm favourite with many European regulatory affairs personnel as the key year-end event to reflect on the year gone by and to plan for the upcoming year.]]></description>
<guid>996</guid>
</item>
<item>
<title>Informa Life Sciences 10th Annual EuroTides 2009</title>
<link>http://www.drugdiscoverytoday.com/view/976/informa-life-sciences-10th-annual-eurotides-2009/</link>
<description><![CDATA[<strong>From:</strong> 02 December 2009<br /><strong>To:</strong> 03 December 2009<br /><br />Holiday Inn Lijnden Schiphol, Amsterdam, Netherlands. ]]></description>
<guid>976</guid>
</item>
<item>
<title>Cold Chain Distribution</title>
<link>http://www.drugdiscoverytoday.com/view/762/cold-chain-distribution/</link>
<description><![CDATA[<strong>From:</strong> 02 December 2009<br /><strong>To:</strong> 03 December 2009<br /><br /> Marriott Regents Park, London, UK. The dangers associated with temperature sensitive products going out of range are well documented and serious - this conference will help you to avoid these unnecessary costs.

The conference will be covering a wide range of topics, including:

Managing costs in the face of rising energy prices  
Enhancing packaging  
Temperature logging  
Environmental sustainability  
Risk assessments for efficiency 
Ambient temperature storage and transport 
]]></description>
<guid>762</guid>
</item>
<item>
<title>Pre-clinical and Clinical Safety Testing for New Drugs</title>
<link>http://www.drugdiscoverytoday.com/view/734/preclinical-and-clinical-safety-testing-for-new-drugs/</link>
<description><![CDATA[<strong>From:</strong> 02 December 2009<br /><strong>To:</strong> 03 December 2009<br /><br />Swisshotel Le Plaza, Basel, Switzerland. Making better 'go/no-go' decisions whilst ensuring regulatory compliance.]]></description>
<guid>734</guid>
</item>
<item>
<title>An Introduction to Immunogenicity</title>
<link>http://www.drugdiscoverytoday.com/view/764/an-introduction-to-immunogenicity/</link>
<description><![CDATA[<strong>From:</strong> 02 December 2009<br /><strong>To:</strong> 03 December 2009<br /><br />Regus Victoria, London, UK. Performance &amp; knowledge objectives of this course:
Understand the basic principles behind immunogenicity
Detect, minimise, and identify the root cause of protein immunogenicity as early as possible
Discuss the advantages/disadvantages of various assay platforms used to detect and characterise unwanted immunogenicity
Appreciate the impact of immunogenicity on PK, efficacy, and safety
Interpret the latest EU and US regulatory guidelines
.Discover successful strategies for validating immunogenicity assays for both pre-clinical and clinical studies
]]></description>
<guid>764</guid>
</item>
<item>
<title>Comparability for Biologics</title>
<link>http://www.drugdiscoverytoday.com/view/765/comparability-for-biologics/</link>
<description><![CDATA[<strong>From:</strong> 03 December 2009<br /><strong>To:</strong> 04 August 2009<br /><br />Regus Victoria, London, UK. Process changes made during the manufacture of recombinant proteins can have profound implications. This 2-day practical course provides valuable insight into the quality, safety, efficacy and regulatory impact of manufacturing changes. Delegates will also learn how to manage process change to ensure regulatory compliance and product consistency at all times. 

Key performance objectives of this course:

Gain insight into the inter-relationship between process change, quality, safety and efficacy
Examine the importance of change control, Good Manufacturing Practice (GMP) and the potential of Process Analytical Technology (PAT)
Discuss the potential significance of various process changes and how these may impact the quality of your products
Understand the physicochemical and biological tools available to monitor the impact of process change
Analyse the US and EU regulatory requirements following process change]]></description>
<guid>765</guid>
</item>
<item>
<title>Dermatological Advances</title>
<link>http://www.drugdiscoverytoday.com/view/846/dermatological-advances/</link>
<description><![CDATA[<strong>From:</strong> 03 December 2009<br /><strong>To:</strong> 04 December 2009<br /><br />BSG House, London, UK. ]]></description>
<guid>846</guid>
</item>
<item>
<title>The Role of Natural Products in Drug Discovery in Drug</title>
<link>http://www.drugdiscoverytoday.com/view/718/the-role-of-natural-products-in-drug-discovery-in-drug/</link>
<description><![CDATA[<strong>From:</strong> 04 December 2009<br /><strong>To:</strong> 01 January 1800<br /><br />Royal Pharmaceutical Society of Great Britain, London, UK. ]]></description>
<guid>718</guid>
</item>
<item>
<title>Antibody Engineering</title>
<link>http://www.drugdiscoverytoday.com/view/839/antibody-engineering/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2009<br /><strong>To:</strong> 10 December 2009<br /><br />Sheraton San Diego Hotel and Marina, CA USA. The 2009 program couples scientific content showcasing basic science research developments with presentations on the progression of industry antibody-based drug products into and through clinical development.

]]></description>
<guid>839</guid>
</item>
<item>
<title>2nd Annual Developments in Drug Safety</title>
<link>http://www.drugdiscoverytoday.com/view/804/2nd-annual-developments-in-drug-safety/</link>
<description><![CDATA[<strong>From:</strong> 07 December 2009<br /><strong>To:</strong> 08 December 2009<br /><br />Grand Hyatt, Washington DC, USA. Hear from industry experts on best practices for completing REMS 

Learn about new developments and how to prepare for them now 

Learn how to incorporate safety measures at every step of the development process 

Prepare yourself by learning from tried and tested methods of drug safety
]]></description>
<guid>804</guid>
</item>
<item>
<title>Antibody Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/840/antibody-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 08 December 2009<br /><strong>To:</strong> 10 December 2009<br /><br />Sheraton San Diego Hotel and Marina, CA, USA. Antibody Therapeutics Session for 2009 includes new presentations on:

Business, Regulatory and Intellectual Property 
Clinical Development for Cancer 
Clinical Development: Alzheimer's and Others 
Clinical Development: Autoimmune Diseases 
Clinical Development: Inflammation and Infection 
Preclinical Development of Antibody Therapeutics 
]]></description>
<guid>840</guid>
</item>
<item>
<title>Exploratory Clinical Trials 2009</title>
<link>http://www.drugdiscoverytoday.com/view/749/exploratory-clinical-trials-2009/</link>
<description><![CDATA[<strong>From:</strong> 08 December 2009<br /><strong>To:</strong> 09 December 2009<br /><br />Brussels, Belgium. ]]></description>
<guid>749</guid>
</item>
<item>
<title>Drug Delivery to the Lungs - DDL20</title>
<link>http://www.drugdiscoverytoday.com/view/812/drug-delivery-to-the-lungs-ddl20/</link>
<description><![CDATA[<strong>From:</strong> 09 December 2009<br /><strong>To:</strong> 11 December 2009<br /><br />The Edinburgh International Conference Centre, The Exchange, Edinburgh EH3 8EE, Scotland, UK. ]]></description>
<guid>812</guid>
</item>
<item>
<title>Genesis 2009 The Leading Biotechnology Partnering Conference</title>
<link>http://www.drugdiscoverytoday.com/view/911/genesis-2009-the-leading-biotechnology-partnering-conference/</link>
<description><![CDATA[<strong>From:</strong> 10 December 2009<br /><strong>To:</strong> 11 December 2009<br /><br />QE II Conference Centre, London, United Kingdom. ]]></description>
<guid>911</guid>
</item>
<item>
<title>The Society for Medicines Research Conference on:  &quot;Recent Disclosures of Clinical Candidates&quot;.</title>
<link>http://www.drugdiscoverytoday.com/view/803/the-society-for-medicines-research-conference-on-recent-disclosures-of-clinical-candidates/</link>
<description><![CDATA[<strong>From:</strong> 10 December 2009<br /><strong>To:</strong> 01 January 1800<br /><br />National Heart &amp; Lung Institute, Kensington, London. ]]></description>
<guid>803</guid>
</item>
<item>
<title>2nd DIA Conference for Harmonization of Risk Management Plans</title>
<link>http://www.drugdiscoverytoday.com/view/1039/2nd-dia-conference-for-harmonization-of-risk-management-plans/</link>
<description><![CDATA[<strong>From:</strong> 10 December 2009<br /><strong>To:</strong> 11 December 2009<br /><br />Washington Marriott Hotel 1221 22nd Street NW Washington, DC 20037-1294 . This conference will teach you how to identify and organize essential components of an RMP vis-&#225;-vis well-described risks, poorly understood risks, and certain potential risks of products, which may be made available to patients and healthcare providers in different regions of the world. It includes hands-on exercises in addition to didactic presentations, interactive examples, and panel discussions.]]></description>
<guid>1039</guid>
</item>
<item>
<title>Developing Personalised Cancer Therapies</title>
<link>http://www.drugdiscoverytoday.com/view/838/developing-personalised-cancer-therapies/</link>
<description><![CDATA[<strong>From:</strong> 11 December 2009<br /><strong>To:</strong> 01 January 1800<br /><br />London, UK. In this master class a general introduction into designing trials with personalised cancer treatments will be provided. Background information will be given on pharmacogenetics, pharmacogenomics, targeted therapies, biomarker development and patient enrichment.  Ideally trials based on personalized cancer treatment should include patients that are most likely to respond and exclude patients that are pre-disposed to toxicity. Best practices in contemporary development of targeted anti-cancer agents will be highlighted.  This will result in a discussion about optimizing designs for trials with new agents, finding the best dosing regimens en selection the correct subpopulation to include in “enriched” studies. Finally, some future diagnostics methods (e.g. based on genetic profiling) will be presented.

]]></description>
<guid>838</guid>
</item>
<item>
<title>First International Conference on Metal Chelation in Biology and Medicine</title>
<link>http://www.drugdiscoverytoday.com/view/719/first-international-conference-on-metal-chelation-in-biology-and-medicine/</link>
<description><![CDATA[<strong>From:</strong> 11 December 2009<br /><strong>To:</strong> 14 December 2009<br /><br />University of Bath, Bath, UK. ]]></description>
<guid>719</guid>
</item>
<item>
<title>Advances in Biopharmaceuticals</title>
<link>http://www.drugdiscoverytoday.com/view/966/advances-in-biopharmaceuticals/</link>
<description><![CDATA[<strong>From:</strong> 08 January 2010<br /><strong>To:</strong> 13 January 2010<br /><br />Zermatt Resort &amp; Spa, Midway, Utah. ]]></description>
<guid>966</guid>
</item>
<item>
<title>Keystone Symposia: Structural Genomics: Expanding the Horizons of Structural Biology</title>
<link>http://www.drugdiscoverytoday.com/view/967/keystone-symposia-structural-genomics-expanding-the-horizons-of-structural-biology/</link>
<description><![CDATA[<strong>From:</strong> 08 January 2010<br /><strong>To:</strong> 13 January 2010<br /><br />Beaver Run Resort, Breckenridge, Colorado, USA. Joint with meeting on Structural Biology]]></description>
<guid>967</guid>
</item>
<item>
<title>9th DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies</title>
<link>http://www.drugdiscoverytoday.com/view/1040/9th-dia-conference-for-contemporary-pharmacovigilance-and-risk-management-strategies/</link>
<description><![CDATA[<strong>From:</strong> 10 January 2010<br /><strong>To:</strong> 13 January 2010<br /><br />Renaissance Washington, DC Hotel, 999 9th Street NW, Washington, DC 20001-9000   . Robust drug safety systems and processes and thorough ongoing safety surveillance are more critical than ever in the development and evaluation of the safe use of marketed medicinal products. This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.

]]></description>
<guid>1040</guid>
</item>
<item>
<title>Enhancing Host Expression</title>
<link>http://www.drugdiscoverytoday.com/view/884/enhancing-host-expression/</link>
<description><![CDATA[<strong>From:</strong> 11 January 2010<br /><strong>To:</strong> 12 January 2010<br /><br />Hotel Del Coronado, San Diego, CA, USA. ]]></description>
<guid>884</guid>
</item>
<item>
<title>Characterization Purification &amp; Screening</title>
<link>http://www.drugdiscoverytoday.com/view/885/characterization-purification-screening/</link>
<description><![CDATA[<strong>From:</strong> 13 January 2010<br /><strong>To:</strong> 14 January 2010<br /><br />Hotel Del Coronado, San Diego, CA, USA. ]]></description>
<guid>885</guid>
</item>
<item>
<title>Engineering Vectors &amp; Designing Clone Constructs</title>
<link>http://www.drugdiscoverytoday.com/view/886/engineering-vectors-designing-clone-constructs/</link>
<description><![CDATA[<strong>From:</strong> 14 January 2010<br /><strong>To:</strong> 15 January 2010<br /><br />Hotel Del Coronado, San Diego, CA, USA. ]]></description>
<guid>886</guid>
</item>
<item>
<title>Next Generation DNA Sequencing</title>
<link>http://www.drugdiscoverytoday.com/view/912/next-generation-dna-sequencing/</link>
<description><![CDATA[<strong>From:</strong> 18 January 2010<br /><strong>To:</strong> 20 January 2010<br /><br />Grand Connaught Rooms, London, UK. ]]></description>
<guid>912</guid>
</item>
<item>
<title>EMBL Workshop: Exploring Modular Protein Architecture 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1098/embl-workshop-exploring-modular-protein-architecture-2010/</link>
<description><![CDATA[<strong>From:</strong> 19 January 2010<br /><strong>To:</strong> 22 January 2010<br /><br />EMBL Heidelberg, Germany. A hands on bioinfomatics training workshop]]></description>
<guid>1098</guid>
</item>
<item>
<title>BioBusiness 2010</title>
<link>http://www.drugdiscoverytoday.com/view/790/biobusiness-2010/</link>
<description><![CDATA[<strong>From:</strong> 19 January 2010<br /><strong>To:</strong> 20 January 2010<br /><br />Tower Guoman, London, UK. Over 8 years BioBusiness has brought together over 2500 business development professionals and CEOs from pharma and biotech as well as key healthcare investors. BioBusiness 2009 showcased deals and experts from leading pharma such as GLAXOSMITHKLINE, MERCK, BAYER SCHERING, PFIZER and ASTELLAS.]]></description>
<guid>790</guid>
</item>
<item>
<title>Stem Cells &amp; Regenerative Medicine World Congress</title>
<link>http://www.drugdiscoverytoday.com/view/758/stem-cells-regenerative-medicine-world-congress/</link>
<description><![CDATA[<strong>From:</strong> 20 January 2010<br /><strong>To:</strong> 21 January 2010<br /><br />South San Francisco, CA, USA. ]]></description>
<guid>758</guid>
</item>
<item>
<title>The 2020 Allosteric and Orthosteric Modulator Congress: Advances in Clinical and Preclinical Development</title>
<link>http://www.drugdiscoverytoday.com/view/868/the-2020-allosteric-and-orthosteric-modulator-congress-advances-in-clinical-and-preclinical-development/</link>
<description><![CDATA[<strong>From:</strong> 25 January 2010<br /><strong>To:</strong> 26 January 2010<br /><br />Philadelphia, PA, USA. ]]></description>
<guid>868</guid>
</item>
<item>
<title>Anti-Infectives 2010</title>
<link>http://www.drugdiscoverytoday.com/view/873/antiinfectives-2010/</link>
<description><![CDATA[<strong>From:</strong> 25 January 2010<br /><strong>To:</strong> 27 January 2010<br /><br />Venue to be confirmed, Philadelphia, PA, USA. ]]></description>
<guid>873</guid>
</item>
<item>
<title>ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development</title>
<link>http://www.drugdiscoverytoday.com/view/750/adme-pktk-and-drug-metabolism-in-drug-discovery-and-development/</link>
<description><![CDATA[<strong>From:</strong> 26 January 2010<br /><strong>To:</strong> 27 January 2010<br /><br />Brussels, Belgium. The conference will include a two day exhibition, with exhibitors representing some of the industry's leading contract research organizations and biotech companies.
]]></description>
<guid>750</guid>
</item>
<item>
<title>Electronic Laboratory Notebooks</title>
<link>http://www.drugdiscoverytoday.com/view/918/electronic-laboratory-notebooks/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2010<br /><strong>To:</strong> 28 January 2010<br /><br />Crowne Plaza Hotel – St James, London.  ]]></description>
<guid>918</guid>
</item>
<item>
<title>Electronic Laboratory Notebooks</title>
<link>http://www.drugdiscoverytoday.com/view/869/electronic-laboratory-notebooks/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2010<br /><strong>To:</strong> 28 January 2010<br /><br />Crowne Plaza Hotel – St James, London, UK. ]]></description>
<guid>869</guid>
</item>
<item>
<title>Predictive Human Toxicity and ADME/Tox Studies</title>
<link>http://www.drugdiscoverytoday.com/view/802/predictive-human-toxicity-and-admetox-studies/</link>
<description><![CDATA[<strong>From:</strong> 28 January 2010<br /><strong>To:</strong> 29 January 2010<br /><br />Brussels, Belgium. ]]></description>
<guid>802</guid>
</item>
<item>
<title>Third Annual Biomarkers Summit</title>
<link>http://www.drugdiscoverytoday.com/view/906/third-annual-biomarkers-summit/</link>
<description><![CDATA[<strong>From:</strong> 01 February 2010<br /><strong>To:</strong> 02 February 2010<br /><br />Crowne Plaza, St. James, London, United Kingdom. ]]></description>
<guid>906</guid>
</item>
<item>
<title>Second International Conference on Drug Discovery and Therapy</title>
<link>http://www.drugdiscoverytoday.com/view/570/second-international-conference-on-drug-discovery-and-therapy/</link>
<description><![CDATA[<strong>From:</strong> 01 February 2010<br /><strong>To:</strong> 04 February 2010<br /><br />Dubai, UAE. (Tel: +971  65 57 11 32)
(Fax: +971  65 57 11 34)
E-mail: info@icddt.com]]></description>
<guid>570</guid>
</item>
<item>
<title>Clinical Outsourcing World</title>
<link>http://www.drugdiscoverytoday.com/view/903/clinical-outsourcing-world/</link>
<description><![CDATA[<strong>From:</strong> 02 February 2010<br /><strong>To:</strong> 05 February 2010<br /><br />Victoria Park Plaza, London, United Kingdom. ]]></description>
<guid>903</guid>
</item>
<item>
<title>5th Workshop in a Series on Pharmacogenomics: Generating and Weighing Evidence in Drug Development and Regulatory Decision Making</title>
<link>http://www.drugdiscoverytoday.com/view/1041/5th-workshop-in-a-series-on-pharmacogenomics-generating-and-weighing-evidence-in-drug-development-and-regulatory-decision-making/</link>
<description><![CDATA[<strong>From:</strong> 02 February 2010<br /><strong>To:</strong> 04 February 2010<br /><br />Marriott Bethesda North Hotel, 5701 Marinelli Road, North Bethesda, MD 20852-2785   . ]]></description>
<guid>1041</guid>
</item>
<item>
<title>Clinical Outsourcing World. Europe 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1101/clinical-outsourcing-world-europe-2010/</link>
<description><![CDATA[<strong>From:</strong> 02 February 2010<br /><strong>To:</strong> 05 February 2010<br /><br />Victoria Park Plaza, London, UK. ]]></description>
<guid>1101</guid>
</item>
<item>
<title>Adaptive Designs in Clinical Drug Development</title>
<link>http://www.drugdiscoverytoday.com/view/902/adaptive-designs-in-clinical-drug-development/</link>
<description><![CDATA[<strong>From:</strong> 03 February 2010<br /><strong>To:</strong> 04 February 2010<br /><br />Crowne Plaza St. James, London, UK. ]]></description>
<guid>902</guid>
</item>
<item>
<title>Molecular Medicine Tri-Conference 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1100/molecular-medicine-triconference-2010/</link>
<description><![CDATA[<strong>From:</strong> 03 February 2010<br /><strong>To:</strong> 05 February 2010<br /><br />Moscone North Convention Center, San Francisco, CA, USA. ]]></description>
<guid>1100</guid>
</item>
<item>
<title>Immunogenicity for Biologics</title>
<link>http://www.drugdiscoverytoday.com/view/866/immunogenicity-for-biologics/</link>
<description><![CDATA[<strong>From:</strong> 08 February 2010<br /><strong>To:</strong> 12 February 2010<br /><br />Movenpick Prague, Czech Republic. ]]></description>
<guid>866</guid>
</item>
<item>
<title>Pharmaceutical Parallel Trade</title>
<link>http://www.drugdiscoverytoday.com/view/1096/pharmaceutical-parallel-trade/</link>
<description><![CDATA[<strong>From:</strong> 10 February 2010<br /><strong>To:</strong> 11 February 2010<br /><br />Crowne Plaza Hotel, London St. James, UK. ]]></description>
<guid>1096</guid>
</item>
<item>
<title>Screening MedChem and ADMET Europe</title>
<link>http://www.drugdiscoverytoday.com/view/720/screening-medchem-and-admet-europe/</link>
<description><![CDATA[<strong>From:</strong> 11 February 2010<br /><strong>To:</strong> 12 February 2010<br /><br />Barcelona, Spain. ]]></description>
<guid>720</guid>
</item>
<item>
<title>Antiobiotics and Resistance: Challenges and Solutions</title>
<link>http://www.drugdiscoverytoday.com/view/968/antiobiotics-and-resistance-challenges-and-solutions/</link>
<description><![CDATA[<strong>From:</strong> 14 February 2010<br /><strong>To:</strong> 19 February 2010<br /><br />Hilton Santa Fe/Historic Plaza, Santa Fe, New Mexico, USA. February 14-19, 2010

]]></description>
<guid>968</guid>
</item>
<item>
<title>Stem Cells 2010</title>
<link>http://www.drugdiscoverytoday.com/view/890/stem-cells-2010/</link>
<description><![CDATA[<strong>From:</strong> 15 February 2010<br /><strong>To:</strong> 16 February 2010<br /><br />Crowne Plaza Hotel - St James, London, United Kingdom.. ]]></description>
<guid>890</guid>
</item>
<item>
<title>23rd Annual DIA Conference for Electronic Document Management: Global Content Management in an Electronic World</title>
<link>http://www.drugdiscoverytoday.com/view/1042/23rd-annual-dia-conference-for-electronic-document-management-global-content-management-in-an-electronic-world/</link>
<description><![CDATA[<strong>From:</strong> 16 February 2010<br /><strong>To:</strong> 19 February 2010<br /><br />Gaylord National Resort &amp; Convention Center, 201 Waterfront Street, National Harbor, MD 20745   . ]]></description>
<guid>1042</guid>
</item>
<item>
<title>Stability testing of pharmaceuticals</title>
<link>http://www.drugdiscoverytoday.com/view/908/stability-testing-of-pharmaceuticals/</link>
<description><![CDATA[<strong>From:</strong> 22 February 2010<br /><strong>To:</strong> 24 February 2010<br /><br />The Moller Centre, Cambridge, UK. ]]></description>
<guid>908</guid>
</item>
<item>
<title>Advances and Progress in Drug Design VIII</title>
<link>http://www.drugdiscoverytoday.com/view/917/advances-and-progress-in-drug-design-viii/</link>
<description><![CDATA[<strong>From:</strong> 22 February 2010<br /><strong>To:</strong> 23 February 2010<br /><br />Crowne Plaza Hotel - St James, London, UK . ]]></description>
<guid>917</guid>
</item>
<item>
<title>2nd Annual Disposable Solutions for Biomanufacturing</title>
<link>http://www.drugdiscoverytoday.com/view/877/2nd-annual-disposable-solutions-for-biomanufacturing/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2010<br /><strong>To:</strong> 24 February 2010<br /><br />Grand Connaught Rooms, London, UK. ]]></description>
<guid>877</guid>
</item>
<item>
<title>Phase I Clinical Trials</title>
<link>http://www.drugdiscoverytoday.com/view/1102/phase-i-clinical-trials/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2010<br /><strong>To:</strong> 24 February 2010<br /><br />Park Plaza Victoria, London, UK. ]]></description>
<guid>1102</guid>
</item>
<item>
<title>Antibody Engineering &amp; Design</title>
<link>http://www.drugdiscoverytoday.com/view/940/antibody-engineering-design/</link>
<description><![CDATA[<strong>From:</strong> 24 February 2010<br /><strong>To:</strong> 25 February 2010<br /><br />Marriot Courtyard Frankfurt Messe, Germany. An agenda designed to accelerate therapeutic antibody development and delivered by the world’s leading antibody experts and companies]]></description>
<guid>940</guid>
</item>
<item>
<title>Antibody Engineering &amp; Design</title>
<link>http://www.drugdiscoverytoday.com/view/941/antibody-engineering-design/</link>
<description><![CDATA[<strong>From:</strong> 24 February 2010<br /><strong>To:</strong> 25 February 2010<br /><br />Marriot Courtyard Frankfurt Messe, Germany. An agenda designed to accelerate therapeutic antibody development and delivered by the world’s leading antibody experts and companies]]></description>
<guid>941</guid>
</item>
<item>
<title>Predictive Toxicology</title>
<link>http://www.drugdiscoverytoday.com/view/915/predictive-toxicology/</link>
<description><![CDATA[<strong>From:</strong> 24 February 2010<br /><strong>To:</strong> 25 February 2010<br /><br />Grand Connaught Rooms, London, United Kingdom. ]]></description>
<guid>915</guid>
</item>
<item>
<title>Visualizing Biological Data (VizBi)</title>
<link>http://www.drugdiscoverytoday.com/view/572/visualizing-biological-data-vizbi/</link>
<description><![CDATA[<strong>From:</strong> 03 March 2010<br /><strong>To:</strong> 05 March 2010<br /><br />Advanced Training Centre, EMBL, Heidelberg, Germany. (Tel: +49 62 21 38 78 39 7)
(Fax: +49 62 21 38 78 15 8)
E-mail: conferences@embl.de ]]></description>
<guid>572</guid>
</item>
<item>
<title>8th International Symposium on Targeted Anticancer Therapies</title>
<link>http://www.drugdiscoverytoday.com/view/995/8th-international-symposium-on-targeted-anticancer-therapies/</link>
<description><![CDATA[<strong>From:</strong> 04 March 2010<br /><strong>To:</strong> 06 March 2010<br /><br />Bethesda, MD, USA. Sponsoring organizations: National Cancer Institute (NCI), the European Society for Medical Oncology (ESMO)]]></description>
<guid>995</guid>
</item>
<item>
<title>Quality by Design for analytical methods: a revolution in method lifecycle management?</title>
<link>http://www.drugdiscoverytoday.com/view/909/quality-by-design-for-analytical-methods-a-revolution-in-method-lifecycle-management/</link>
<description><![CDATA[<strong>From:</strong> 04 March 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Royal Pharmaceutical Society of Great Britain. ]]></description>
<guid>909</guid>
</item>
<item>
<title>ELRIG Meeting on: Liquid Handling and Label-Free Detection Technologies</title>
<link>http://www.drugdiscoverytoday.com/view/907/elrig-meeting-on-liquid-handling-and-labelfree-detection-technologies/</link>
<description><![CDATA[<strong>From:</strong> 04 March 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Whittlebury Hall, nr. Silverstone, UK. ]]></description>
<guid>907</guid>
</item>
<item>
<title>7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology</title>
<link>http://www.drugdiscoverytoday.com/view/867/7th-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology/</link>
<description><![CDATA[<strong>From:</strong> 08 March 2010<br /><strong>To:</strong> 11 March 2010<br /><br />The Mediterranean Conference Centre, Valetta, Malta. ]]></description>
<guid>867</guid>
</item>
<item>
<title>Global Discovery &amp; Development Innovation Forum</title>
<link>http://www.drugdiscoverytoday.com/view/961/global-discovery-development-innovation-forum/</link>
<description><![CDATA[<strong>From:</strong> 08 March 2010<br /><strong>To:</strong> 09 March 2010<br /><br />Edinburgh. ]]></description>
<guid>961</guid>
</item>
<item>
<title>Polymorphism &amp; Crystallisation 2010</title>
<link>http://www.drugdiscoverytoday.com/view/878/polymorphism-crystallisation-2010/</link>
<description><![CDATA[<strong>From:</strong> 09 March 2010<br /><strong>To:</strong> 11 March 2010<br /><br />Venue to be confirmed, London, UK . ]]></description>
<guid>878</guid>
</item>
<item>
<title>Imaging in Oncology</title>
<link>http://www.drugdiscoverytoday.com/view/1449/imaging-in-oncology/</link>
<description><![CDATA[<strong>From:</strong> 10 March 2010<br /><strong>To:</strong> 11 March 2010<br /><br />Crowne Plaza St. James Hotel, London. ]]></description>
<guid>1449</guid>
</item>
<item>
<title>Respiratory Disorders Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1074/respiratory-disorders-conference/</link>
<description><![CDATA[<strong>From:</strong> 10 March 2010<br /><strong>To:</strong> 11 March 2010<br /><br />BSG Conference Centre, London, UK. ]]></description>
<guid>1074</guid>
</item>
<item>
<title>BIO-Europe Spring&#174; 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1949/bioeurope-spring-2011/</link>
<description><![CDATA[<strong>From:</strong> 14 March 2010<br /><strong>To:</strong> 16 March 2010<br /><br />Milano Convention Centre, Milan, Italy. BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities.
Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE&#174;, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
]]></description>
<guid>1949</guid>
</item>
<item>
<title>Pharmacovigilance </title>
<link>http://www.drugdiscoverytoday.com/view/1200/pharmacovigilance-/</link>
<description><![CDATA[<strong>From:</strong> 15 March 2010<br /><strong>To:</strong> 16 March 2010<br /><br />Crowne Plaza London - St James, UK . 

]]></description>
<guid>1200</guid>
</item>
<item>
<title>Pharma R&amp;D Partnering World Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/823/pharma-rd-partnering-world-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 16 March 2010<br /><strong>To:</strong> 19 March 2010<br /><br />Raffles City Convention Centre, Singapore. ]]></description>
<guid>823</guid>
</item>
<item>
<title>Biologic Manufacturing World Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/824/biologic-manufacturing-world-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 16 March 2010<br /><strong>To:</strong> 19 March 2010<br /><br />Raffles City Convention Centre, Singapore. ]]></description>
<guid>824</guid>
</item>
<item>
<title>Pharma &amp; Biotech Supply Chain Management World Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/825/pharma-biotech-supply-chain-management-world-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 16 March 2010<br /><strong>To:</strong> 19 March 2010<br /><br />Raffles City Convention Centre, Singapore. ]]></description>
<guid>825</guid>
</item>
<item>
<title>Biomedica Life Science Summit</title>
<link>http://www.drugdiscoverytoday.com/view/1099/biomedica-life-science-summit/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />Aachen, Germany. ]]></description>
<guid>1099</guid>
</item>
<item>
<title>8th Annual Congress: G Protein-Coupled Receptors in Drug Discovery </title>
<link>http://www.drugdiscoverytoday.com/view/1095/8th-annual-congress-g-proteincoupled-receptors-in-drug-discovery-/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />Maritim proArte Hotel, Berlin, Germany. ]]></description>
<guid>1095</guid>
</item>
<item>
<title>Drug Discovery Technology World Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/816/drug-discovery-technology-world-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />Raffles City Convention Center, Singapore Location Address: 2 Stamford Rd, Singapore ?178882. Drug Discovery Technology World Asia 2010 will bring together scientists and discovery technology providers from Asia and globally to discuss and share new tools, innovative methodologies and novel cutting-edge technologies that can be utilized to fast track biomarker research and drug discovery.

]]></description>
<guid>816</guid>
</item>
<item>
<title>Superbugs and Superdrugs</title>
<link>http://www.drugdiscoverytoday.com/view/1199/superbugs-and-superdrugs/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />Crowne Plaza St James Hotel, London. 
 


]]></description>
<guid>1199</guid>
</item>
<item>
<title>9th Annual PROTEIN KINASES CONGRESS</title>
<link>http://www.drugdiscoverytoday.com/view/999/9th-annual-protein-kinases-congress/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />Maritim proArte Hotel, Berlin, Germany. The 2010 programme will deliver the expert insights you need to enhance your protein kinase discovery and development programmes AND successfully progress products beyond Phase 1 clinical trials.  ]]></description>
<guid>999</guid>
</item>
<item>
<title>4th Annual: HIGH CONTENT ANALYSIS</title>
<link>http://www.drugdiscoverytoday.com/view/997/4th-annual-high-content-analysis/</link>
<description><![CDATA[<strong>From:</strong> 17 March 2010<br /><strong>To:</strong> 18 March 2010<br /><br />MARITIM proArte Hotel, Berlin, Germany . The latest developments in HCA assay design and the impact of HCA on drug discovery research.  An opportunity to explore the potential of HCA for in vitro toxicology studies, primary, stem, live and tissue cell screening, 3D imaging, bio therapeutic research and label free technologies.
]]></description>
<guid>997</guid>
</item>
<item>
<title>Keystone Symposia: Nucelar Receptors: Development, Physiology and Disease</title>
<link>http://www.drugdiscoverytoday.com/view/969/keystone-symposia-nucelar-receptors-development-physiology-and-disease/</link>
<description><![CDATA[<strong>From:</strong> 21 March 2010<br /><strong>To:</strong> 26 March 2010<br /><br />Keystone Resort, Keystone, Colorado, USA. Joint with meeting on Nuclear Receptors: Signaling, Gene Regulation and Cancer ]]></description>
<guid>969</guid>
</item>
<item>
<title>DIA/FDA CDER/CBER Computational Science Annual Meeting</title>
<link>http://www.drugdiscoverytoday.com/view/1043/diafda-cdercber-computational-science-annual-meeting/</link>
<description><![CDATA[<strong>From:</strong> 22 March 2010<br /><strong>To:</strong> 23 March 2010<br /><br />Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852   . ]]></description>
<guid>1043</guid>
</item>
<item>
<title>3rd Annual Oligonucleotides-Based Therapeutic Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1044/3rd-annual-oligonucleotidesbased-therapeutic-conference/</link>
<description><![CDATA[<strong>From:</strong> 22 March 2010<br /><strong>To:</strong> 24 March 2010<br /><br />DoubleTree Hotel and Executive Meeting Center, 8120 Wisconsin Avenue, Bethesda, MD 20814   . ]]></description>
<guid>1044</guid>
</item>
<item>
<title>Discovery Summit 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1183/discovery-summit-2010/</link>
<description><![CDATA[<strong>From:</strong> 22 March 2010<br /><strong>To:</strong> 24 March 2010<br /><br />The Majestic Barri&#232;re, Cannes, France. A world leading drug discovery event, the highly acclaimed 10th Annual Discovery Summit offers global perspectives on the challenges of innovative drug discovery and their respective solutions, organised by marcus evans.]]></description>
<guid>1183</guid>
</item>
<item>
<title>Keystone Symposia: New Paradigms in Cancer Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/970/keystone-symposia-new-paradigms-in-cancer-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 23 March 2010<br /><strong>To:</strong> 28 March 2010<br /><br />Victoria, British Columbia, Canada. Joint with meeting on Integration of evelopmental Signaling Pathways]]></description>
<guid>970</guid>
</item>
<item>
<title>2nd Annual World Vaccine Congress 2010</title>
<link>http://www.drugdiscoverytoday.com/view/721/2nd-annual-world-vaccine-congress-2010/</link>
<description><![CDATA[<strong>From:</strong> 24 March 2010<br /><strong>To:</strong> 26 March 2010<br /><br />Beijing International Convention Centre, Beijing, China. ]]></description>
<guid>721</guid>
</item>
<item>
<title>Improving Solubility 2010</title>
<link>http://www.drugdiscoverytoday.com/view/874/improving-solubility-2010/</link>
<description><![CDATA[<strong>From:</strong> 29 March 2010<br /><strong>To:</strong> 31 March 2010<br /><br />Venue to be confirmed, Philadelphia, PA, USA. ]]></description>
<guid>874</guid>
</item>
<item>
<title>BioFine Europe 2010 - The Peptide Conference 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1436/biofine-europe-2010-the-peptide-conference-2010/</link>
<description><![CDATA[<strong>From:</strong> 30 March 2010<br /><strong>To:</strong> 31 March 2010<br /><br />The Wellcome Trust Conference Centre, Cambridge, UK. ]]></description>
<guid>1436</guid>
</item>
<item>
<title>BioFine Europe 2010 - Synthetic Biology in Pharma</title>
<link>http://www.drugdiscoverytoday.com/view/1438/biofine-europe-2010-synthetic-biology-in-pharma/</link>
<description><![CDATA[<strong>From:</strong> 30 March 2010<br /><strong>To:</strong> 31 March 2010<br /><br />The Wellcome Trust Conference Centre, Cambridge, UK . ]]></description>
<guid>1438</guid>
</item>
<item>
<title>Keystone Symposia: G Protein-Coupled Receptors</title>
<link>http://www.drugdiscoverytoday.com/view/971/keystone-symposia-g-proteincoupled-receptors/</link>
<description><![CDATA[<strong>From:</strong> 07 April 2010<br /><strong>To:</strong> 12 April 2010<br /><br />Beaver Run Resort, Breckenridge, Colorado, USA. ]]></description>
<guid>971</guid>
</item>
<item>
<title>ADMET Europe</title>
<link>http://www.drugdiscoverytoday.com/view/722/admet-europe/</link>
<description><![CDATA[<strong>From:</strong> 08 April 2010<br /><strong>To:</strong> 09 April 2010<br /><br />Munich, Germany. ]]></description>
<guid>722</guid>
</item>
<item>
<title>Advances in Synthetic Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/723/advances-in-synthetic-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 08 April 2010<br /><strong>To:</strong> 09 April 2010<br /><br />Munich, Germany. ]]></description>
<guid>723</guid>
</item>
<item>
<title>MedChem Europe</title>
<link>http://www.drugdiscoverytoday.com/view/724/medchem-europe/</link>
<description><![CDATA[<strong>From:</strong> 08 April 2010<br /><strong>To:</strong> 09 April 2010<br /><br />Munich, Germany. ]]></description>
<guid>724</guid>
</item>
<item>
<title>SBS 16th Annual Conference &amp; Exhibition</title>
<link>http://www.drugdiscoverytoday.com/view/725/sbs-16th-annual-conference-exhibition/</link>
<description><![CDATA[<strong>From:</strong> 11 April 2010<br /><strong>To:</strong> 15 April 2010<br /><br />Phoenix, Arizona, USA. ]]></description>
<guid>725</guid>
</item>
<item>
<title>Natural Peptides to Drugs - NP2D • 4th International Congress</title>
<link>http://www.drugdiscoverytoday.com/view/1159/natural-peptides-to-drugs-np2d-4th-international-congress/</link>
<description><![CDATA[<strong>From:</strong> 11 April 2010<br /><strong>To:</strong> 14 April 2010<br /><br />Zermatt, Switzerland. NP2D focuses on cutting-edge aspects of peptide science, from discovery to market. The most exciting recent developments related to discovery programmes, molecular characterisation, target receptor identification, peptide-receptor mapping, molecular pharmacology, structure-function studies and protein engineering will be adressed by specialists with worldwide recognition.

]]></description>
<guid>1159</guid>
</item>
<item>
<title>Keystone Symposia: Diabetes</title>
<link>http://www.drugdiscoverytoday.com/view/972/keystone-symposia-diabetes/</link>
<description><![CDATA[<strong>From:</strong> 12 April 2010<br /><strong>To:</strong> 17 April 2010<br /><br />Whistler, British Columbia, Canada . Joint with meeting on Islet Biology ]]></description>
<guid>972</guid>
</item>
<item>
<title>National System of Biological Screening</title>
<link>http://www.drugdiscoverytoday.com/view/1528/national-system-of-biological-screening/</link>
<description><![CDATA[<strong>From:</strong> 13 April 2010<br /><strong>To:</strong> 01 January 1800<br /><br />International Science and Technology Center, Moscow, Russia. ]]></description>
<guid>1528</guid>
</item>
<item>
<title>Biopharmaceutical Change Control</title>
<link>http://www.drugdiscoverytoday.com/view/1546/biopharmaceutical-change-control/</link>
<description><![CDATA[<strong>From:</strong> 13 April 2010<br /><strong>To:</strong> 15 April 2010<br /><br />San Diego, CA, USA. ]]></description>
<guid>1546</guid>
</item>
<item>
<title>Human Antibodies and Hybridomas 2010</title>
<link>http://www.drugdiscoverytoday.com/view/726/human-antibodies-and-hybridomas-2010/</link>
<description><![CDATA[<strong>From:</strong> 14 April 2010<br /><strong>To:</strong> 16 April 2010<br /><br />Tiara Park Hotel, Porto, Portugal. ]]></description>
<guid>726</guid>
</item>
<item>
<title>logichem2010  The 9th Annual European Bulk and Specialty Chemical Supply Chain Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1073/logichem2010-the-9th-annual-european-bulk-and-specialty-chemical-supply-chain-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 April 2010<br /><strong>To:</strong> 22 April 2010<br /><br />The Hilton Hotel, Dusseldorf, Germany. ]]></description>
<guid>1073</guid>
</item>
<item>
<title>Keystone Symposia: Computer-Aided Drug Design</title>
<link>http://www.drugdiscoverytoday.com/view/973/keystone-symposia-computeraided-drug-design/</link>
<description><![CDATA[<strong>From:</strong> 20 April 2010<br /><strong>To:</strong> 25 April 2010<br /><br />Whistler, British Columbia, Canada. Joint with meeting on New Directions in Small Molecule Drug Discovery]]></description>
<guid>973</guid>
</item>
<item>
<title>Computer Systems Validation in the Pharmaceutical Industry</title>
<link>http://www.drugdiscoverytoday.com/view/1450/computer-systems-validation-in-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 21 April 2010<br /><strong>To:</strong> 22 April 2010<br /><br />Crowne Plaza St. James Hotel, London. Discussing issues such as regulatory aspects to CSV - whether the current guidelines need expanding, reinterpreting or rewriting - CSV in an R&amp;D context, the need for a risk-based approach to CSV and many more, this conference promises to be an unmissable event.]]></description>
<guid>1450</guid>
</item>
<item>
<title>Asthma &amp; COPD</title>
<link>http://www.drugdiscoverytoday.com/view/1448/asthma-copd/</link>
<description><![CDATA[<strong>From:</strong> 21 April 2010<br /><strong>To:</strong> 22 April 2010<br /><br />London Marriott Hotel, Regents Park, London. ]]></description>
<guid>1448</guid>
</item>
<item>
<title>High Throughput Screening: The Route to Intelligent Screening</title>
<link>http://www.drugdiscoverytoday.com/view/1153/high-throughput-screening-the-route-to-intelligent-screening/</link>
<description><![CDATA[<strong>From:</strong> 26 April 2010<br /><strong>To:</strong> 27 April 2010<br /><br />Crowne Plaza Hotel - St James, London, United Kingdom. SMi's industry-leading High Throughput Screening conference returns for its fourth year.  The theme of this year's conference will be how to lead HTS down an intelligent route towards lead generation.

]]></description>
<guid>1153</guid>
</item>
<item>
<title>High Throughput Screening - The Route to Intelligent Screening</title>
<link>http://www.drugdiscoverytoday.com/view/1571/high-throughput-screening-the-route-to-intelligent-screening/</link>
<description><![CDATA[<strong>From:</strong> 26 April 2010<br /><strong>To:</strong> 27 April 2010<br /><br />Crowne Plaza Hotel – St James, London, UK. ]]></description>
<guid>1571</guid>
</item>
<item>
<title>LogiPharma 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1151/logipharma-2010/</link>
<description><![CDATA[<strong>From:</strong> 27 April 2010<br /><strong>To:</strong> 29 April 2010<br /><br />Intercontinental Hotel, Geneva, Switzerland. LogiPharma Europe is the Biggest and Most Senior Pharma Supply Chain Conference]]></description>
<guid>1151</guid>
</item>
<item>
<title>Advances and Opportunities in Controlled Release</title>
<link>http://www.drugdiscoverytoday.com/view/1451/advances-and-opportunities-in-controlled-release/</link>
<description><![CDATA[<strong>From:</strong> 28 April 2010<br /><strong>To:</strong> 29 April 2010<br /><br />Crowne Plaza St. James Hotel, London. This conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release products and information on the latest advances in delivery methods.]]></description>
<guid>1451</guid>
</item>
<item>
<title>Generics, Supergenerics and Patent Strategies</title>
<link>http://www.drugdiscoverytoday.com/view/1608/generics-supergenerics-and-patent-strategies/</link>
<description><![CDATA[<strong>From:</strong> 10 May 2010<br /><strong>To:</strong> 11 May 2010<br /><br />Crowne Plaza Hotel - St James, London. The worldwide generics industry has seen strong growth in recent times as the demand for affordable treatment has increased worldwide. In addition to this, from 2008-2010 a total of 36 key drugs are expected to lose patent protection providing a huge opportunity for the sector to expand further.
Join us for SMi's 13th annual Generics, Super-Generics and Patent Strategies and discover the future of the generics market. Hear experts in the field discuss the latest patent strategies, regulatory updates and growth strategies that will be key to the future of the industry.
]]></description>
<guid>1608</guid>
</item>
<item>
<title>Cardiovascular Clinical Trials in Emerging Countries 2010 (CVCTEC 2010) </title>
<link>http://www.drugdiscoverytoday.com/view/1167/cardiovascular-clinical-trials-in-emerging-countries-2010-cvctec-2010-/</link>
<description><![CDATA[<strong>From:</strong> 10 May 2010<br /><strong>To:</strong> 11 May 2010<br /><br />Hilton Hotel Prague, Czech Republic . The Congress will focus on the current results, problems and solutions of conducting cardiovascular clinical trials in key emerging markets as well as examining the challenges facing the pharmaceutical industry in pursuing a contemporary approach in the development of drugs and treatment in key areas. 

]]></description>
<guid>1167</guid>
</item>
<item>
<title>3rd Annual Bio / Pharmaceutical Cold Chain Management Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1461/3rd-annual-bio-pharmaceutical-cold-chain-management-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 12 May 2010<br /><strong>To:</strong> 13 May 2010<br /><br />Rendezvous Hotel, Singapore. Strengthening end to end cold chain practices in storage, distribution, and ensuring compliance of temperature sensitive pharmaceuticals, biopharmaceuticals and clinical supplies]]></description>
<guid>1461</guid>
</item>
<item>
<title>EMBL Conference: Stem Cells, Tissue Homeostasis and Cancer</title>
<link>http://www.drugdiscoverytoday.com/view/1097/embl-conference-stem-cells-tissue-homeostasis-and-cancer/</link>
<description><![CDATA[<strong>From:</strong> 12 May 2010<br /><strong>To:</strong> 15 May 2010<br /><br />EMBL Heidelberg, Germany. Stem Cells, Tissue Homeostasis, Cancer]]></description>
<guid>1097</guid>
</item>
<item>
<title>The twelth advanced level workshop on Pharmacokinetic - Pharmacodynamic data analysis: A hands-on residential course using WinNonlin</title>
<link>http://www.drugdiscoverytoday.com/view/910/the-twelth-advanced-level-workshop-on-pharmacokinetic-pharmacodynamic-data-analysis-a-handson-residential-course-using-winnonlin/</link>
<description><![CDATA[<strong>From:</strong> 16 May 2010<br /><strong>To:</strong> 20 May 2010<br /><br />Madingley Hall, Cambridge, UK. ]]></description>
<guid>910</guid>
</item>
<item>
<title>Clinical Trial Logistics</title>
<link>http://www.drugdiscoverytoday.com/view/1568/clinical-trial-logistics/</link>
<description><![CDATA[<strong>From:</strong> 17 May 2010<br /><strong>To:</strong> 18 May 2010<br /><br />Marriott Hotel, Regents Park, London, UK. ]]></description>
<guid>1568</guid>
</item>
<item>
<title>The International Pharmaceutical and Regulatory Compliance Congress and Best Practices Forum</title>
<link>http://www.drugdiscoverytoday.com/view/1416/the-international-pharmaceutical-and-regulatory-compliance-congress-and-best-practices-forum/</link>
<description><![CDATA[<strong>From:</strong> 17 May 2010<br /><strong>To:</strong> 18 May 2010<br /><br />Intercontinental Berlin, Berlin, Germany . ]]></description>
<guid>1416</guid>
</item>
<item>
<title>Biopharmaceuticals: Exploring Synergies Across Drug Formats</title>
<link>http://www.drugdiscoverytoday.com/view/1639/biopharmaceuticals-exploring-synergies-across-drug-formats/</link>
<description><![CDATA[<strong>From:</strong> 20 May 2010<br /><strong>To:</strong> 21 May 2010<br /><br />Hilton San Francisco Union Square, San Francisco, CA, USA. ]]></description>
<guid>1639</guid>
</item>
<item>
<title>Frontiers of Chemistry. From Molecules to Systems</title>
<link>http://www.drugdiscoverytoday.com/view/1166/frontiers-of-chemistry-from-molecules-to-systems/</link>
<description><![CDATA[<strong>From:</strong> 21 May 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Maison de la Chemie, Paris, France. A celebratory symposium on the occasion of the 10th anniversary of ChemBioChem and ChemPhysChem, European journals of chemical biology and physical chemistry/chemical physics at the Maison de la Chimie in Paris on 21st May 2010.

]]></description>
<guid>1166</guid>
</item>
<item>
<title>58th ASMS Conference on Mass Spectrometry </title>
<link>http://www.drugdiscoverytoday.com/view/1417/58th-asms-conference-on-mass-spectrometry-/</link>
<description><![CDATA[<strong>From:</strong> 23 May 2010<br /><strong>To:</strong> 27 May 2010<br /><br />The Salt Palace Convention Center, Salt Lake City,Utah, USA. ]]></description>
<guid>1417</guid>
</item>
<item>
<title>Keystone Symposia: Bioactive Lipids: Biochemistry and Diseases</title>
<link>http://www.drugdiscoverytoday.com/view/974/keystone-symposia-bioactive-lipids-biochemistry-and-diseases/</link>
<description><![CDATA[<strong>From:</strong> 06 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />Westin Miyako Kyoto, Japan. ]]></description>
<guid>974</guid>
</item>
<item>
<title>GRC Phosphorylation &amp; G-protein mediated Signaling Networks</title>
<link>http://www.drugdiscoverytoday.com/view/1666/grc-phosphorylation-gprotein-mediated-signaling-networks/</link>
<description><![CDATA[<strong>From:</strong> 06 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />University of New England, Biddeford, ME, USA. ]]></description>
<guid>1666</guid>
</item>
<item>
<title>Pain Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/1572/pain-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 07 June 2010<br /><strong>To:</strong> 08 June 2010<br /><br />Crowne Plaza - The City, London, United Kingdom. SMi’s 10th annual Pain Therapeutics conference is a must-attend event for anyone wanting to discover the latest research, development and market trends in medication targeting pain.  Building on the experience and success of the past nine conferences, once again we bring together the leading experts from industry and academia in this field.]]></description>
<guid>1572</guid>
</item>
<item>
<title>5th Annual Cell-Based Assays</title>
<link>http://www.drugdiscoverytoday.com/view/1463/5th-annual-cellbased-assays/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 09 June 2010<br /><br />Renaissance Hotel, Cologne, Germany. ]]></description>
<guid>1463</guid>
</item>
<item>
<title>Asia Infectious Diseases Forum 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1537/asia-infectious-diseases-forum-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 08 June 2010<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1537</guid>
</item>
<item>
<title>World Vaccine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1538/world-vaccine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1538</guid>
</item>
<item>
<title>World Vaccine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1540/world-vaccine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1540</guid>
</item>
<item>
<title>World Vaccine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1539/world-vaccine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1539</guid>
</item>
<item>
<title>World Vaccine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1541/world-vaccine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 11 June 2010<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1541</guid>
</item>
<item>
<title>Thermo Scientific UK Summer Symposium</title>
<link>http://www.drugdiscoverytoday.com/view/1721/thermo-scientific-uk-summer-symposium/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Palace Hotel, Manchester, UK. ]]></description>
<guid>1721</guid>
</item>
<item>
<title>Cancer Proteomics</title>
<link>http://www.drugdiscoverytoday.com/view/727/cancer-proteomics/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 09 June 2010<br /><br />Berlin, Germany. ]]></description>
<guid>727</guid>
</item>
<item>
<title>Advances in Antibody and Peptide Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/728/advances-in-antibody-and-peptide-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2010<br /><strong>To:</strong> 09 June 2010<br /><br />Berlin, Germany. ]]></description>
<guid>728</guid>
</item>
<item>
<title>ViE Asia Awards - World Vaccine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1536/vie-asia-awards-world-vaccine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 09 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Singapore. ]]></description>
<guid>1536</guid>
</item>
<item>
<title>Thermo Scientific UK Summer Symposium</title>
<link>http://www.drugdiscoverytoday.com/view/1722/thermo-scientific-uk-summer-symposium/</link>
<description><![CDATA[<strong>From:</strong> 10 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />QE II Conference Centre, London, UK. ]]></description>
<guid>1722</guid>
</item>
<item>
<title>World Influenza Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1535/world-influenza-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 11 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Grand Hyatt, Singapore. ]]></description>
<guid>1535</guid>
</item>
<item>
<title>“Science: A Matter of Life” ~Novel Technologies in Life Science from Western Japan~</title>
<link>http://www.drugdiscoverytoday.com/view/1698/science-a-matter-of-life-novel-technologies-in-life-science-from-western-japan/</link>
<description><![CDATA[<strong>From:</strong> 11 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />The Nippon Club, 145 West 57th Street, New York, NY 10019. Technology Showcase of Hiroshima University and Western Japan’s Innovative Academia]]></description>
<guid>1698</guid>
</item>
<item>
<title>GRC Bioorganic Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/1667/grc-bioorganic-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 13 June 2010<br /><strong>To:</strong> 18 June 2010<br /><br />Proctor Academy, Andover, NH, USA. ]]></description>
<guid>1667</guid>
</item>
<item>
<title>46th DIA Annual Meeting</title>
<link>http://www.drugdiscoverytoday.com/view/1045/46th-dia-annual-meeting/</link>
<description><![CDATA[<strong>From:</strong> 13 June 2010<br /><strong>To:</strong> 17 June 2010<br /><br />Washington, DC, USA. ]]></description>
<guid>1045</guid>
</item>
<item>
<title>DDI-2010: International Conference on Drug-Drug Interactions</title>
<link>http://www.drugdiscoverytoday.com/view/1093/ddi2010-international-conference-on-drugdrug-interactions/</link>
<description><![CDATA[<strong>From:</strong> 14 June 2010<br /><strong>To:</strong> 16 June 2010<br /><br />Seattle, Washington, USA. ]]></description>
<guid>1093</guid>
</item>
<item>
<title>Recombinant Antibodies 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1610/recombinant-antibodies-2010/</link>
<description><![CDATA[<strong>From:</strong> 14 June 2010<br /><strong>To:</strong> 18 June 2010<br /><br />Crown Plaza, Berlin City Centre. Over 50 industry experts and academics deliver cutting edge data on antibody research and developments 

NEW Flexible Format for 2010: Choose between a 2,3,4,5 Day pass- for further information and to book your places today visit:
]]></description>
<guid>1610</guid>
</item>
<item>
<title>Encouraging Development of Therapeutics for Neglected Diseases</title>
<link>http://www.drugdiscoverytoday.com/view/1566/encouraging-development-of-therapeutics-for-neglected-diseases/</link>
<description><![CDATA[<strong>From:</strong> 16 June 2010<br /><strong>To:</strong> 17 June 2010<br /><br />Sheraton Philadelphia City Center Hotel, Philadelphia, PA, USA. ]]></description>
<guid>1566</guid>
</item>
<item>
<title>ETS-2010: International Conference on Early Toxicity Screening</title>
<link>http://www.drugdiscoverytoday.com/view/1094/ets2010-international-conference-on-early-toxicity-screening/</link>
<description><![CDATA[<strong>From:</strong> 17 June 2010<br /><strong>To:</strong> 18 June 2010<br /><br />Seattle, Washington, USA. ]]></description>
<guid>1094</guid>
</item>
<item>
<title>Gordon Research Conference &quot;High Throughput Chemistry &amp; Chemical Biology&quot;</title>
<link>http://www.drugdiscoverytoday.com/view/1657/gordon-research-conference-high-throughput-chemistry-chemical-biology/</link>
<description><![CDATA[<strong>From:</strong> 20 June 2010<br /><strong>To:</strong> 25 June 2010<br /><br />Les Diablerets Conference Center, Les Diablerets, Switzerland . ]]></description>
<guid>1657</guid>
</item>
<item>
<title>Improving Solubility, Permeability and Bioavailability</title>
<link>http://www.drugdiscoverytoday.com/view/1462/improving-solubility-permeability-and-bioavailability/</link>
<description><![CDATA[<strong>From:</strong> 21 June 2010<br /><strong>To:</strong> 23 June 2010<br /><br />CCT Venues, Canary Wharf, London. Ensure Maximum Output Of Soluble Drugs At Minimum Cost

In the current economic climate, there is more pressure than ever before to ensure that drug candidates are developed into target effective and profit-making drugs in the most efficient manner. With this in mind, pharmaceutical companies are concentrating on streamlining their formulation and development strategies to ensure that optimal solubility and bioavailablity is achieved in the most cost-effective way.

Pharma IQ’s 6th Annual Improving Solubility conference taking place in London on 22nd- 23rd June with pre-conference workshops on 21st June will explore the newest solubility enhancement technologies, and the best practice strategies of their implementation to ensure efficiency from discovery to preclinical development.
]]></description>
<guid>1462</guid>
</item>
<item>
<title>Nanotech Conference &amp; Expo 2010</title>
<link>http://www.drugdiscoverytoday.com/view/957/nanotech-conference-expo-2010/</link>
<description><![CDATA[<strong>From:</strong> 21 June 2010<br /><strong>To:</strong> 25 June 2010<br /><br />Anaheim Convention Center, Anaheim, CA, USA. The world's largest and most anticipated
annual nanotechnology conference and 
expo. For their 13th year, they expect over 
5,000 attendees and 350 exhibitors. ]]></description>
<guid>957</guid>
</item>
<item>
<title>The Eleventh Tetrahedron Symposium</title>
<link>http://www.drugdiscoverytoday.com/view/1437/the-eleventh-tetrahedron-symposium/</link>
<description><![CDATA[<strong>From:</strong> 22 June 2010<br /><strong>To:</strong> 25 June 2010<br /><br />Beijing, China. ]]></description>
<guid>1437</guid>
</item>
<item>
<title>Beyond Sequencing. Strategies for Success</title>
<link>http://www.drugdiscoverytoday.com/view/1565/beyond-sequencing-strategies-for-success/</link>
<description><![CDATA[<strong>From:</strong> 22 June 2010<br /><strong>To:</strong> 23 June 2010<br /><br />Hotel Kabuki, San Francisco, CA, USA. ]]></description>
<guid>1565</guid>
</item>
<item>
<title>Microfluidics &amp; Nanotechnology in Life Sciences and Medicine </title>
<link>http://www.drugdiscoverytoday.com/view/1555/microfluidics-nanotechnology-in-life-sciences-and-medicine-/</link>
<description><![CDATA[<strong>From:</strong> 23 June 2010<br /><strong>To:</strong> 01 January 1800<br /><br />AstraZeneca, Alderley Park, Cheshire, UK. ]]></description>
<guid>1555</guid>
</item>
<item>
<title>Global Proteins Summit - Next Generation Protein Therapeutics &amp; Immunogenicity</title>
<link>http://www.drugdiscoverytoday.com/view/1454/global-proteins-summit-next-generation-protein-therapeutics-immunogenicity/</link>
<description><![CDATA[<strong>From:</strong> 23 June 2010<br /><strong>To:</strong> 24 June 2010<br /><br />Crowne Plaza Hotel - St James, London, United Kingdom. ]]></description>
<guid>1454</guid>
</item>
<item>
<title>GRC Metals in Medicine</title>
<link>http://www.drugdiscoverytoday.com/view/1668/grc-metals-in-medicine/</link>
<description><![CDATA[<strong>From:</strong> 27 June 2010<br /><strong>To:</strong> 02 July 2010<br /><br />Proctor Academy, Andover, NH, USA. ]]></description>
<guid>1668</guid>
</item>
<item>
<title>Pharmaceutical Portfolio &amp; Product Life-Cycle Management</title>
<link>http://www.drugdiscoverytoday.com/view/1554/pharmaceutical-portfolio-product-lifecycle-management/</link>
<description><![CDATA[<strong>From:</strong> 28 June 2010<br /><strong>To:</strong> 29 June 2010<br /><br />Crowne Plaza Hotel - St. James, London, UK. SMi’s 5th Annual Pharmaceutical Portfolio &amp; Product Life Cycle Management Conference will provide an unmissable learning and networking opportunity with the leading experts from the world of Portfolio and Life Cycle Management.]]></description>
<guid>1554</guid>
</item>
<item>
<title>Clinically Relevant Drug Transporters 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1569/clinically-relevant-drug-transporters-2010/</link>
<description><![CDATA[<strong>From:</strong> 30 June 2010<br /><strong>To:</strong> 01 July 2010<br /><br />CCT Venues - Canary Wharf, London, UK. Since the publication of the much-anticipated International Transporter Consortium white paper, there has been much industry and academic debate as to its content and impact on the field of transporters. This conference will provide pharmaceutical professionals with the first opportunity in Europe to discuss the content of the white paper and its impact on both you and your company with not only your peers and esteemed colleagues, but also 2 members of the ITC itself (Raymond Evers from Merck &amp; and Caroline Lee from Pfizer).  The conference is a high level forum that enables manufacturers to network and discuss the key challenges in this area such as the role of transporters in drug disposition and polymorphism, effective modelling techniques, the regulatory stance on transporters and discussion on the International Transporter Consortium (ITC) white paper.]]></description>
<guid>1569</guid>
</item>
<item>
<title>RICT 2010 - Interfacing Chemical Biology and Drug Discovery</title>
<link>http://www.drugdiscoverytoday.com/view/1564/rict-2010-interfacing-chemical-biology-and-drug-discovery/</link>
<description><![CDATA[<strong>From:</strong> 30 June 2010<br /><strong>To:</strong> 02 July 2010<br /><br />Reims, France. ]]></description>
<guid>1564</guid>
</item>
<item>
<title>Clinical Trials in Cancer</title>
<link>http://www.drugdiscoverytoday.com/view/1609/clinical-trials-in-cancer/</link>
<description><![CDATA[<strong>From:</strong> 05 July 2010<br /><strong>To:</strong> 06 July 2010<br /><br />Crowne Plaza St James Hotel, London. SMi’s 9th annual Clinical Trials in Cancer conference will feature presentations from industry professionals and academic experts on how to manage clinical development in this crucial therapeutic area.]]></description>
<guid>1609</guid>
</item>
<item>
<title>Fundamentals of Toxicology in Drug Development</title>
<link>http://www.drugdiscoverytoday.com/view/1640/fundamentals-of-toxicology-in-drug-development/</link>
<description><![CDATA[<strong>From:</strong> 06 July 2010<br /><strong>To:</strong> 07 July 2010<br /><br />Regus Poultry, London, UK. Learn all you need to know to communicate effectively with toxicologists]]></description>
<guid>1640</guid>
</item>
<item>
<title>12th Belgian Organic Synthesis Symposium - BOSS XII</title>
<link>http://www.drugdiscoverytoday.com/view/1455/12th-belgian-organic-synthesis-symposium-boss-xii/</link>
<description><![CDATA[<strong>From:</strong> 11 July 2010<br /><strong>To:</strong> 16 July 2010<br /><br />Namur, Belgium . The BOSS-conference is a unique international symposium as, apart from invited lectures delivered by established organic chemists as well as younger rising stars, two prestigious events are associated with it: a lecture delivered by the recipient of the “Janssen Pharmaceutica Prize for Creativity in Organic Synthesis”, and the “Tetrahedron Chair”: a one-day course on a specific topic in organic synthesis by an eminent lecturer. The conference covers a broad range of timely subjects in the field of organic chemistry.]]></description>
<guid>1455</guid>
</item>
<item>
<title>GRC Drug Metabolism</title>
<link>http://www.drugdiscoverytoday.com/view/1669/grc-drug-metabolism/</link>
<description><![CDATA[<strong>From:</strong> 11 July 2010<br /><strong>To:</strong> 16 July 2010<br /><br />Holderness School, Holderness, NH, USA. ]]></description>
<guid>1669</guid>
</item>
<item>
<title>In Vitro Diagnostics</title>
<link>http://www.drugdiscoverytoday.com/view/1630/in-vitro-diagnostics/</link>
<description><![CDATA[<strong>From:</strong> 12 July 2010<br /><strong>To:</strong> 13 July 2010<br /><br />Crowne Plaza St James Hotel, London, UK. SMi’s 2nd annual In Vitro Diagnostics conference taking place on the 12th &amp; 13th July 2010 in London, will provide a complete overview of the In Vitro Diagnostics marketplace and enable you to identify and overcome industry specific challenges. ]]></description>
<guid>1630</guid>
</item>
<item>
<title>4th Annual Advances in Stem Cell Discovery &amp; Development Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1801/4th-annual-advances-in-stem-cell-discovery-development-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 July 2010<br /><strong>To:</strong> 22 July 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1801</guid>
</item>
<item>
<title>GRC Medicinal Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/1670/grc-medicinal-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 08 August 2010<br /><strong>To:</strong> 13 August 2010<br /><br />Colby-Sawyer College, New London, NH, USA. ]]></description>
<guid>1670</guid>
</item>
<item>
<title>GRC Drug Carriers in Medicine &amp; Biology</title>
<link>http://www.drugdiscoverytoday.com/view/1671/grc-drug-carriers-in-medicine-biology/</link>
<description><![CDATA[<strong>From:</strong> 15 August 2010<br /><strong>To:</strong> 20 August 2010<br /><br />Waterville Valley Resort, Waterville, NH, USA. ]]></description>
<guid>1671</guid>
</item>
<item>
<title>The Immunotherapeutics &amp; Vaccine Summit</title>
<link>http://www.drugdiscoverytoday.com/view/1654/the-immunotherapeutics-vaccine-summit/</link>
<description><![CDATA[<strong>From:</strong> 17 August 2010<br /><strong>To:</strong> 19 August 2010<br /><br />Royal Sonesta Hotel • Cambridge, MA, USA. ]]></description>
<guid>1654</guid>
</item>
<item>
<title>NDDS India 2010: Novel Drug Delivery Systems</title>
<link>http://www.drugdiscoverytoday.com/view/1820/ndds-india-2010-novel-drug-delivery-systems/</link>
<description><![CDATA[<strong>From:</strong> 19 August 2010<br /><strong>To:</strong> 20 August 2010<br /><br />The Westin Mumbai Garden City, Mumbai, India. NDDS India 2010 is a two-day strategic conference which will help you to uncover the key challenges and opportunities that will enable you to drive the potential of new drug delivery systems in your organisation]]></description>
<guid>1820</guid>
</item>
<item>
<title>Ubiquitin Drug Discovery and Diagnostics 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1563/ubiquitin-drug-discovery-and-diagnostics-2010/</link>
<description><![CDATA[<strong>From:</strong> 23 August 2010<br /><strong>To:</strong> 25 August 2010<br /><br />Four Seasons Hotel, Philadelphia, PA, USA. ]]></description>
<guid>1563</guid>
</item>
<item>
<title>GRC Computational Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/1672/grc-computational-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 29 August 2010<br /><strong>To:</strong> 03 September 2010<br /><br />Les Diablerets Conference Center, Les Diablerets, Switzerland. ]]></description>
<guid>1672</guid>
</item>
<item>
<title>Drug Discovery 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1943/drug-discovery-2010/</link>
<description><![CDATA[<strong>From:</strong> 01 September 2010<br /><strong>To:</strong> 02 September 2010<br /><br />Ricoh Arena, Coventry, UK. ELRIG (European Laboratory and Robotics Interest Group), SBS  (the Society of Biomolecular Sciences) and  BPS (British Pharmacological Society) are now preparing for the fourth Annual Drug Discovery Conference to be held at the ‘Ricoh’ Arena, Coventry on 1st and 2nd September 2010.

As in previous years the objective of this conference is to provide a communication, education and networking opportunity for  scientists engaged in early-phase drug discovery whether in academia, biotech or industry.  As with our highly successful meeting in 2009, attendees will hear world class speakers discussing the challenges and opportunities facing the drug discovery scientist.  The scientific sessions will be complemented by a poster session, a vendor exhibition with over 80 exhibitors, and a number of training sessions.

]]></description>
<guid>1943</guid>
</item>
<item>
<title>XXIst International Symposium on Medicinal Chemistry</title>
<link>http://www.drugdiscoverytoday.com/view/582/xxist-international-symposium-on-medicinal-chemistry/</link>
<description><![CDATA[<strong>From:</strong> 05 September 2010<br /><strong>To:</strong> 09 September 2010<br /><br />Brussels, Belgium. (Tel: +32 10 45 47 77)
(Fax: +32 10 45 97 19) 
E-mail: secretariat@ISMC2010.org]]></description>
<guid>582</guid>
</item>
<item>
<title>Pharmaceutical Distribution 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1688/pharmaceutical-distribution-2010/</link>
<description><![CDATA[<strong>From:</strong> 08 September 2010<br /><strong>To:</strong> 09 September 2010<br /><br />Amsterdam, The Netherlands. ]]></description>
<guid>1688</guid>
</item>
<item>
<title>19th Annual GFST Symposium on RNA in Motion</title>
<link>http://www.drugdiscoverytoday.com/view/1611/19th-annual-gfst-symposium-on-rna-in-motion/</link>
<description><![CDATA[<strong>From:</strong> 09 September 2010<br /><strong>To:</strong> 12 September 2010<br /><br />Iowa State University, Scheman Conference Center. The sessions in the symposium will emphasize current research by which we are obtaining an understanding of the role of molecular motion in the function of RNAs: 1) Ribosomes; 2) Viral RNAs; 3) Functional RNAs and molecular motors; 4) Small RNAs: Riboswitches, ribozymes and aptamers. The final session will consider RNA conformational analysis, folding and simulations of molecular motion.]]></description>
<guid>1611</guid>
</item>
<item>
<title>The Future of Bio-Based Chemicals – Inception to Marketplace</title>
<link>http://www.drugdiscoverytoday.com/view/1934/the-future-of-biobased-chemicals-inception-to-marketplace/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2010<br /><strong>To:</strong> 14 September 2010<br /><br />San Francisco, CA. ]]></description>
<guid>1934</guid>
</item>
<item>
<title>ADAPT2010 Accelerating Development &amp; Advancing Personal Therapy</title>
<link>http://www.drugdiscoverytoday.com/view/1763/adapt2010-accelerating-development-advancing-personal-therapy/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2010<br /><strong>To:</strong> 16 September 2010<br /><br />Hyatt Regency Crystal City, Arlington, VA, USA. ]]></description>
<guid>1763</guid>
</item>
<item>
<title>World Pharma Trials Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1699/world-pharma-trials-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2010<br /><strong>To:</strong> 16 September 2010<br /><br />Gran Melia- Shanghai, China. World Pharma Trials Asia is the only Asia-focused event in China in 2010, where the World’s Top Pharmas, biotechs, CROs, and regulators convene to provide the most comprehensive knowledge into the best operational strategies and practices in fast-tracking clinical drug development in Asia.]]></description>
<guid>1699</guid>
</item>
<item>
<title>The Future of Bio-Based Chemicals – Inception to Marketplace</title>
<link>http://www.drugdiscoverytoday.com/view/1798/the-future-of-biobased-chemicals-inception-to-marketplace/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2010<br /><strong>To:</strong> 14 September 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1798</guid>
</item>
<item>
<title>Antibody Manufacturing</title>
<link>http://www.drugdiscoverytoday.com/view/1717/antibody-manufacturing/</link>
<description><![CDATA[<strong>From:</strong> 14 September 2010<br /><strong>To:</strong> 16 September 2010<br /><br />Berlin, Germany. ]]></description>
<guid>1717</guid>
</item>
<item>
<title>2nd Successful eCTD Lifecycle Management</title>
<link>http://www.drugdiscoverytoday.com/view/1665/2nd-successful-ectd-lifecycle-management/</link>
<description><![CDATA[<strong>From:</strong> 14 September 2010<br /><strong>To:</strong> 15 September 2010<br /><br />Marriot Prague, Prague, Czech Republic. Topics to be discuss include: 
•	Harmonising document management globally, representation from the US and Europe  
•	Migrating to New Submission Processes: Migrating to the PIM System, EFPIA Standards and Practical Pfizer Case Studies
•	Getting the dossier right first time: Uncovering best practice in the development of local and centralized dossiers
•	Managing different submission forms such as MRP and DCP
•	Establishing best practice when implementing eCTD across the wider business: How to approach both the roll-out and internal training that is required for smooth adoption
]]></description>
<guid>1665</guid>
</item>
<item>
<title>Pharmaceutical Stability Testing Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1809/pharmaceutical-stability-testing-conference/</link>
<description><![CDATA[<strong>From:</strong> 15 September 2010<br /><strong>To:</strong> 16 September 2010<br /><br />CCT Venues – Smithfield, London, UK. ]]></description>
<guid>1809</guid>
</item>
<item>
<title>2nd International Lhasa Symposium on New Horizons in Toxicity Prediction</title>
<link>http://www.drugdiscoverytoday.com/view/1182/2nd-international-lhasa-symposium-on-new-horizons-in-toxicity-prediction/</link>
<description><![CDATA[<strong>From:</strong> 15 September 2010<br /><strong>To:</strong> 16 September 2010<br /><br />at Leeds Royal Armouries Museum, Leeds, UK. The Symposium will feature presentations from high profile speakers working in the area of toxicity prediction, representing commerce, academia and associated industry bodies. 
]]></description>
<guid>1182</guid>
</item>
<item>
<title>BioPharm America™ 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1946/biopharm-america-2010/</link>
<description><![CDATA[<strong>From:</strong> 15 September 2010<br /><strong>To:</strong> 17 September 2010<br /><br />Marriott Boston Copley Place, Boston, MA, USA. BioPharm America™ is where biotech industry partnerships get started. This three day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE&#174;, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring&#174;. In 2009, BioPharm America attracted 700 delegates from 430 companies who participated in 1,550+ scheduled one-to-one meetings. ]]></description>
<guid>1946</guid>
</item>
<item>
<title>5th Assay and Drug Discovery Technologies</title>
<link>http://www.drugdiscoverytoday.com/view/1935/5th-assay-and-drug-discovery-technologies/</link>
<description><![CDATA[<strong>From:</strong> 20 September 2010<br /><strong>To:</strong> 21 September 2010<br /><br />San Diego, CA. ]]></description>
<guid>1935</guid>
</item>
<item>
<title>Biomarkers in Clinical Trials </title>
<link>http://www.drugdiscoverytoday.com/view/1632/biomarkers-in-clinical-trials-/</link>
<description><![CDATA[<strong>From:</strong> 20 September 2010<br /><strong>To:</strong> 21 September 2010<br /><br />Hilton London Kensington, London, United Kingdom. ]]></description>
<guid>1632</guid>
</item>
<item>
<title>5th Annual Assay and Drug Discovery Technologies Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1799/5th-annual-assay-and-drug-discovery-technologies-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 September 2010<br /><strong>To:</strong> 21 September 2010<br /><br />San Francisco, CA, USA . ]]></description>
<guid>1799</guid>
</item>
<item>
<title>Targeted Cancer Therapies World Europe 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1902/targeted-cancer-therapies-world-europe-2010/</link>
<description><![CDATA[<strong>From:</strong> 21 September 2010<br /><strong>To:</strong> 23 September 2010<br /><br />Swisshotel, Zurich, Switzerland. ]]></description>
<guid>1902</guid>
</item>
<item>
<title>Biosimilars &amp; Biobetters - </title>
<link>http://www.drugdiscoverytoday.com/view/1621/biosimilars-biobetters-/</link>
<description><![CDATA[<strong>From:</strong> 22 September 2010<br /><strong>To:</strong> 23 September 2010<br /><br />Crowne Plaza London – The City, London, UK. ]]></description>
<guid>1621</guid>
</item>
<item>
<title>NGX: Evolution of Next-Generation Sequencing</title>
<link>http://www.drugdiscoverytoday.com/view/1655/ngx-evolution-of-nextgeneration-sequencing/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2010<br /><strong>To:</strong> 29 September 2010<br /><br />Rhode Island Convention Center •  Providence, RI, USA. ]]></description>
<guid>1655</guid>
</item>
<item>
<title>Next-Generation Sequencing Data Management</title>
<link>http://www.drugdiscoverytoday.com/view/1656/nextgeneration-sequencing-data-management/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2010<br /><strong>To:</strong> 29 September 2010<br /><br />Rhode Island Convention Center •  Providence, RI. ]]></description>
<guid>1656</guid>
</item>
<item>
<title>Predictive In Vitro Models in Drug Development</title>
<link>http://www.drugdiscoverytoday.com/view/1861/predictive-in-vitro-models-in-drug-development/</link>
<description><![CDATA[<strong>From:</strong> 28 September 2010<br /><strong>To:</strong> 29 September 2010<br /><br />Marriott Courtyard, Cambridge, MA, USA. The meeting will bring together safety and pharmacokinetics experts from big pharma and biotech to explore how in vitro models can transform your ability to predict clinical outcomes and increase your organization's productivity.]]></description>
<guid>1861</guid>
</item>
<item>
<title>KOL: Knowledge Leader Partnership</title>
<link>http://www.drugdiscoverytoday.com/view/1887/kol-knowledge-leader-partnership/</link>
<description><![CDATA[<strong>From:</strong> 29 September 2010<br /><strong>To:</strong> 30 September 2010<br /><br />Copthorne Tara Hotel, London, United Kingdom. ]]></description>
<guid>1887</guid>
</item>
<item>
<title>2nd conference on Innovation in Drug Delivery: From Preformulation to Development through Innovative Evaluation Process</title>
<link>http://www.drugdiscoverytoday.com/view/822/2nd-conference-on-innovation-in-drug-delivery-from-preformulation-to-development-through-innovative-evaluation-process/</link>
<description><![CDATA[<strong>From:</strong> 03 October 2010<br /><strong>To:</strong> 06 October 2010<br /><br />Aix-en-Provence, France. ]]></description>
<guid>822</guid>
</item>
<item>
<title>4th Vaccine &amp; ISV Annual Global Congress</title>
<link>http://www.drugdiscoverytoday.com/view/1575/4th-vaccine-isv-annual-global-congress/</link>
<description><![CDATA[<strong>From:</strong> 03 October 2010<br /><strong>To:</strong> 05 October 2010<br /><br />The Hilton Vienna Am Stadtpark in Vienna, Austria.. ]]></description>
<guid>1575</guid>
</item>
<item>
<title>Partnerships with CROs</title>
<link>http://www.drugdiscoverytoday.com/view/1888/partnerships-with-cros/</link>
<description><![CDATA[<strong>From:</strong> 04 October 2010<br /><strong>To:</strong> 05 October 2010<br /><br />Hilton London Kensington, London, United Kingdom. ]]></description>
<guid>1888</guid>
</item>
<item>
<title>Annual Pain Therapeutics Summit</title>
<link>http://www.drugdiscoverytoday.com/view/1484/annual-pain-therapeutics-summit/</link>
<description><![CDATA[<strong>From:</strong> 04 October 2010<br /><strong>To:</strong> 05 October 2010<br /><br />Philadelphia, Pennsylvania USA. ]]></description>
<guid>1484</guid>
</item>
<item>
<title>Accelerating Proof of Concept</title>
<link>http://www.drugdiscoverytoday.com/view/1864/accelerating-proof-of-concept/</link>
<description><![CDATA[<strong>From:</strong> 04 October 2010<br /><strong>To:</strong> 06 October 2010<br /><br />Crowne Plaza Hotel, Philadelphia, PA, USA. ]]></description>
<guid>1864</guid>
</item>
<item>
<title>The 7th TOPRA Annual Symposium 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1905/the-7th-topra-annual-symposium-2010/</link>
<description><![CDATA[<strong>From:</strong> 04 October 2010<br /><strong>To:</strong> 06 October 2010<br /><br />Hilton Park Lane, London, UK. ]]></description>
<guid>1905</guid>
</item>
<item>
<title>7th Annual Anti-Infectives Partnering &amp; Deal-Making Summit </title>
<link>http://www.drugdiscoverytoday.com/view/1800/7th-annual-antiinfectives-partnering-dealmaking-summit-/</link>
<description><![CDATA[<strong>From:</strong> 07 October 2010<br /><strong>To:</strong> 08 October 2010<br /><br />Boston, MA, USA . ]]></description>
<guid>1800</guid>
</item>
<item>
<title>Personalised Medicine </title>
<link>http://www.drugdiscoverytoday.com/view/1890/personalised-medicine-/</link>
<description><![CDATA[<strong>From:</strong> 11 October 2010<br /><strong>To:</strong> 12 October 2010<br /><br />Crowne Plaza - The City, London, United Kingdom. ]]></description>
<guid>1890</guid>
</item>
<item>
<title>FIP Quality International 2009 Managing quality across the drug supply chain: from product inception to patient utilization</title>
<link>http://www.drugdiscoverytoday.com/view/827/fip-quality-international-2009-managing-quality-across-the-drug-supply-chain-from-product-inception-to-patient-utilization/</link>
<description><![CDATA[<strong>From:</strong> 15 October 2010<br /><strong>To:</strong> 16 October 2010<br /><br />Royal Pharmaceutical Society of Great Britain. This international and well-established conference is designed to:

Explore - through plenary presentations, case studies showing real-life examples, panel discussions and poster presentations - the meaning of quality in the various phases of the drug supply chain.

Interrelate and discuss the current practice of managing quality of drugs from early drug design, through the development phase to supply chain management and final dispensing to patients.

Increase delegates’ understanding and implementation of quality in a holistic sense as it relates to the development, manufacture and distribution of drugs.

Clarify and asses the enormous effort in the management of quality from different sectors of the drug supply chain - is it enough or are other approaches needed?

Provide opportunities to network with leading experts and colleagues in the field through a full social programme.

]]></description>
<guid>827</guid>
</item>
<item>
<title>Vaccine Manufacturing World</title>
<link>http://www.drugdiscoverytoday.com/view/1785/vaccine-manufacturing-world/</link>
<description><![CDATA[<strong>From:</strong> 18 October 2010<br /><strong>To:</strong> 21 October 2010<br /><br />Shanghai, China. ]]></description>
<guid>1785</guid>
</item>
<item>
<title>BioManufacturing World</title>
<link>http://www.drugdiscoverytoday.com/view/1687/biomanufacturing-world/</link>
<description><![CDATA[<strong>From:</strong> 18 October 2010<br /><strong>To:</strong> 21 October 2010<br /><br />Shanghai, China. ]]></description>
<guid>1687</guid>
</item>
<item>
<title>SBS Biomolecular Screening Symposium: Advanced Applications Across Academia, Government &amp; Industry</title>
<link>http://www.drugdiscoverytoday.com/view/1718/sbs-biomolecular-screening-symposium-advanced-applications-across-academia-government-industry/</link>
<description><![CDATA[<strong>From:</strong> 18 October 2010<br /><strong>To:</strong> 19 October 2010<br /><br />Sheraton Imperial Hotel &amp; Convention Center, Durham, NC, USA  . ]]></description>
<guid>1718</guid>
</item>
<item>
<title>Immunogenicity Summit 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1906/immunogenicity-summit-2010/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2010<br /><strong>To:</strong> 21 October 2010<br /><br />Loews Philadelphia Hotel, Philadelphia, PA, USA. ]]></description>
<guid>1906</guid>
</item>
<item>
<title>Global discovery outsourcing and collaborations forum 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1903/global-discovery-outsourcing-and-collaborations-forum-2010/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 21 October 2010<br /><br />CCT Venues, Canary Wharf, London, UK. ]]></description>
<guid>1903</guid>
</item>
<item>
<title>6th Modern Drug Discovery &amp; Development Summit</title>
<link>http://www.drugdiscoverytoday.com/view/1937/6th-modern-drug-discovery-development-summit/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA. ]]></description>
<guid>1937</guid>
</item>
<item>
<title>2nd Cancer Targets and Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/1938/2nd-cancer-targets-and-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA. ]]></description>
<guid>1938</guid>
</item>
<item>
<title>5th Biological Therapeutics Research and Development</title>
<link>http://www.drugdiscoverytoday.com/view/1939/5th-biological-therapeutics-research-and-development/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA. ]]></description>
<guid>1939</guid>
</item>
<item>
<title>4th Biomarker Discovery and Development</title>
<link>http://www.drugdiscoverytoday.com/view/1941/4th-biomarker-discovery-and-development/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA. ]]></description>
<guid>1941</guid>
</item>
<item>
<title>5th Annual Biological Therapeutics Research &amp; Development Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1803/5th-annual-biological-therapeutics-research-development-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1803</guid>
</item>
<item>
<title>4th Annual Biomarker Discovery &amp; Development Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1804/4th-annual-biomarker-discovery-development-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1804</guid>
</item>
<item>
<title>2nd Annual Cancer Targets &amp; Therapeutics Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1805/2nd-annual-cancer-targets-therapeutics-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1805</guid>
</item>
<item>
<title>6th Annual Modern Drug Discovery and Development (M3D) Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1806/6th-annual-modern-drug-discovery-and-development-m3d-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1806</guid>
</item>
<item>
<title>4th Annual Advances in Stem Cell Discovery &amp; Development Conference</title>
<link>http://www.drugdiscoverytoday.com/view/1802/4th-annual-advances-in-stem-cell-discovery-development-conference/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />San Francisco, CA, USA. ]]></description>
<guid>1802</guid>
</item>
<item>
<title>Global Discovery Outsourcing and Collaborations Forum</title>
<link>http://www.drugdiscoverytoday.com/view/1658/global-discovery-outsourcing-and-collaborations-forum/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 21 October 2010<br /><br />Venue to be confirmed, London, UK. ]]></description>
<guid>1658</guid>
</item>
<item>
<title>The XIth Annual Pharmaceutical Regulatory and Compliance Congress</title>
<link>http://www.drugdiscoverytoday.com/view/1723/the-xith-annual-pharmaceutical-regulatory-and-compliance-congress/</link>
<description><![CDATA[<strong>From:</strong> 20 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />JW Marriott Hotel, Washington, DC, USA. ]]></description>
<guid>1723</guid>
</item>
<item>
<title>Regulatory Myeloid Cells (Immunopharmacology)</title>
<link>http://www.drugdiscoverytoday.com/view/1651/regulatory-myeloid-cells-immunopharmacology/</link>
<description><![CDATA[<strong>From:</strong> 21 October 2010<br /><strong>To:</strong> 24 October 2010<br /><br />Arlington, VA, USA. ]]></description>
<guid>1651</guid>
</item>
<item>
<title>Screening Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1559/screening-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 21 October 2010<br /><strong>To:</strong> 22 October 2010<br /><br />Singapore, Asia. ]]></description>
<guid>1559</guid>
</item>
<item>
<title>Pathology Visions Conference - The Annual Meeting of the Digital Pathology Association (DPA)</title>
<link>http://www.drugdiscoverytoday.com/view/1710/pathology-visions-conference-the-annual-meeting-of-the-digital-pathology-association-dpa/</link>
<description><![CDATA[<strong>From:</strong> 24 October 2010<br /><strong>To:</strong> 27 October 2010<br /><br />San Diego Sheraton Hotel and Marina, San Diego, CA, USA . 


]]></description>
<guid>1710</guid>
</item>
<item>
<title>Point of Care Diagnostics - Market Opportunities and Technology Trends</title>
<link>http://www.drugdiscoverytoday.com/view/1898/point-of-care-diagnostics-market-opportunities-and-technology-trends/</link>
<description><![CDATA[<strong>From:</strong> 25 October 2010<br /><strong>To:</strong> 26 October 2010<br /><br />Crowne Plaza - The City, London, United Kingdom. ]]></description>
<guid>1898</guid>
</item>
<item>
<title>2nd Annual World Stem Cells &amp; Regenerative Medicine Congress Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1700/2nd-annual-world-stem-cells-regenerative-medicine-congress-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2010<br /><strong>To:</strong> 29 October 2010<br /><br />Grand Hyatt – Singapore. The 2nd Annual World Stem Cells &amp; Regenerative Medicine Congress Asia 2010 brings together regional pharmas, biotechs and scientific leaders from the stem cell and regenerative medicines field to uncover Asia’s collaboration opportunities in R&amp;D and commercialization of therapies and applications]]></description>
<guid>1700</guid>
</item>
<item>
<title>Pharmacovigilance Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1932/pharmacovigilance-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2010<br /><strong>To:</strong> 27 October 2010<br /><br />Novotel Singapore Clarke Quay, Singapore. ]]></description>
<guid>1932</guid>
</item>
<item>
<title>9th Annual World Drug Discovery &amp; Development Summit </title>
<link>http://www.drugdiscoverytoday.com/view/1821/9th-annual-world-drug-discovery-development-summit-/</link>
<description><![CDATA[<strong>From:</strong> 26 October 2010<br /><strong>To:</strong> 27 October 2010<br /><br />Scandic Hotel Copenhagen, Copenhagen, Denmark. The 9th Annual World Drug Discovery &amp; Development Summit is the conference and networking event for innovation in drug discovery and pre-clinical development. The 2010 programme will discuss through a mixture of strategic and scientific sessions, how the industry is dealing with threats from dwindling pipelines, generic competition and patent expiries through advances in R&amp;D.]]></description>
<guid>1821</guid>
</item>
<item>
<title>European Pharmaceutical Pricing and Reimbursement</title>
<link>http://www.drugdiscoverytoday.com/view/1889/european-pharmaceutical-pricing-and-reimbursement/</link>
<description><![CDATA[<strong>From:</strong> 27 October 2010<br /><strong>To:</strong> 28 October 2010<br /><br />Hilton Munich City, Munich, Germany. ]]></description>
<guid>1889</guid>
</item>
<item>
<title>Fifth Annual Portfolio Management: Make Your Bets Count in the Face of Budget Cuts</title>
<link>http://www.drugdiscoverytoday.com/view/2069/fifth-annual-portfolio-management-make-your-bets-count-in-the-face-of-budget-cuts/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2010<br /><strong>To:</strong> 03 November 2010<br /><br />Crowne Plaza, Philadelphia, PA, USA. ]]></description>
<guid>2069</guid>
</item>
<item>
<title>MEEGID X - 10th International Conference on Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases</title>
<link>http://www.drugdiscoverytoday.com/view/1652/meegid-x-10th-international-conference-on-molecular-epidemiology-and-evolutionary-genetics-of-infectious-diseases/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2010<br /><strong>To:</strong> 05 November 2010<br /><br />Amsterdam, the Netherlands. ]]></description>
<guid>1652</guid>
</item>
<item>
<title>Eighth Annual Strategic Resource Management :Increase Productivity in an Evolving Business Environment</title>
<link>http://www.drugdiscoverytoday.com/view/2070/eighth-annual-strategic-resource-management-increase-productivity-in-an-evolving-business-environment/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2010<br /><strong>To:</strong> 04 November 2010<br /><br />Crowne Plaza, Philadelphia, PA, USA. ]]></description>
<guid>2070</guid>
</item>
<item>
<title>Biological Assays</title>
<link>http://www.drugdiscoverytoday.com/view/1904/biological-assays/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2010<br /><strong>To:</strong> 04 November 2010<br /><br />Millennium Gloucester Hotel, London, UK. ]]></description>
<guid>1904</guid>
</item>
<item>
<title>Antivirals Congress</title>
<link>http://www.drugdiscoverytoday.com/view/1653/antivirals-congress/</link>
<description><![CDATA[<strong>From:</strong> 07 November 2010<br /><strong>To:</strong> 09 November 2010<br /><br />Amsterdam, The Netherlands. ]]></description>
<guid>1653</guid>
</item>
<item>
<title>8th Annual Vaccines Conference: All Things Considered</title>
<link>http://www.drugdiscoverytoday.com/view/1807/8th-annual-vaccines-conference-all-things-considered/</link>
<description><![CDATA[<strong>From:</strong> 08 November 2010<br /><strong>To:</strong> 09 November 2010<br /><br />Washington D.C., USA . ]]></description>
<guid>1807</guid>
</item>
<item>
<title>Healthcare Reform: Dealing with Hurdles &amp; Building Up Success Conference </title>
<link>http://www.drugdiscoverytoday.com/view/1808/healthcare-reform-dealing-with-hurdles-building-up-success-conference-/</link>
<description><![CDATA[<strong>From:</strong> 08 November 2010<br /><strong>To:</strong> 09 November 2010<br /><br />Washington D.C., USA. ]]></description>
<guid>1808</guid>
</item>
<item>
<title>Emerging Therapeutic Strategies for Metabolic Disorders </title>
<link>http://www.drugdiscoverytoday.com/view/1891/emerging-therapeutic-strategies-for-metabolic-disorders-/</link>
<description><![CDATA[<strong>From:</strong> 10 November 2010<br /><strong>To:</strong> 11 November 2010<br /><br />Copthorne Tara Hotel, London, United Kingdom. ]]></description>
<guid>1891</guid>
</item>
<item>
<title>Neuroscience 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1418/neuroscience-2010/</link>
<description><![CDATA[<strong>From:</strong> 13 November 2010<br /><strong>To:</strong> 17 November 2010<br /><br />San Diego, California, USA. ]]></description>
<guid>1418</guid>
</item>
<item>
<title>NanoBioTech-Montreux 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1510/nanobiotechmontreux-2010/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2010<br /><strong>To:</strong> 17 November 2010<br /><br />Montreux, Switzerland. ]]></description>
<guid>1510</guid>
</item>
<item>
<title>Clinical Trials in CNS</title>
<link>http://www.drugdiscoverytoday.com/view/1892/clinical-trials-in-cns/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2010<br /><strong>To:</strong> 16 November 2010<br /><br />Marriott Regents Park, London, United Kingdom. ]]></description>
<guid>1892</guid>
</item>
<item>
<title>BIO-Europe 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1948/bioeurope-2010/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2010<br /><strong>To:</strong> 17 November 2010<br /><br />International Congress Centre Munich, Germany . The 16th annual BIO-Europe event will be the largest biotechnology partnering conference held in Europe. Over 2,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.]]></description>
<guid>1948</guid>
</item>
<item>
<title>RNAi Asia 2010 </title>
<link>http://www.drugdiscoverytoday.com/view/1944/rnai-asia-2010-/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2010<br /><strong>To:</strong> 16 November 2010<br /><br />Matrix Building, Biopolis, Singapore. ]]></description>
<guid>1944</guid>
</item>
<item>
<title>Screening Asia 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1945/screening-asia-2010/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2010<br /><strong>To:</strong> 16 November 2010<br /><br />Matrix Building, Biopolis, Singapore. ]]></description>
<guid>1945</guid>
</item>
<item>
<title>Safety and Selectivity in the Scale Up of Chemical Reactions</title>
<link>http://www.drugdiscoverytoday.com/view/2144/safety-and-selectivity-in-the-scale-up-of-chemical-reactions/</link>
<description><![CDATA[<strong>From:</strong> 16 November 2010<br /><strong>To:</strong> 17 November 2010<br /><br />The Grand Hotel Baglioni, Florence, Italy. ]]></description>
<guid>2144</guid>
</item>
<item>
<title>Tabletting technology for the pharmaceutical industry</title>
<link>http://www.drugdiscoverytoday.com/view/1759/tabletting-technology-for-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 22 November 2010<br /><strong>To:</strong> 24 November 2010<br /><br />Cambridge UK. The course offers delegates the unique opportunity to discuss real challenges faced in day-to-day work with the expert lecturers and delegates are encouraged to send in advance, or bring to the course, their own problems in tablet formulation or production for discussion.]]></description>
<guid>1759</guid>
</item>
<item>
<title>Next Generation Sequencing; Technologies and Applications</title>
<link>http://www.drugdiscoverytoday.com/view/2043/next-generation-sequencing-technologies-and-applications/</link>
<description><![CDATA[<strong>From:</strong> 23 November 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Hinxton Hall Conference Centre, Wellcome Trust Genome Campus, Cambridge. ]]></description>
<guid>2043</guid>
</item>
<item>
<title>World Orphan Drugs Congress: Europe 2010</title>
<link>http://www.drugdiscoverytoday.com/view/2064/world-orphan-drugs-congress-europe-2010/</link>
<description><![CDATA[<strong>From:</strong> 29 November 2010<br /><strong>To:</strong> 01 December 2010<br /><br />Crowne Plaza, Geneva, Switzerland. Strategy, partnerships and opportunity for Pharma, Biotech and Investors

The World Orphan Drug Congress is the World’s first industry-led conference tackling global trends, market access and Big Pharma impact in rare diseases. 

By attending you will learn about strategy, innovation and the future of the orphan drugs industry. From global trends and orphan drug success stories to crucial partnerships and commercial strategies, the World Orphan Drugs Congress is the only executive-level industry meeting place for new ideas in the rare disease space.
]]></description>
<guid>2064</guid>
</item>
<item>
<title>Annual General Meeting of Adebiotech, French Biotech Association</title>
<link>http://www.drugdiscoverytoday.com/view/2116/annual-general-meeting-of-adebiotech-french-biotech-association/</link>
<description><![CDATA[<strong>From:</strong> 30 November 2010<br /><strong>To:</strong> 01 January 1800<br /><br />Biocitech Life Science Park, Paris, France. ]]></description>
<guid>2116</guid>
</item>
<item>
<title>Pharmaceutical Cold Chain Distribution</title>
<link>http://www.drugdiscoverytoday.com/view/2029/pharmaceutical-cold-chain-distribution/</link>
<description><![CDATA[<strong>From:</strong> 01 December 2010<br /><strong>To:</strong> 02 December 2010<br /><br />Marriott Regents Park, London, United Kingdom. ]]></description>
<guid>2029</guid>
</item>
<item>
<title>The Influence of Patient Groups On Drug Development</title>
<link>http://www.drugdiscoverytoday.com/view/2183/the-influence-of-patient-groups-on-drug-development/</link>
<description><![CDATA[<strong>From:</strong> 03 December 2010<br /><strong>To:</strong> 01 January 1800<br /><br />The Plaza 770 Fifth Avenue (at Central Park South) New York City . New York Pharma Forum’s 21st Annual General Assembly will focus on the role and influence of patient groups on the drug development and approval process. Speakers will discuss biopharmaceutical industry funding of and involvement in patient advocacy group activities, direct input by patients to the FDA, and the influence of these groups on healthcare policy and funding.]]></description>
<guid>2183</guid>
</item>
<item>
<title>BioPharma India Convention 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1701/biopharma-india-convention-2010/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2010<br /><strong>To:</strong> 08 December 2010<br /><br />Grand Hyatt- Mumbai, India. BioPharma India Convention 2010 is where global and Indian pharmaceutical companies, biotechs, CMOs, CROs, academic institutions and many others come together to assess the latest trends, partnerships and solutions. Held concurrently are the World Pharma Trials India 2010, Biologic Manufacturing World India 2010 and R&amp;D Partnering World India 2010.]]></description>
<guid>1701</guid>
</item>
<item>
<title>Biologic Manufacturing World India 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1702/biologic-manufacturing-world-india-2010/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2010<br /><strong>To:</strong> 08 December 2010<br /><br />Grand Hyatt- Mumbai, India. Biologic Manufacturing World India is the only event in India where senior level executives from global and Indian biopharmas share their best practices in biologic manufacturing technology applications and outsourcing strategies.]]></description>
<guid>1702</guid>
</item>
<item>
<title>Drug Discovery World India 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1704/drug-discovery-world-india-2010/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2010<br /><strong>To:</strong> 08 December 2010<br /><br />Grand Hyatt, Mumbai - India. Drug Discovery World India is designed to facilitate collaboration and technology transfer for scientists, researchers, R&amp;D executives and clinicians from research institutions, pharmas, biotechs and CROs in India.]]></description>
<guid>1704</guid>
</item>
<item>
<title>Pharma Trials World India 2010</title>
<link>http://www.drugdiscoverytoday.com/view/1705/pharma-trials-world-india-2010/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2010<br /><strong>To:</strong> 08 December 2010<br /><br />Grand Hyatt, Mumbai - India. Pharma Trials World India brings together global and Indian pharmas, biotechs, CROs and clinical trial solution providers to explore effective and effi cient clinical trial development in India.]]></description>
<guid>1705</guid>
</item>
<item>
<title>The First Annual SBS China Conference - Innovation in Drug Discovery: Science &amp; Technology </title>
<link>http://www.drugdiscoverytoday.com/view/2024/the-first-annual-sbs-china-conference-innovation-in-drug-discovery-science-technology-/</link>
<description><![CDATA[<strong>From:</strong> 07 December 2010<br /><strong>To:</strong> 09 December 2010<br /><br />Pudong Shangri-La Hotel, Shanghai, China. The Society for Biomolecular Sciences (SBS), now officially the Biomolecular Sciences Section (BSS) of the Society for Laboratory Automation and Screening (SLAS), will be hosting Innovation in Drug Discovery: Science &amp; Technology in Shanghai. This conference will bring to China the traditional strengths of SBS as a forum for sharing best practices in drug discovery. The First Annual SBS China Conference will offer a unique opportunity to meet leaders in the field from Europe, North America and China. Attendees can expand their network, enhance their knowledge and explore a top-notch vendor exhibition to learn about the latest advances in the application of novel drug discovery technologies]]></description>
<guid>2024</guid>
</item>
<item>
<title>The Compound Management Forum </title>
<link>http://www.drugdiscoverytoday.com/view/2052/the-compound-management-forum-/</link>
<description><![CDATA[<strong>From:</strong> 07 December 2010<br /><strong>To:</strong> 08 December 2010<br /><br />Westin Providence Hotel, Providence, RI, USA . ]]></description>
<guid>2052</guid>
</item>
<item>
<title>National Nanotechnology Innovation Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2119/national-nanotechnology-innovation-summit/</link>
<description><![CDATA[<strong>From:</strong> 08 December 2010<br /><strong>To:</strong> 10 December 2010<br /><br />Gaylord Conference Center, Washington DC, USA. Don't miss this once in a decade gathering of the nation’s top Funding Agencies, Innovators and Investors at the National Nanotechnology Innovation Summit. Join the Nation’s top nanotech leaders showcasing their successes and discussing strategic insights into Nanotechnology Funding opportunities.

]]></description>
<guid>2119</guid>
</item>
<item>
<title>2nd Oxford Symposium on 'Epigenetic mechanisms in health and disease - Role of Chromatin Modifications in Inflammation' </title>
<link>http://www.drugdiscoverytoday.com/view/2133/2nd-oxford-symposium-on-epigenetic-mechanisms-in-health-and-disease-role-of-chromatin-modifications-in-inflammation-/</link>
<description><![CDATA[<strong>From:</strong> 09 December 2010<br /><strong>To:</strong> 10 December 2010<br /><br />Said Business School, Oxford, UK. The 2nd Oxford symposium aims to bring together clinical and preclinical scientists engaged at the forefront of control of inflammation and cancer through epigenetic and chromatin mechanisms.
We aim to explore future trends in epigenetics and related fields of gene regulation and signalling with an emphasis on prospects of translation into clinical treatments of inflammatory disorders.
]]></description>
<guid>2133</guid>
</item>
<item>
<title>International Conference on Diabetes and Metabolism</title>
<link>http://www.drugdiscoverytoday.com/view/2145/international-conference-on-diabetes-and-metabolism/</link>
<description><![CDATA[<strong>From:</strong> 13 December 2010<br /><strong>To:</strong> 14 December 2010<br /><br />Santa Clara, California, USA. ]]></description>
<guid>2145</guid>
</item>
<item>
<title>Transversales Sant&#233; (Medical devices)</title>
<link>http://www.drugdiscoverytoday.com/view/2117/transversales-sant-medical-devices/</link>
<description><![CDATA[<strong>From:</strong> 14 December 2010<br /><strong>To:</strong> 14 December 2010<br /><br />Biocitech Life Science Park, Paris, France. ]]></description>
<guid>2117</guid>
</item>
<item>
<title>Biotech Showcase™ 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1947/biotech-showcase-2011/</link>
<description><![CDATA[<strong>From:</strong> 10 January 2011<br /><strong>To:</strong> 12 January 2011<br /><br />Parc 55 Wyndham – Union Square, San Francisco, CA, USA. ]]></description>
<guid>1947</guid>
</item>
<item>
<title>PepTalk</title>
<link>http://www.drugdiscoverytoday.com/view/2111/peptalk/</link>
<description><![CDATA[<strong>From:</strong> 10 January 2011<br /><strong>To:</strong> 14 January 2011<br /><br />Hotel del Coronado, San Diego, CA, USA. ]]></description>
<guid>2111</guid>
</item>
<item>
<title>New Paradigms to Fund and Manage Product Development for Biotech and Small Pharma </title>
<link>http://www.drugdiscoverytoday.com/view/2328/new-paradigms-to-fund-and-manage-product-development-for-biotech-and-small-pharma-/</link>
<description><![CDATA[<strong>From:</strong> 13 January 2011<br /><strong>To:</strong> 14 January 2011<br /><br />The Westin San Francisco Market St., San Francisco, CA, USA. ]]></description>
<guid>2328</guid>
</item>
<item>
<title>Biomarkers, Comparative Effectiveness Research &amp; Outsourcing Strategies to Drive Value &amp; Improve Success Rates</title>
<link>http://www.drugdiscoverytoday.com/view/2327/biomarkers-comparative-effectiveness-research-outsourcing-strategies-to-drive-value-improve-success-rates/</link>
<description><![CDATA[<strong>From:</strong> 14 January 2011<br /><strong>To:</strong> 01 January 1800<br /><br />The Westin San Francisco Market St., San Francisco, CA. USA. ]]></description>
<guid>2327</guid>
</item>
<item>
<title>Pharmaceutical Microbiology </title>
<link>http://www.drugdiscoverytoday.com/view/2213/pharmaceutical-microbiology-/</link>
<description><![CDATA[<strong>From:</strong> 17 January 2011<br /><strong>To:</strong> 18 January 2011<br /><br />Copthorne Tara Hotel, Central London, UK. 

]]></description>
<guid>2213</guid>
</item>
<item>
<title>Pre-Filled Syringes</title>
<link>http://www.drugdiscoverytoday.com/view/2147/prefilled-syringes/</link>
<description><![CDATA[<strong>From:</strong> 19 January 2011<br /><strong>To:</strong> 20 January 2011<br /><br />Marriott Hotel Regents Park, London, United Kingdom. ]]></description>
<guid>2147</guid>
</item>
<item>
<title>BioBusiness 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2044/biobusiness-2011/</link>
<description><![CDATA[<strong>From:</strong> 19 January 2011<br /><strong>To:</strong> 20 January 2011<br /><br />Radisson Blu Portman Hotel, London, UK. BioBusiness 2011 will provide with you two days of networking, case studies, roundtable discussions and investment challenges, ensuring you make the most of your experience at the forum. ]]></description>
<guid>2044</guid>
</item>
<item>
<title>Paediatric Clinical Trials </title>
<link>http://www.drugdiscoverytoday.com/view/2148/paediatric-clinical-trials-/</link>
<description><![CDATA[<strong>From:</strong> 24 January 2011<br /><strong>To:</strong> 25 January 2011<br /><br />Copthorne Tara Hotel London, United Kingdom. ]]></description>
<guid>2148</guid>
</item>
<item>
<title>3rd Annual Risk Evaluation and Mitigation Strategies Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2281/3rd-annual-risk-evaluation-and-mitigation-strategies-summit/</link>
<description><![CDATA[<strong>From:</strong> 24 January 2011<br /><strong>To:</strong> 25 January 2011<br /><br />Westin Arlington Gateway, Arlington, VA, USA. ExL’s 3rd Risk Evaluation and Mitigation Strategies (REMS) Summit brings some of the most experienced professionals in the industry together to determine when risks become regulatory mandates for mitigation and how the industry is responding. We examine the impact of mandates on your drug safety programs above and beyond normal operation, and how to best implement and ensure the effectiveness of your REMS programs.

]]></description>
<guid>2281</guid>
</item>
<item>
<title>Social Media in the Pharmaceutical Industry</title>
<link>http://www.drugdiscoverytoday.com/view/2149/social-media-in-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 26 January 2011<br /><strong>To:</strong> 27 January 2011<br /><br />Copthorne Tara Hotel London, United Kingdom. ]]></description>
<guid>2149</guid>
</item>
<item>
<title>GTCbio's 9th Cytokines and Inflammation </title>
<link>http://www.drugdiscoverytoday.com/view/2242/gtcbios-9th-cytokines-and-inflammation-/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2011<br /><strong>To:</strong> 28 January 2011<br /><br />San Diego, CA, USA. In 2011, the conference will cover ever-important topics such as the TNF family, the inflammasome, chemokines, costimulation and innate immunity. In addition, timely coverage will be devoted to areas of current rapid expansion, such as the IL-17 and Th17 fields and JAK/STAT kinases, at a time when phase 2 and even phase 3 studies are being conducted and reported in these areas. Intriguing recently discovered cytokines, such as IL-25, novel alarmins and novel IL-1 family members will also be covered.

]]></description>
<guid>2242</guid>
</item>
<item>
<title>GTCbio's 8th Cancer Drugs Research and Development</title>
<link>http://www.drugdiscoverytoday.com/view/2243/gtcbios-8th-cancer-drugs-research-and-development/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2011<br /><strong>To:</strong> 28 January 2011<br /><br />Paradise Point Resort &amp; Spa, San Diego, CA, USA. The 8th Annual Cancer Drugs Research and Development Conference on January 27-28, 2011 in San Diego, California, USA will provide an extensive look at the successes as well as the challenges that face modern cancer drug development and provide you with an update on cancer drugs currently in development through clinical trials. A look at live cancer vaccines, novel  compounds and antibody drug conjugates will prime you with the future direction of cancer drugs with key topics to be discussed by leading experts.
]]></description>
<guid>2243</guid>
</item>
<item>
<title>GTCbio's 3rd Oncology Biomarkers</title>
<link>http://www.drugdiscoverytoday.com/view/2244/gtcbios-3rd-oncology-biomarkers/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2011<br /><strong>To:</strong> 28 January 2011<br /><br />Paradise Point Resort &amp; Spa, San Diego, CA, USA. GTCbio’s 3rd Oncology Biomarkers Conference focuses on topics paramount to the continuing progress of biomarker research and development. This two-day summit will bring together top leaders from the pharmaceutical and biotechnology communities, officials from the FDA and NIH, and researchers from esteemed academic institutions to discuss the landscape of research, the challenges of regulations, and the future of biomarker opportunities
]]></description>
<guid>2244</guid>
</item>
<item>
<title>Ubiquitin Research and Drug Discovery in Cancer</title>
<link>http://www.drugdiscoverytoday.com/view/2245/ubiquitin-research-and-drug-discovery-in-cancer/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2011<br /><strong>To:</strong> 28 January 2011<br /><br />Paradise Point Resort &amp; Spa, San Diego, CA, USA. This meeting, taking place on January 27-28, 2011 in San Diego, CA, will bring together leaders from biotech and pharmaceutical companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of ubiquitin and ubiquitin-like proteins and some solutions to the challenges associated with ubiquitin drug development. 

]]></description>
<guid>2245</guid>
</item>
<item>
<title>6th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies</title>
<link>http://www.drugdiscoverytoday.com/view/2136/6th-annual-international-conference-on-predictive-human-toxicity-and-admetox-studies/</link>
<description><![CDATA[<strong>From:</strong> 27 January 2011<br /><strong>To:</strong> 28 January 2011<br /><br />Brussels, Belgium. The desire to bring new drugs to market faster is a key driver of pharmaceutical companies. Being able to identify drug candidates faster with fewer missed hits has streamlined the screening process, but having insufficient knowledge of potential human toxicity early on can turn a successful drug into a devastating loss.

Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process. 
]]></description>
<guid>2136</guid>
</item>
<item>
<title>Advances In Integrative Medicine 2011 </title>
<link>http://www.drugdiscoverytoday.com/view/2214/advances-in-integrative-medicine-2011-/</link>
<description><![CDATA[<strong>From:</strong> 28 January 2011<br /><strong>To:</strong> 30 January 2010<br /><br />Waldorf Astoria/Disney Property, Orlando FL USA. 



]]></description>
<guid>2214</guid>
</item>
<item>
<title>Biomarkers Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2150/biomarkers-summit/</link>
<description><![CDATA[<strong>From:</strong> 31 January 2011<br /><strong>To:</strong> 01 February 2011<br /><br />Crowne Plaza City, Central London, UK. ]]></description>
<guid>2150</guid>
</item>
<item>
<title>Adaptive Designs in Clinical Drug Development</title>
<link>http://www.drugdiscoverytoday.com/view/2212/adaptive-designs-in-clinical-drug-development/</link>
<description><![CDATA[<strong>From:</strong> 02 February 2011<br /><strong>To:</strong> 03 February 2011<br /><br />Crowne Plaza - The City, London, UK. 
2nd &amp; 3rd February 2011, 
]]></description>
<guid>2212</guid>
</item>
<item>
<title>Keystone Symposia: Antibodies as Drugs</title>
<link>http://www.drugdiscoverytoday.com/view/2423/keystone-symposia-antibodies-as-drugs/</link>
<description><![CDATA[<strong>From:</strong> 06 February 2011<br /><strong>To:</strong> 11 February 2011<br /><br />Keystone Resort, Keystone, Colorado, USA. This conference will highlight the actual clinical experience stemming from protein engineering efforts and bring basic scientists, translational clinicians and pharmaceutical industry scientists together to discuss the next generation of antibody therapeutics and the next generation of therapeutic combinations.]]></description>
<guid>2423</guid>
</item>
<item>
<title>Pharmaceutical Parallel Trade</title>
<link>http://www.drugdiscoverytoday.com/view/2151/pharmaceutical-parallel-trade/</link>
<description><![CDATA[<strong>From:</strong> 07 February 2011<br /><strong>To:</strong> 08 February 2011<br /><br />Millennium Gloucester Hotel, London, United Kingdom. ]]></description>
<guid>2151</guid>
</item>
<item>
<title>3rd International Conference on Drug Discovery and Therapy</title>
<link>http://www.drugdiscoverytoday.com/view/1612/3rd-international-conference-on-drug-discovery-and-therapy/</link>
<description><![CDATA[<strong>From:</strong> 07 February 2011<br /><strong>To:</strong> 10 February 2011<br /><br />Dubai, UAE. This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments on drug discovery and on new therapeutics.

A conference organized by Eureka Science with support of the Higher Colleges of Technology, UAE, it focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. ]]></description>
<guid>1612</guid>
</item>
<item>
<title>Pharma R&amp;D World Asia Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2031/pharma-rd-world-asia-congress/</link>
<description><![CDATA[<strong>From:</strong> 07 February 2011<br /><strong>To:</strong> 08 February 2011<br /><br />Singapore. ]]></description>
<guid>2031</guid>
</item>
<item>
<title>Commercialization Strategies &amp; Market Access for Personalized Medicines &amp; Companion Diagnostics</title>
<link>http://www.drugdiscoverytoday.com/view/2215/commercialization-strategies-market-access-for-personalized-medicines-companion-diagnostics/</link>
<description><![CDATA[<strong>From:</strong> 09 February 2011<br /><strong>To:</strong> 10 February 2011<br /><br />Miami, Florida, USA. Gain a complete understanding and overview of the economic and business realities and potential of personalized healthcare today and in the future. 
Find out if the blockbuster strategy is alive or dead in the eyes of industry experts, payers and health technology assessors. 
Understand how to design and implement a commercially viable business model for both drugs and companion diagnostics. 
Discover how to overcome scientific, technical, regulatory, intellectual property hurdles to launching pharmacogenomics products. 
Determine the real market value of personalized medicines and companion diagnostics in terms of how much payers are willing to invest in such innovation and how to gain access. 
]]></description>
<guid>2215</guid>
</item>
<item>
<title>Keystone Symposia: MicroRNAs and Non-Coding RNAs and Cancer (Joint with MicroRNAs and Human Disease)</title>
<link>http://www.drugdiscoverytoday.com/view/2424/keystone-symposia-micrornas-and-noncoding-rnas-and-cancer-joint-with-micrornas-and-human-disease/</link>
<description><![CDATA[<strong>From:</strong> 11 February 2011<br /><strong>To:</strong> 16 February 2011<br /><br />Fairmont Banff Springs, Banff, Alberta, Canada. This meeting will bring together biologists studying the basic principles of non-coding RNA-based regulation and non-coding RNAs in cancer with industrial and clinical researchers translating non-coding RNA-based therapies into the clinic. The goal is to better understand gene regulatory mechanisms and how they are altered in cancer, and to exploit this understanding for the benefit of cancer patients. ]]></description>
<guid>2424</guid>
</item>
<item>
<title>Keystone Symposia: MicroRNAs and Human Disease (Joint with MicroRNAs and Non-Coding RNAs and Cancer)</title>
<link>http://www.drugdiscoverytoday.com/view/2425/keystone-symposia-micrornas-and-human-disease-joint-with-micrornas-and-noncoding-rnas-and-cancer/</link>
<description><![CDATA[<strong>From:</strong> 11 February 2011<br /><strong>To:</strong> 16 February 2011<br /><br />Fairmont Banff Springs, Banff, Alberta, Canada. MicroRNAs have also emerged as key regulators of additional diseases including heart disease, neurological and muscular disorders, infectious disease and vascular abnormalities. This conference will bring together international leaders in the field of microRNA biology and its relationship to human disease. ]]></description>
<guid>2425</guid>
</item>
<item>
<title>World ADC Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2280/world-adc-summit/</link>
<description><![CDATA[<strong>From:</strong> 21 February 2011<br /><strong>To:</strong> 22 February 2011<br /><br />Frankfurt, Germany. Building on the huge success of the World ADC Summit 2010, this industry gathering again brings together the perfect blend of world beating speakers, innovative drug developers and expert solution providers to meet, learn and network. Take home a new ideas and ADC-specific contacts that will drive your business and research forward.

]]></description>
<guid>2280</guid>
</item>
<item>
<title>Advances &amp; Progress in Drug Design</title>
<link>http://www.drugdiscoverytoday.com/view/2153/advances-progress-in-drug-design/</link>
<description><![CDATA[<strong>From:</strong> 21 February 2011<br /><strong>To:</strong> 22 February 2011<br /><br />Copthorne Tara Hotel, London, UK. ]]></description>
<guid>2153</guid>
</item>
<item>
<title>Stem Cells 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2152/stem-cells-2011/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2011<br /><strong>To:</strong> 24 February 2011<br /><br />Crowne Plaza - The City, London, United Kingdom. ]]></description>
<guid>2152</guid>
</item>
<item>
<title>MolecularMed Tri-Con 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2247/molecularmed-tricon-2011/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2011<br /><strong>To:</strong> 25 February 2011<br /><br />Moscone North Convention Center. ]]></description>
<guid>2247</guid>
</item>
<item>
<title>6th Annual Biomarkers Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2032/6th-annual-biomarkers-congress-/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2011<br /><strong>To:</strong> 24 February 2011<br /><br />Hilton Deansgate, Manchester UK . 

]]></description>
<guid>2032</guid>
</item>
<item>
<title>Oncology Biomarkers Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2033/oncology-biomarkers-congress-/</link>
<description><![CDATA[<strong>From:</strong> 23 February 2011<br /><strong>To:</strong> 24 February 2011<br /><br />Hilton Deansgate, Manchester UK . 
]]></description>
<guid>2033</guid>
</item>
<item>
<title>Bio/Pharmaceutical Cold Chain China</title>
<link>http://www.drugdiscoverytoday.com/view/2094/biopharmaceutical-cold-chain-china/</link>
<description><![CDATA[<strong>From:</strong> 28 February 2011<br /><strong>To:</strong> 01 March 2011<br /><br />Venue to be confirmed, China. Bio/Pharmaceutical Cold Chain China is the first and only conference that will bring together Chinese authorities and cold chain specialists from pharmaceutical companies, 3PL providers, packaging solutions and temperature monitoring solution providers to discuss how an unbroken cold chain system can be achieved in China.]]></description>
<guid>2094</guid>
</item>
<item>
<title>Vaccine World Summit India 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2178/vaccine-world-summit-india-2011/</link>
<description><![CDATA[<strong>From:</strong> 01 March 2011<br /><strong>To:</strong> 03 March 2011<br /><br />New Delhi, India. Vaccine World Summit India is the LARGEST and ONLY vaccine conference India to bring together Indian and international vaccine industry’s leading players, innovative biotechs, technocrats to showcase latest innovations from discovery to development, from manufacturing to delivery and formulation, and exchange ideas for new strategies and next generation technologies that help facilitate access to new vaccines both in the developing and the developed world, in order to combat global pandemic threats.]]></description>
<guid>2178</guid>
</item>
<item>
<title>Fifth International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum </title>
<link>http://www.drugdiscoverytoday.com/view/2331/fifth-international-pharmaceutical-regulatory-and-compliance-congress-and-best-practices-forum-/</link>
<description><![CDATA[<strong>From:</strong> 03 March 2011<br /><strong>To:</strong> 05 March 2011<br /><br />Polat Renaissance Istanbul Hotel, Istanbul, Turkey . ]]></description>
<guid>2331</guid>
</item>
<item>
<title>Generics &amp; Biosimilars Asia 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2118/generics-biosimilars-asia-2011/</link>
<description><![CDATA[<strong>From:</strong> 03 March 2011<br /><strong>To:</strong> 04 March 2011<br /><br />tbc, Singapore. With strong demand for affordable healthcare throughout Asia governments are favoring the production and prescription of generics and biosimilars. The Generics &amp; Biosimilars Asia 2011 conference is set to address many of the pressing issues faced by both innovator and generic drug companies. Attendees will be able to network, discuss and learn from peers facing similar challenges in market access, pricing and the evolving pharmaceutical industry.]]></description>
<guid>2118</guid>
</item>
<item>
<title>The Traumatic Brain Injury &amp; Neurorehabilitation Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2087/the-traumatic-brain-injury-neurorehabilitation-conference/</link>
<description><![CDATA[<strong>From:</strong> 07 March 2011<br /><strong>To:</strong> 08 March 2011<br /><br />Washington, DC, USA. Arrowhead’s Annual Traumatic Brain Injury Conference is being organized to bring together individuals from industry, government and academia to discuss the challenges and opportunities facing those involved in the research and development of new therapies for acute and chronic TBI.]]></description>
<guid>2087</guid>
</item>
<item>
<title>Imaging in Cancer Drug Development (SMi Group)</title>
<link>http://www.drugdiscoverytoday.com/view/2431/imaging-in-cancer-drug-development-smi-group/</link>
<description><![CDATA[<strong>From:</strong> 07 March 2011<br /><strong>To:</strong> 08 March 2011<br /><br />Copthorne Tara Hotel London UK. ]]></description>
<guid>2431</guid>
</item>
<item>
<title>Pharmacovigilance</title>
<link>http://www.drugdiscoverytoday.com/view/2415/pharmacovigilance/</link>
<description><![CDATA[<strong>From:</strong> 14 March 2011<br /><strong>To:</strong> 15 March 2011<br /><br />Copthorne Tara Hotel, London, UK. ]]></description>
<guid>2415</guid>
</item>
<item>
<title>Advances in Cell Based Screening Technologies</title>
<link>http://www.drugdiscoverytoday.com/view/2381/advances-in-cell-based-screening-technologies/</link>
<description><![CDATA[<strong>From:</strong> 15 March 2011<br /><strong>To:</strong> 01 January 1800<br /><br />Hinxton Hall Cambridge, UK. ELRIG Announce Free Online Registration for Cell Based Screening, March 2011 
ELRIG, the European Laboratory and Robotics Interest Group, announces free registration to ‘Advances in Cell Based Screening Technologies’ is now open online.  This meeting is being held at Hinxton Hall on 15th March 2011.
At this conference we will hear talks on the latest cutting edge detection technologies and biological techniques transitioning into screening labs. How they are faring and what might we be using in 10 years’ time.
]]></description>
<guid>2381</guid>
</item>
<item>
<title>Superbugs &amp; Superdrugs</title>
<link>http://www.drugdiscoverytoday.com/view/2416/superbugs-superdrugs/</link>
<description><![CDATA[<strong>From:</strong> 16 March 2011<br /><strong>To:</strong> 17 March 2011<br /><br />Millenium Gloucester Hotel, London, UK. ]]></description>
<guid>2416</guid>
</item>
<item>
<title>Innovations in Healthcare Management and Informatics 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2093/innovations-in-healthcare-management-and-informatics-2011/</link>
<description><![CDATA[<strong>From:</strong> 16 March 2011<br /><strong>To:</strong> 17 March 2011<br /><br />Kuala Lumpur, Malaysia. The theme of the 2011 congress is “forging new healthcare models through informatics”, with the programme covering areas of interest below:
•	Drivers of the region’s healthcare innovation - demographic and disease patterns in Asia 
•	Hospital group, nation-wide and regional EMR implementation 
•	System interoperability, data standardization, data sharing and governance for nationwide and regional healthcare provision 
•	Providing care to rural and underserved populations through telemedicine and mobile health technology 
•	Hospital system integration for streamlined management and improved patient safety 
•	Incorporating data into doctors’ decision-making processes 
•	Increasing staff awareness through education - healthcare informatics as a necessity 

]]></description>
<guid>2093</guid>
</item>
<item>
<title>Keystone Symposia: Mechanism and Biology of Silencing</title>
<link>http://www.drugdiscoverytoday.com/view/2426/keystone-symposia-mechanism-and-biology-of-silencing/</link>
<description><![CDATA[<strong>From:</strong> 20 March 2011<br /><strong>To:</strong> 25 March 2011<br /><br />Portola Hotel &amp; Spa, Monterey, California, USA. Genetic, molecular and biochemical research into RNA silencing continues to reveal new insights and understanding of processes fundamental to human development and disease. This conference will seek to unite an increasingly fragmented field by emphasizing broad themes shared by small silencing pathways in plants, animals and fungi.]]></description>
<guid>2426</guid>
</item>
<item>
<title>Discovery Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2510/discovery-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 21 March 2011<br /><strong>To:</strong> 23 March 2011<br /><br />Majestic Barri&#232;re, Cannes, France. ]]></description>
<guid>2510</guid>
</item>
<item>
<title>Accelerating Patient Recruitment &amp; Retention in Clinical Trials</title>
<link>http://www.drugdiscoverytoday.com/view/2417/accelerating-patient-recruitment-retention-in-clinical-trials/</link>
<description><![CDATA[<strong>From:</strong> 23 March 2011<br /><strong>To:</strong> 24 March 2011<br /><br />Millennium Gloucester Hotel, London, UK. ]]></description>
<guid>2417</guid>
</item>
<item>
<title>BIT Life Sciences’ 3rd Annual World Vaccines Congress-2011 </title>
<link>http://www.drugdiscoverytoday.com/view/2211/bit-life-sciences-3rd-annual-world-vaccines-congress2011-/</link>
<description><![CDATA[<strong>From:</strong> 23 March 2011<br /><strong>To:</strong> 25 March 2011<br /><br />Beijing,China. BIT Life Sciences is proud to announce that the 3rd Annual World Vaccine Congress (WCV-2011) will be held in Beijing, China during March 23-25, 2011, with a theme of “The Future of Global Vaccines”. WCV-2011 will be the largest meeting devoted exclusively to the research on vaccines and will be associated with technologies of infectious and non-infectious diseases in China. We hope that the meeting features today's exciting breakthroughs and gathers experts from all over the world to share information and discuss emerging vaccine technologies. ]]></description>
<guid>2211</guid>
</item>
<item>
<title>SBS 17th Annual Conference &amp; Exhibition </title>
<link>http://www.drugdiscoverytoday.com/view/2179/sbs-17th-annual-conference-exhibition-/</link>
<description><![CDATA[<strong>From:</strong> 27 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Orlando. Advancing the Science of Drug Discovery 

At SBS 2011 more than 2,000 scientists, engineers and other professionals from around the globe will gather to advance their skills and understanding of drug discovery and screening. At the core of this important conference is a content-rich educational agenda that offers 15 technical sessions organized in three main areas of interest: Innovations in the Screening Sciences, Translational Research, and Sequenced Genomes: Reducing Opportunities to Practice. 

For those interested in fast-tracking their knowledge of important drug discovery topics, pre-conference short courses offer in-depth focus and active audience involvement. Participants can also explore the latest advancements in technology presented by more than 200 exhibitors; enjoy thought-provoking keynote presentations and further personal career objectives through a variety of networking events. 
Join SBS in Orlando March 27 – 31, 2011. For more information, visit www.slas.org/events/sbs11. 
]]></description>
<guid>2179</guid>
</item>
<item>
<title>BioVision 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2143/biovision-2011/</link>
<description><![CDATA[<strong>From:</strong> 27 March 2011<br /><strong>To:</strong> 29 March 2011<br /><br />Lyon Convention Centre, Lyons, France. ]]></description>
<guid>2143</guid>
</item>
<item>
<title>4th annual Drug Discovery World Asia 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1706/4th-annual-drug-discovery-world-asia-2011/</link>
<description><![CDATA[<strong>From:</strong> 28 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Marina Bay Sands - Singapore. Drug Discovery World Asia 2011 is a strategic and scientific conference for discussing innovation, technology and partnership in driving drug discovery and pre-clinical development in India.]]></description>
<guid>1706</guid>
</item>
<item>
<title>4th annual Pharma Partnering World Asia 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1707/4th-annual-pharma-partnering-world-asia-2011/</link>
<description><![CDATA[<strong>From:</strong> 28 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Marina Bay Sands - Singapore. Pharma Partnering World Asia 2011 will bring together pharmas, start-up &amp; spin-off biotechs, research and academic institutions, professional investors, contract research service providers to network and evaluate partnering opportunities in Asia.]]></description>
<guid>1707</guid>
</item>
<item>
<title>4th annual Pharma Trials World Asia 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1708/4th-annual-pharma-trials-world-asia-2011/</link>
<description><![CDATA[<strong>From:</strong> 28 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Marina Bay Sands - Singapore. Pharma Trials World Asia brings together global and Asian pharmas, biotechs, CROs and clinical trial solution providers to explore effective and efficient clinical trial development in Asia.]]></description>
<guid>1708</guid>
</item>
<item>
<title>DIA 23rd annual EuroMeeting</title>
<link>http://www.drugdiscoverytoday.com/view/2419/dia-23rd-annual-euromeeting/</link>
<description><![CDATA[<strong>From:</strong> 28 March 2011<br /><strong>To:</strong> 30 March 2011<br /><br />Geneva Palexpo, Switzerland. The landscape of drug development is changing. Pharmaceutical industry, academia and regulators are facing unprecedented challenges. Great expectations exist for groundbreaking scientific innovation, efficient cost-effective delivery, high standards of patient protection, excellent communications and transparency and best value for the payers as well as patients and professionals. ]]></description>
<guid>2419</guid>
</item>
<item>
<title>4th annual BioPharma Asia Convention 2011</title>
<link>http://www.drugdiscoverytoday.com/view/1709/4th-annual-biopharma-asia-convention-2011/</link>
<description><![CDATA[<strong>From:</strong> 28 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Marina Bay Sands - Singapore. BioPharma Asia Convention 2011 is uniquely positioned as Asia's only exhibition that showcases leading technocrats, solution and service suppliers across the entire value chain of the biopharma indstury in Asia!]]></description>
<guid>1709</guid>
</item>
<item>
<title>LogiPharma Europe</title>
<link>http://www.drugdiscoverytoday.com/view/2237/logipharma-europe/</link>
<description><![CDATA[<strong>From:</strong> 29 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Hotel President Wilson, Geneva, Switzerland. LogiPharma Europe is the annual gathering of senior-level pharmaceutical supply chain executives in Geneva, where over 120 Global Heads and VPs of supply chain, logistics and procurement gather to share best practice and identify solutions to the most prevalent challenges affecting pharmaceutical logistics.

]]></description>
<guid>2237</guid>
</item>
<item>
<title>Controlled Release (SMi Group)</title>
<link>http://www.drugdiscoverytoday.com/view/2432/controlled-release-smi-group/</link>
<description><![CDATA[<strong>From:</strong> 30 March 2011<br /><strong>To:</strong> 31 March 2011<br /><br />Copthorne Tara Hotel, London, UK. ]]></description>
<guid>2432</guid>
</item>
<item>
<title>Keystone Symposia: Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow</title>
<link>http://www.drugdiscoverytoday.com/view/2427/keystone-symposia-drugs-from-bugs-the-antiinflammatory-drugs-of-tomorrow/</link>
<description><![CDATA[<strong>From:</strong> 03 April 2011<br /><strong>To:</strong> 07 April 2011<br /><br />Snowbird Resort, Snowbird, Utah, US. Joint with Evolving Approaches to Early-Stage Drug Discovery

This meeting will bring together cross-disciplinary scientists to examine the growing opportunities for discovery of novel drugs from pathogens. Novel therapeutic strategies and new drugs can be developed by both understanding how pathogens modulate and usurp the immune system, and also by identifying the functional molecules from pathogens. ]]></description>
<guid>2427</guid>
</item>
<item>
<title>Keystone Symposia: Evolving Approaches to Early-Stage Drug Discovery </title>
<link>http://www.drugdiscoverytoday.com/view/2428/keystone-symposia-evolving-approaches-to-earlystage-drug-discovery-/</link>
<description><![CDATA[<strong>From:</strong> 03 April 2011<br /><strong>To:</strong> 07 April 2011<br /><br />Snowbird Resort, Snowbird, Utah, USA. Joint with Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow

This meeting will cover multiple challenges and opportunities facing drug discovery scientists, including diverse approaches to early-stage discovery in a resource-constrained environment, evolution of preclinical drug discovery in academia, evolution of drug leads/target validation from the NIH (MLPCN), funding early-stage/risky programs, external licensing of programs, and advances in biomarkers/imaging to enable target selection and rapid go/no go decisions.]]></description>
<guid>2428</guid>
</item>
<item>
<title>Encouraging Development of Therapeutics for Neglected Diseases</title>
<link>http://www.drugdiscoverytoday.com/view/2394/encouraging-development-of-therapeutics-for-neglected-diseases/</link>
<description><![CDATA[<strong>From:</strong> 04 April 2011<br /><strong>To:</strong> 05 April 2011<br /><br />Crowne Plaza Philadelphia Downtown Hotel,Philadelphia, PA , USA . ]]></description>
<guid>2394</guid>
</item>
<item>
<title>RNA Single Cell Biology-2011 Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2395/rna-single-cell-biology2011-summit/</link>
<description><![CDATA[<strong>From:</strong> 04 April 2011<br /><strong>To:</strong> 05 April 2011<br /><br />Hilton Garden Inn, 420 Totten Pond Road, Waltham 02451 USA. This Year RNAi-2011-Meeting Will Be held in Conjunction with Single Cell Biology-2011-Meeting. 
Two Tracks, One Venue


]]></description>
<guid>2395</guid>
</item>
<item>
<title>4th Annual Proteins Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2034/4th-annual-proteins-congress-/</link>
<description><![CDATA[<strong>From:</strong> 04 April 2011<br /><strong>To:</strong> 05 April 2011<br /><br />Copthorne Tara Hotel, London, UK . ]]></description>
<guid>2034</guid>
</item>
<item>
<title>Vaccines Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2035/vaccines-congress-/</link>
<description><![CDATA[<strong>From:</strong> 04 April 2011<br /><strong>To:</strong> 05 April 2011<br /><br />Copthorne Tara Hotel, London, UK . 
]]></description>
<guid>2035</guid>
</item>
<item>
<title>LogiChem 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2329/logichem-2011/</link>
<description><![CDATA[<strong>From:</strong> 05 April 2011<br /><strong>To:</strong> 07 April 2011<br /><br />Hilton, Antwerp, Belgium. ]]></description>
<guid>2329</guid>
</item>
<item>
<title>Personalized Medicine Partnerships Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2088/personalized-medicine-partnerships-conference/</link>
<description><![CDATA[<strong>From:</strong> 11 April 2011<br /><strong>To:</strong> 13 April 2011<br /><br />Washington, DC, USA. At Arrowhead’s 2011 Personalized Medicine Partnerships Conference, we will highlight key issues in forming partnerships and engage the best speakers to share their experiences with you. These key issues include:
•	what pharmaceutical and diagnostic companies are looking for in a partner
•	partnering challenges that arise within the realm of contractual negotiations, IP protection, regulatory affairs and commercialization
•	benefits of partnerships, including more effective, efficient and safer clinical trials
•	how and when to start a relationship, ie. discovery, clinical, post-commercialization?
•	the risks of partnering
]]></description>
<guid>2088</guid>
</item>
<item>
<title>Proteinase 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2578/proteinase-2011/</link>
<description><![CDATA[<strong>From:</strong> 11 April 2011<br /><strong>To:</strong> 12 April 2011<br /><br />Novartis, Basel, Switzerland. This symposium will cover progress in the design and synthesis of aspartic, serine, cysteine and metalloprotease inhibitors for a diverse range of target indications, while also covering a range of drug discovery activities: from Molecules to Medicines.]]></description>
<guid>2578</guid>
</item>
<item>
<title>World Orphan Drug Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2326/world-orphan-drug-congress/</link>
<description><![CDATA[<strong>From:</strong> 12 April 2011<br /><strong>To:</strong> 15 April 2011<br /><br />Hilton Embassy Row, Washington D.C.. ]]></description>
<guid>2326</guid>
</item>
<item>
<title>Asthma &amp; COPD</title>
<link>http://www.drugdiscoverytoday.com/view/2418/asthma-copd/</link>
<description><![CDATA[<strong>From:</strong> 13 April 2011<br /><strong>To:</strong> 14 April 2011<br /><br />London Marriott Hotel Regent's Park, London, UK. ]]></description>
<guid>2418</guid>
</item>
<item>
<title>Pharma - Nutrition 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2027/pharma-nutrition-2011/</link>
<description><![CDATA[<strong>From:</strong> 18 April 2011<br /><strong>To:</strong> 20 April 2011<br /><br />Amsterdam, The Netherlands. Pharma - Nutrition 2011 is the first and foremost platform entirely dedicated to the scientific interface between pharma and food. Key thought leaders from both pharmacology and food science communities will converge to discuss the latest research, concepts and applications of medical nutrition in patient treatment and disease management for the purpose of improving patient outcomes.]]></description>
<guid>2027</guid>
</item>
<item>
<title>GTCbio's 2nd Cancer Immunotherapy &amp; Immunomonitoring</title>
<link>http://www.drugdiscoverytoday.com/view/2246/gtcbios-2nd-cancer-immunotherapy-immunomonitoring/</link>
<description><![CDATA[<strong>From:</strong> 02 May 2011<br /><strong>To:</strong> 05 May 2011<br /><br />art'otel budapest, by park plaza, Bem Rakpart 16-19, Budapest H-1011 , HUNGARY . The 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) Conference on May 2-5, 2011 in Budapest, Hungary allows scientists, clinicians, medical practitioners and specialists, students, R&amp;D experts and patients to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field. 
]]></description>
<guid>2246</guid>
</item>
<item>
<title>Fifth International Pharma Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2386/fifth-international-pharma-congress-/</link>
<description><![CDATA[<strong>From:</strong> 03 May 2011<br /><strong>To:</strong> 05 May 2011<br /><br />Polat Renaissance Istanbul Hotel, Istanbul, Turkey  . Sponsored by the Pharmaceutical Compliance Forum ]]></description>
<guid>2386</guid>
</item>
<item>
<title>Evolution Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2509/evolution-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 04 May 2011<br /><strong>To:</strong> 06 May 2011<br /><br />The Westin Diplomat Resort &amp; Spa, Hollywood, FL, USA. ]]></description>
<guid>2509</guid>
</item>
<item>
<title>Ubiquitin Proteasome: The Business of Therapeutic Intervention</title>
<link>http://www.drugdiscoverytoday.com/view/2513/ubiquitin-proteasome-the-business-of-therapeutic-intervention/</link>
<description><![CDATA[<strong>From:</strong> 09 May 2011<br /><strong>To:</strong> 10 May 2011<br /><br />Marriott Hotel, Two Cambridge Center, 50 Broadway, Cambridge, MA, USA . This conference sits at the confluence of basic research, public policy, investment opportunity and the escalating cost of healthcare debate. Does the world urgently need shared access to an effective and complete screening library for identifying inhibitors of the many E3 ubiquitin ligases? Is ubiquitination more versatile than phosphorylation? In whose world would the ratio of Kinase inhibitors to approved UP drugs remain 16:1? 
]]></description>
<guid>2513</guid>
</item>
<item>
<title>Generics, Super-Generics and Patent Strategies (SMi Group)</title>
<link>http://www.drugdiscoverytoday.com/view/2433/generics-supergenerics-and-patent-strategies-smi-group/</link>
<description><![CDATA[<strong>From:</strong> 11 May 2011<br /><strong>To:</strong> 12 May 2011<br /><br />Millennium Gloucester Hotel, Central London, UK. ]]></description>
<guid>2433</guid>
</item>
<item>
<title>Keystone Symposia: Lipid Biology and Lipotoxicity</title>
<link>http://www.drugdiscoverytoday.com/view/2429/keystone-symposia-lipid-biology-and-lipotoxicity/</link>
<description><![CDATA[<strong>From:</strong> 15 May 2011<br /><strong>To:</strong> 20 May 2011<br /><br />INEC-Ireland’s National Events and Conference Centre, Killarney, County Kerry, Ireland. This conference will review advances in genomics and lipidomics that have improved our understanding of pathogenic conditions resulting from the excessive production and/or underutilization of fat. It places specific emphasis on relationships between ectopic lipid deposition and metabolic disease, mechanisms through which lipid excess alters tissue function, regulatory processes that control lipid storage and advances in the area of lipid analysis.]]></description>
<guid>2429</guid>
</item>
<item>
<title>Society for Clinical Trials Annual Meeting</title>
<link>http://www.drugdiscoverytoday.com/view/2521/society-for-clinical-trials-annual-meeting/</link>
<description><![CDATA[<strong>From:</strong> 15 May 2011<br /><strong>To:</strong> 18 May 2011<br /><br />Hyatt Regency, Vancouver, British Columbia, Canada. ]]></description>
<guid>2521</guid>
</item>
<item>
<title>Clinical Trial Logistics</title>
<link>http://www.drugdiscoverytoday.com/view/2594/clinical-trial-logistics/</link>
<description><![CDATA[<strong>From:</strong> 16 May 2011<br /><strong>To:</strong> 17 May 2011<br /><br />Marriott Regents Park, London, UK. ]]></description>
<guid>2594</guid>
</item>
<item>
<title>Advances in Neuropsychiatric Treatment Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2734/advances-in-neuropsychiatric-treatment-conference/</link>
<description><![CDATA[<strong>From:</strong> 19 May 2011<br /><strong>To:</strong> 19 May 2011<br /><br />Hotel Kabuki, San Francisco, CA 94115 USA. ]]></description>
<guid>2734</guid>
</item>
<item>
<title>Discovery Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2508/discovery-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 21 May 2011<br /><strong>To:</strong> 23 May 2011<br /><br />Majestic Barri&#232;re, Cannes, France. ]]></description>
<guid>2508</guid>
</item>
<item>
<title>3rd Ocular Diseases &amp; Drug Discovery</title>
<link>http://www.drugdiscoverytoday.com/view/2559/3rd-ocular-diseases-drug-discovery/</link>
<description><![CDATA[<strong>From:</strong> 26 May 2011<br /><strong>To:</strong> 27 May 2011<br /><br />Seaport Hotel, One Seaport Lane, Boston, MA 02210 USA. To help promote the discovery of ocular disease and drug development, GTCbio is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research and drugs available in combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases at the 3rd Ocular Diseases &amp; Drug Discovery Conference. 

]]></description>
<guid>2559</guid>
</item>
<item>
<title>Pain Therapeutics: Clinical Studies in Pain</title>
<link>http://www.drugdiscoverytoday.com/view/2527/pain-therapeutics-clinical-studies-in-pain/</link>
<description><![CDATA[<strong>From:</strong> 01 June 2011<br /><strong>To:</strong> 02 June 2011<br /><br />Crowne Plaza City Hotel, London, UK. Now in its 11th year, SMi's annual Pain Therapeutic conference series has gone from strength to strength. This year's event seeks to address the current issues facing the Clinical R&amp;D field of Pain drug development, and the challenges when taking a new drug from pre- to post-clinical trials.

]]></description>
<guid>2527</guid>
</item>
<item>
<title>Clinical Trials in Oncology</title>
<link>http://www.drugdiscoverytoday.com/view/2764/clinical-trials-in-oncology/</link>
<description><![CDATA[<strong>From:</strong> 03 June 2011<br /><strong>To:</strong> 03 June 2011<br /><br />Amara Hotel, Tanjong Pagar Road, Singapore 088539. Attend Clinical Trials in Oncology Asia and join the leading pharma and biotech companies, CROs and related solution providers to discuss the in-depth insights into the planning and effective methods to mitigate risks, raise efficiency and control cost for clinical trials in oncology in the Asia Pacific region]]></description>
<guid>2764</guid>
</item>
<item>
<title>DDI-2011: International Conference on Drug-Drug Interactions</title>
<link>http://www.drugdiscoverytoday.com/view/2349/ddi2011-international-conference-on-drugdrug-interactions/</link>
<description><![CDATA[<strong>From:</strong> 06 June 2011<br /><strong>To:</strong> 08 June 2011<br /><br />Seattle, Washington, USA. ]]></description>
<guid>2349</guid>
</item>
<item>
<title>Thermo Fisher Scientific - UK Summer Symposium Seminar</title>
<link>http://www.drugdiscoverytoday.com/view/2690/thermo-fisher-scientific-uk-summer-symposium-seminar/</link>
<description><![CDATA[<strong>From:</strong> 07 June 2011<br /><strong>To:</strong> 01 January 1800<br /><br />QEII Conference Centre, London, UK. The Symposium will include presentations from scientists both from within the company and key users from representative organisations who are utilising Thermo Scientific products and equipment to further their daily research. In addition, Thermo Scientific representatives will be available throughout the day to discuss any technical questions. A parallel exhibition will showcase the latest updates in Thermo Scientific products from across the company including scientific instrumentation, laboratory products, microbiology and cellomics as well as related products from selected third party suppliers to enhance your research and analyses.]]></description>
<guid>2690</guid>
</item>
<item>
<title>Structure Based Drug Design</title>
<link>http://www.drugdiscoverytoday.com/view/2573/structure-based-drug-design/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2011<br /><strong>To:</strong> 10 June 2011<br /><br />Royal Sonesta Hotel, Boston, MA. USA. Cambridge Healthtech Institute’s Eleventh Annual Structure-Based Drug Design conference brings to focus the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.

]]></description>
<guid>2573</guid>
</item>
<item>
<title>12th Annual Drug Discovery Leaders Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2036/12th-annual-drug-discovery-leaders-summit/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2011<br /><strong>To:</strong> 09 June 2011<br /><br />Montreux Palace, Switzerland .  

]]></description>
<guid>2036</guid>
</item>
<item>
<title>2nd Annual Drug Development Congress </title>
<link>http://www.drugdiscoverytoday.com/view/2037/2nd-annual-drug-development-congress-/</link>
<description><![CDATA[<strong>From:</strong> 08 June 2011<br /><strong>To:</strong> 09 June 2011<br /><br />Montreux Palace, Switzerland . 
]]></description>
<guid>2037</guid>
</item>
<item>
<title>ETS-2011: International Conference on Early Toxicity Screening</title>
<link>http://www.drugdiscoverytoday.com/view/2350/ets2011-international-conference-on-early-toxicity-screening/</link>
<description><![CDATA[<strong>From:</strong> 09 June 2011<br /><strong>To:</strong> 10 June 2011<br /><br />Seattle, Washington, USA. ]]></description>
<guid>2350</guid>
</item>
<item>
<title>Pharmaceutical Sciences for the Future of Medicines</title>
<link>http://www.drugdiscoverytoday.com/view/2557/pharmaceutical-sciences-for-the-future-of-medicines/</link>
<description><![CDATA[<strong>From:</strong> 13 June 2011<br /><strong>To:</strong> 17 June 2011<br /><br />Prague, Czech Republic. ]]></description>
<guid>2557</guid>
</item>
<item>
<title>High Throughput BioProcess Development</title>
<link>http://www.drugdiscoverytoday.com/view/2556/high-throughput-bioprocess-development/</link>
<description><![CDATA[<strong>From:</strong> 22 June 2011<br /><strong>To:</strong> 01 January 1800<br /><br />Daresbury Park Hotel, Warrington, UK . This conference will bring together leading experts in a number of these fields in order to both look at the state of the art today and what may be available in the future. The meeting will consist of presentations covering early R&amp;D in the area of Bioprocessing and also the move to use the information found by high through put methods to assist in the scale up process including the use of single-use components.

]]></description>
<guid>2556</guid>
</item>
<item>
<title>RNAi, miRNA &amp; siRNA</title>
<link>http://www.drugdiscoverytoday.com/view/2525/rnai-mirna-sirna/</link>
<description><![CDATA[<strong>From:</strong> 27 June 2011<br /><strong>To:</strong> 28 June 2011<br /><br />Copthorne Tara Hotel, London, UK. ]]></description>
<guid>2525</guid>
</item>
<item>
<title>2nd Annual Clinically Relevant Drug Transporters</title>
<link>http://www.drugdiscoverytoday.com/view/2519/2nd-annual-clinically-relevant-drug-transporters/</link>
<description><![CDATA[<strong>From:</strong> 28 June 2011<br /><strong>To:</strong> 29 June 2011<br /><br />venue to be confirmed, London, UK. Exploring assay development approaches for a range of transporter subfamilies

Evaluating and clarifying the FDA guidelines and if the EMA will follow suit

Using in vitro data to uncover clinically relevant drug-drug interactions

Assessing the possible vitro modelling techniques that will improve the efficiency of your clinical development

Developing a strategy - in house vs. outsourcing
]]></description>
<guid>2519</guid>
</item>
<item>
<title>7th Annual Improving Solubility Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2608/7th-annual-improving-solubility-summit/</link>
<description><![CDATA[<strong>From:</strong> 28 June 2011<br /><strong>To:</strong> 30 June 2011<br /><br />America Square Conference Centre, London. The 7th Annual Improving Solubility conference will investigate classic and novel drug delivery solutions utilised to improve bioavailability, increase uptake and minimise time-to-market of new chemical entities as well as reformulated compounds in the development pipeline.

]]></description>
<guid>2608</guid>
</item>
<item>
<title>Improving Solubility</title>
<link>http://www.drugdiscoverytoday.com/view/2654/improving-solubility/</link>
<description><![CDATA[<strong>From:</strong> 28 June 2011<br /><strong>To:</strong> 29 June 2011<br /><br />America Square Conference Centre, London, United Kingdom. The 5th Annual Improving Solubility conference will investigate classic and novel drug delivery solutions utilized to improve bioavailability, increase uptake and minimize time-to-market of new chemical entities as well as reformulated compounds in the development pipeline. Attend to learn of the best practices, techniques and technologies that help streamline the pharmaceutical drug development process and move compounds out of the formulation and pre-clinical phase.

]]></description>
<guid>2654</guid>
</item>
<item>
<title>KOL Management and MSL Best Practice in Europe </title>
<link>http://www.drugdiscoverytoday.com/view/2595/kol-management-and-msl-best-practice-in-europe-/</link>
<description><![CDATA[<strong>From:</strong> 29 June 2011<br /><strong>To:</strong> 30 June 2011<br /><br />Hotel Vier Jahreszeiten Kempinski, Munich, Germany. ]]></description>
<guid>2595</guid>
</item>
<item>
<title>Pharmaceutical Nanotechnology: Applications &amp; Commercialisation</title>
<link>http://www.drugdiscoverytoday.com/view/2524/pharmaceutical-nanotechnology-applications-commercialisation/</link>
<description><![CDATA[<strong>From:</strong> 29 June 2011<br /><strong>To:</strong> 30 June 2011<br /><br />Copthorne Tara Hotel, London, UK. ]]></description>
<guid>2524</guid>
</item>
<item>
<title>European Lab Automation Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2593/european-lab-automation-congress/</link>
<description><![CDATA[<strong>From:</strong> 30 June 2011<br /><strong>To:</strong> 01 July 2011<br /><br />Hamburg, Germany. The conference, which is the first of its kind to be held in Europe, will offer delegates the chance to sample the latest automation products for life science from over 120 of the world's leading equipment vendors.
Running alongside the exhibition will be 10 distinct conference tracks with over 150 scientific presentations, ranging from compound management in screening to effective tissue and cell biobanking.]]></description>
<guid>2593</guid>
</item>
<item>
<title>University of Oxford Nanomedicine Summer School 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2646/university-of-oxford-nanomedicine-summer-school-2011/</link>
<description><![CDATA[<strong>From:</strong> 04 July 2011<br /><strong>To:</strong> 08 July 2011<br /><br />University of Oxford, UK. This is the third of Oxford University's highly successful nanotechnology Summer Schools. This year it will be focusing on applications of nanotechnology to medicine and healthcare reflecting growing interest in the subject and the University of Oxford's position at the cutting-edge of research and development. The Summer School lasts for five days and the following topics are covered:

Monday 4 July: Introduction to nanomedicine - challenges and opportunities
Tuesday 5 July: Nanotechnologies for regenerative medicine and tissue engineering
Wednesday 6 July: Nano-Diagnostics
Thursday 7 July: Nano-Biosensors
Friday 8 July: Nano-Pharmaceuticals
]]></description>
<guid>2646</guid>
</item>
<item>
<title>Admet</title>
<link>http://www.drugdiscoverytoday.com/view/2597/admet/</link>
<description><![CDATA[<strong>From:</strong> 06 July 2011<br /><strong>To:</strong> 07 July 2011<br /><br />Copthorne Tara Hotel, London. ]]></description>
<guid>2597</guid>
</item>
<item>
<title>3rd WIN Symposium - Personalized Cancer Medicine; </title>
<link>http://www.drugdiscoverytoday.com/view/2714/3rd-win-symposium-personalized-cancer-medicine-/</link>
<description><![CDATA[<strong>From:</strong> 06 July 2011<br /><strong>To:</strong> 08 July 2011<br /><br />Palais des Congr&#232;s, Paris, France. The WIN Symposium will inaugurate an unprecedented format, where pharma, biotech, academia and patient organizations will be presenting their views on how to address the challenges of efficacy of cancer diagnostics and therapeutics in the era of personalized healthcare, to the benefit of the patients.]]></description>
<guid>2714</guid>
</item>
<item>
<title>Social Media in the Pharmaceutical Industry</title>
<link>http://www.drugdiscoverytoday.com/view/2721/social-media-in-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 06 July 2011<br /><strong>To:</strong> 07 July 2011<br /><br />Crown Plaza - London, UK. ]]></description>
<guid>2721</guid>
</item>
<item>
<title>Novel Technologies  in Drug Discovery Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2715/novel-technologies-in-drug-discovery-summit/</link>
<description><![CDATA[<strong>From:</strong> 07 July 2011<br /><strong>To:</strong> 08 July 2011<br /><br />Hyatt at Fisherman's Wharf, San Francisco, CA, USA . The Novel Technologies in Drug Discovery Summit brings together experts from academia and industry to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields]]></description>
<guid>2715</guid>
</item>
<item>
<title>6th Assay &amp; Drug Discovery Technologies</title>
<link>http://www.drugdiscoverytoday.com/view/2716/6th-assay-drug-discovery-technologies/</link>
<description><![CDATA[<strong>From:</strong> 07 July 2011<br /><strong>To:</strong> 08 July 2011<br /><br />Hyatt at Fisherman's Wharf, San Francisco, CA, USA . Over the years, the field of assay technologies, laboratory automation, and informatics has taken great leaps in advancement. Present demands from the drug discovery process have propelled a shift in focus from high throughput screening to high content analysis in the assay and drug discovery technology arena. There has also been a push for more physiologically relevant biochemical and cell based assays for compound screening. New avenues for exploration like label-free technology and the use of stem cell screening and nano screening are also emerging on the forefront of discovery techniques. The economic landscape has also created a sense of urgency for the pharmaceutical industry to further reduce the cost of research and development, leading to discussions of the feasibility of outsourcing screening and analysis. ]]></description>
<guid>2716</guid>
</item>
<item>
<title>Biobanking 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2596/biobanking-2011/</link>
<description><![CDATA[<strong>From:</strong> 11 July 2011<br /><strong>To:</strong> 12 July 2011<br /><br />Crowne Plaza – The City, London, UK. ]]></description>
<guid>2596</guid>
</item>
<item>
<title>Epigenomics, Sequencing &amp; SNiPs-2011</title>
<link>http://www.drugdiscoverytoday.com/view/2396/epigenomics-sequencing-snips2011/</link>
<description><![CDATA[<strong>From:</strong> 11 July 2011<br /><strong>To:</strong> 12 July 2011<br /><br />The Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA . Mechanisms of Chromatin in gene regulation
Nuclear dynamics and Methylation Assays
Parental imprinting and Histone Deacetylation inhibitors as drugs 
Epigenetic re-programming in stem cells
Cutting-edge sequencing technology; Epigenome Sequencing
Epigenetic regulatory processes in diseases &amp; environment
PharmacoEpigenomics
]]></description>
<guid>2396</guid>
</item>
<item>
<title>The Drug Repositioning Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2420/the-drug-repositioning-conference/</link>
<description><![CDATA[<strong>From:</strong> 13 July 2011<br /><strong>To:</strong> 14 July 2011<br /><br />San Francisco, CA, USA. ]]></description>
<guid>2420</guid>
</item>
<item>
<title>2nd Annual Biosimilars India 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2788/2nd-annual-biosimilars-india-2011/</link>
<description><![CDATA[<strong>From:</strong> 14 July 2011<br /><strong>To:</strong> 15 July 2011<br /><br />Mumbai, India. ]]></description>
<guid>2788</guid>
</item>
<item>
<title>Pharmaceutical and Clinical Trial Logistics Asia Pacific</title>
<link>http://www.drugdiscoverytoday.com/view/2722/pharmaceutical-and-clinical-trial-logistics-asia-pacific/</link>
<description><![CDATA[<strong>From:</strong> 18 July 2011<br /><strong>To:</strong> 19 July 2011<br /><br />Grand Copthorne Waterfront Hotel, Singapore. ]]></description>
<guid>2722</guid>
</item>
<item>
<title>2nd Annual PharmaLytica India 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2789/2nd-annual-pharmalytica-india-2011/</link>
<description><![CDATA[<strong>From:</strong> 26 July 2011<br /><strong>To:</strong> 28 July 2011<br /><br />Mumbai, India. ]]></description>
<guid>2789</guid>
</item>
<item>
<title>12th International Congress on Amino Acids, Peptides and Proteins</title>
<link>http://www.drugdiscoverytoday.com/view/2483/12th-international-congress-on-amino-acids-peptides-and-proteins/</link>
<description><![CDATA[<strong>From:</strong> 01 August 2011<br /><strong>To:</strong> 05 August 2011<br /><br />Beijing International Convention Center, Beijing, China. This is a bi-annual congress based on the journal AMINO ACIDS (impact factor 3.877). The journal AMINO ACIDS, The forum for amino acid, peptide and protein research, has been established in 1991 by Gert Lubec, FRSC (UK). The editorial board consists of section editors that are major experts in the corresponding areas of this multidisciplinary journal covering most areas in chemistry, biology, medicine, nutrition and pharmacology, to name a few. 

]]></description>
<guid>2483</guid>
</item>
<item>
<title>2nd Annual NDDS India 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2790/2nd-annual-ndds-india-2011/</link>
<description><![CDATA[<strong>From:</strong> 10 August 2011<br /><strong>To:</strong> 12 August 2011<br /><br />Mumbai, India. ]]></description>
<guid>2790</guid>
</item>
<item>
<title>Targeted Antibodies for Cancer 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2652/targeted-antibodies-for-cancer-2011/</link>
<description><![CDATA[<strong>From:</strong> 10 August 2011<br /><strong>To:</strong> 11 August 2011<br /><br />Etc. Venues Paddington, 57 North Wharf Road, London. In recent years, targeted antibodies have emerged as playing a pivotal role in cancer therapeutics and are an increasingly important research area for the pharmaceutical, biotech and medical industries.

In such a fast-paced and competitive field, it is crucial for the key players to stay up-to date with the recent advances in antibody research and development.

TAC 2011 will address the critical scientific issues and challenges associated with developing targeted therapeutic antibodies for cancer. It will highlight improvements in antibody development, global trends and current clinical progress.
]]></description>
<guid>2652</guid>
</item>
<item>
<title>World Drug Delivery Congress 2011 </title>
<link>http://www.drugdiscoverytoday.com/view/2782/world-drug-delivery-congress-2011-/</link>
<description><![CDATA[<strong>From:</strong> 05 September 2011<br /><strong>To:</strong> 07 September 2011<br /><br />Singapore. ]]></description>
<guid>2782</guid>
</item>
<item>
<title>5th Annual ELRIG Drug Discovery Conference </title>
<link>http://www.drugdiscoverytoday.com/view/2458/5th-annual-elrig-drug-discovery-conference-/</link>
<description><![CDATA[<strong>From:</strong> 07 September 2011<br /><strong>To:</strong> 08 September 2011<br /><br />Manchester Central, UK. As with our highly successful meeting in 2010, attendees will hear world class speakers discussing the challenges and opportunities facing the drug discovery scientist.  The scientific sessions will be complemented by a poster session, a growing vendor exhibition with over 85 exhibitors and a number of training workshops.]]></description>
<guid>2458</guid>
</item>
<item>
<title>BioPharm America™ 2011—4th Annual International Partnering Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2493/biopharm-america-20114th-annual-international-partnering-conference/</link>
<description><![CDATA[<strong>From:</strong> 07 September 2011<br /><strong>To:</strong> 09 September 2011<br /><br />Boston, MA, USA. BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE&#174;, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe&#174; and BIO-Europe Spring&#174;. In 2010, BioPharm America attracted 850 delegates from 565 companies who participated in 2,550+ scheduled one-to-one meetings. ]]></description>
<guid>2493</guid>
</item>
<item>
<title>Pharma ChemOutsourcing Conference &amp; Exhibition</title>
<link>http://www.drugdiscoverytoday.com/view/2514/pharma-chemoutsourcing-conference-exhibition/</link>
<description><![CDATA[<strong>From:</strong> 12 September 2011<br /><strong>To:</strong> 15 September 2011<br /><br />Ocean Place Resort - Long Branch, NJ, USA . Small Molecule Biotech Chemist Sourcing Focus
The Conference is Especially Geared to Your Unique Sourcing Needs 
High Value Networking
Attended by the Highest Ratio of Pharmaceutical Attendees of Any Chemistry Show 
High Value Conference Program Available Nowhere Else
Hear from 120 Pharma Company Chemistry Speakers Who Do Your Job 
Exhibition is Strictly Limited to 100 Booths
85% of 2010 Exhibitors Have Returned for Two Reasons - NEW BUSINESS &amp; THEIR CLIENTS ATTEND 
]]></description>
<guid>2514</guid>
</item>
<item>
<title>The First Asian Pharmaceutical Compliance Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2765/the-first-asian-pharmaceutical-compliance-congress/</link>
<description><![CDATA[<strong>From:</strong> 13 September 2011<br /><strong>To:</strong> 15 September 2011<br /><br />The Ritz-Carlton, Millenia, Singapore. ]]></description>
<guid>2765</guid>
</item>
<item>
<title>Discovery Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2511/discovery-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 14 September 2011<br /><strong>To:</strong> 16 September 2011<br /><br />Red Rock Casino Resort &amp; Spa, Las Vegas, NV, USA. ]]></description>
<guid>2511</guid>
</item>
<item>
<title>Poorly soluble drugs workshop</title>
<link>http://www.drugdiscoverytoday.com/view/2683/poorly-soluble-drugs-workshop/</link>
<description><![CDATA[<strong>From:</strong> 15 September 2011<br /><strong>To:</strong> 01 January 1800<br /><br />The University of Lille, College of Pharmacy, 3 Rue du Professeur Laguesse, 59006 Lille, France. The APGI (Association de Pharmacie Gal&#233;nique Industrielle) is organizing for the first time a workshop dedicated to the appropriate formulation of poorly water-soluble drugs. During the one day event, oral and poster presentations from academia and industry as well as practical demonstrations (in small groups) are foreseen. 
]]></description>
<guid>2683</guid>
</item>
<item>
<title>20TH HELSINKI DRUG RESEARCH CONGRESS</title>
<link>http://www.drugdiscoverytoday.com/view/2784/20th-helsinki-drug-research-congress/</link>
<description><![CDATA[<strong>From:</strong> 18 September 2011<br /><strong>To:</strong> 20 September 2011<br /><br />University of Helsinki, Finland. This conference presents an update of modern and emerging ADMET tools for drug discovery and delivery.  Drug discovery and drug delivery are facing major challenges and these fields are in rapid transition.  FDA and EMEA have addressed the need for predictive tools that reduce the attrition rate of the drug candidates in the clinical phases. Such tools are critical in the selection of the lead compounds with proper ADMET and other features, while new drug delivery systems are essential in improving the ADME features of gene medicines, anti-cancer drugs, drugs acting on the CNS and retina.  Nanotechnology will provide new opportunities for tool development in drug delivery and ADMET research. The new and emerging methods are expected to augment the discovery and development of new drugs and drug delivery systems. 


]]></description>
<guid>2784</guid>
</item>
<item>
<title>Biomarkers in Clinical Trials</title>
<link>http://www.drugdiscoverytoday.com/view/2663/biomarkers-in-clinical-trials/</link>
<description><![CDATA[<strong>From:</strong> 19 September 2011<br /><strong>To:</strong> 20 September 2011<br /><br />Copthorne Tara Hotel, Central London, UK. SMi is proud to present their 3rd annual conference on Biomarkers in Clinical Trials. With the 2011 event aiming to explore the use of biomarkers in Cancer drug development.

Concerns over efficacy, cost, and drug safety have stimulated a need for personalized medicine; and to increase the predictability of clinical research to reduce development cost and time. The use of biomarkers in no longer limited to whether a patient will responsd to a treatment, but has extended to aid drug development in all its forms.

As a result biomarkers have now gained significant attention in the R&amp;D process. Which are seen as an emerging but lucrative segment that is opening up new development opportunities, and attracting much commercial interest
]]></description>
<guid>2663</guid>
</item>
<item>
<title>3rd China Clinical Trials Outsourcing Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2759/3rd-china-clinical-trials-outsourcing-congress/</link>
<description><![CDATA[<strong>From:</strong> 19 September 2011<br /><strong>To:</strong> 20 September 2011<br /><br />The Sheraton Skyline Hotel London Heathrow, London, UK. The 3rd China Clinical Trials Outsourcing Congress will focus on how to meet the challenges of conducting clinical trials in China and assessing the challenges and advantages of partnering with regional CROs versus setting up operations in China. The programme will focus on issues such as regulatory procedures, patient recruitment and retention, logistics and data management through case studies and keynote presentations from industry experts all actively involved in conducting clinical studies in China.]]></description>
<guid>2759</guid>
</item>
<item>
<title>5th Annual Pain Therapeutics Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2460/5th-annual-pain-therapeutics-summit/</link>
<description><![CDATA[<strong>From:</strong> 20 September 2011<br /><strong>To:</strong> 21 September 2011<br /><br />San Francisco, CA, USA. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.]]></description>
<guid>2460</guid>
</item>
<item>
<title>Predictive in Vitro Models</title>
<link>http://www.drugdiscoverytoday.com/view/2691/predictive-in-vitro-models/</link>
<description><![CDATA[<strong>From:</strong> 21 September 2011<br /><strong>To:</strong> 22 September 2011<br /><br />Boston Conference and Exhibition Centre, MA. Predictive In Vitro Models gathers industry leaders to discuss how to increase pre-clinical predictive capability.]]></description>
<guid>2691</guid>
</item>
<item>
<title>5th Neurodegenerative Conditions Research and Development</title>
<link>http://www.drugdiscoverytoday.com/view/2735/5th-neurodegenerative-conditions-research-and-development/</link>
<description><![CDATA[<strong>From:</strong> 22 September 2011<br /><strong>To:</strong> 23 September 2011<br /><br />Hotel Kabuki, San Francisco, CA, USA. At GTCbio’s 5th annual Neurodegenerative Diseases Drug Discovery conference, leading scientists and experts will discuss the latest breakthroughs, new drug targets, new models, the development of new biomarkers, imaging modalities, and several other novel developments and therapeutics to combat neurodegenerative conditions. ]]></description>
<guid>2735</guid>
</item>
<item>
<title>The 4th CNS Partnering &amp; Deal Making Conference </title>
<link>http://www.drugdiscoverytoday.com/view/2732/the-4th-cns-partnering-deal-making-conference-/</link>
<description><![CDATA[<strong>From:</strong> 22 September 2011<br /><strong>To:</strong> 24 September 2011<br /><br />Hotel Kabuki,San Francisco, CA, USA . The 4th CNS Partnering &amp; Deal Making Conference is a CNS Diseases partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry.]]></description>
<guid>2732</guid>
</item>
<item>
<title>CNS Diseases World Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2733/cns-diseases-world-summit/</link>
<description><![CDATA[<strong>From:</strong> 22 September 2011<br /><strong>To:</strong> 23 September 2011<br /><br />Hotel Kabuki, San Francisco, CA USA. The CNS Diseases World Summit brings together experts from academia and industry to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields. The summit takes place in San Francisco, CA on September 22-23, 2011 and includes three concurrent tracks.]]></description>
<guid>2733</guid>
</item>
<item>
<title>Biosimilars and Biobetters </title>
<link>http://www.drugdiscoverytoday.com/view/2724/biosimilars-and-biobetters-/</link>
<description><![CDATA[<strong>From:</strong> 26 September 2011<br /><strong>To:</strong> 27 September 2011<br /><br />Copthorne Tara Hotel, London, UK  . ]]></description>
<guid>2724</guid>
</item>
<item>
<title>Quantum Science Symposium-2011</title>
<link>http://www.drugdiscoverytoday.com/view/2397/quantum-science-symposium2011/</link>
<description><![CDATA[<strong>From:</strong> 26 September 2011<br /><strong>To:</strong> 27 September 2011<br /><br />777 Memorial Drive at Courtyard Marriott, Cambridge, Massachusetts 02139 USA. Applications of Physical &amp; Chemical Methods in Biological Systems'
]]></description>
<guid>2397</guid>
</item>
<item>
<title>Pharmaceutical Amorphous Materials 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2677/pharmaceutical-amorphous-materials-2011/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2011<br /><strong>To:</strong> 28 September 2011<br /><br />tbc. Amsterdam, The Netherlands. The conference is being held to explore the development, optimisation, engineering, stability and application of amorphous materials as an alternative solution to overcoming negative drug attributes during solid state development by improving:

Solubility, Dissolution, Stability,  Delivery and Bioavailability 
 
]]></description>
<guid>2677</guid>
</item>
<item>
<title>Pharmaceutical Co-Crystals </title>
<link>http://www.drugdiscoverytoday.com/view/2678/pharmaceutical-cocrystals-/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2011<br /><strong>To:</strong> 28 September 2011<br /><br />tbc Amsterdam, The Netherlands. This year’s conference will not only focus on the characterising, optimising, engineering and application of co-crystals but exclusive to this year:

EXPLORE the latest technological developments 
BRAND NEW CASE STUDIES covering previously unheard material on: 
co-crystal scale up, from research to manufacture from industry perspective 
co-crystal control through formulation stages using novel methods and techniques 
co-crystallisation from solution and solid state chemistry 
]]></description>
<guid>2678</guid>
</item>
<item>
<title>Generics and Biosimilars Strategies EMEA</title>
<link>http://www.drugdiscoverytoday.com/view/2773/generics-and-biosimilars-strategies-emea/</link>
<description><![CDATA[<strong>From:</strong> 27 September 2011<br /><strong>To:</strong> 29 September 2011<br /><br />Istanbul, Turkey. The inaugural Generics and Biosimilars Strategies EMEA conference is a unique business and networking opportunity for CEOs and Senior Executives keen to implement profitable and sustainable generics and biosimilars strategies.

]]></description>
<guid>2773</guid>
</item>
<item>
<title>KOL Liaison and MSL Best Practice</title>
<link>http://www.drugdiscoverytoday.com/view/2830/kol-liaison-and-msl-best-practice/</link>
<description><![CDATA[<strong>From:</strong> 28 September 2011<br /><strong>To:</strong> 29 September 2011<br /><br />Copthorne Tara Hotel, London, UK. Following the tremendous successes of our KOL/MSL conferences in London, Munich and Stockholm, SMi presents its KOL Liaison and MSL Best Practice conference, which will focus on the increasingly varied role of MSLs, from their traditional function working with KOLs, to associated role challenges and in Medical Affairs in general.]]></description>
<guid>2830</guid>
</item>
<item>
<title>KOL Liaison and MSL Best Practice </title>
<link>http://www.drugdiscoverytoday.com/view/2723/kol-liaison-and-msl-best-practice-/</link>
<description><![CDATA[<strong>From:</strong> 28 September 2011<br /><strong>To:</strong> 29 September 2011<br /><br />Copthorne Tara Hotel, London, UK  . ]]></description>
<guid>2723</guid>
</item>
<item>
<title>Managing Partnerships with CROs</title>
<link>http://www.drugdiscoverytoday.com/view/2831/managing-partnerships-with-cros/</link>
<description><![CDATA[<strong>From:</strong> 03 October 2011<br /><strong>To:</strong> 04 October 2011<br /><br />Holiday Inn Bloomsbury, London, UK. The SMi Group is pleased their 3rd annual conference on Managing Partnerships with CROs, taking place on the 3rd and 4th October 2011. This event aims to bring together key industry professionals from within the healthcare sector, and will provide you with an ideal platform to discuss the latest issued faced with CRO outsourcing.]]></description>
<guid>2831</guid>
</item>
<item>
<title>Business Strategies for Biologics: Positioning and Partnering for the Biopharmaceutical Evolution</title>
<link>http://www.drugdiscoverytoday.com/view/2878/business-strategies-for-biologics-positioning-and-partnering-for-the-biopharmaceutical-evolution/</link>
<description><![CDATA[<strong>From:</strong> 05 October 2011<br /><strong>To:</strong> 06 October 2011<br /><br />Marriott Copley Place, Boston, MA, USA. New Conference Offers Solutions for Success in the Growing Biologics Market]]></description>
<guid>2878</guid>
</item>
<item>
<title>Current Status and Future of Anti-Cancer Targeted Therapies   </title>
<link>http://www.drugdiscoverytoday.com/view/2795/current-status-and-future-of-anticancer-targeted-therapies--/</link>
<description><![CDATA[<strong>From:</strong> 06 October 2011<br /><strong>To:</strong> 07 October 2011<br /><br />Alvear Palace Hotel, Buenos Aires, Argentina. ]]></description>
<guid>2795</guid>
</item>
<item>
<title>Pharmaceutical m-Health</title>
<link>http://www.drugdiscoverytoday.com/view/2832/pharmaceutical-mhealth/</link>
<description><![CDATA[<strong>From:</strong> 10 October 2011<br /><strong>To:</strong> 11 October 2011<br /><br />The Grange Holborn Hotel, London, UK. This conference will address the numerous ways in which the pharmaceutical industry can contribute to, and benefit from the increasing mobility of healthcare. With the vast importance mobile phones hold on everyday life, the healthcare sector is certainly no exception, with several areas of the pharmaceutical industry that are either undergoing fundamental changes to accommodate and gain from this mobility, or are about to. * BCC Research, 2011]]></description>
<guid>2832</guid>
</item>
<item>
<title>Neurodegenerative Diseases &amp; Genomics Symposium</title>
<link>http://www.drugdiscoverytoday.com/view/2398/neurodegenerative-diseases-genomics-symposium/</link>
<description><![CDATA[<strong>From:</strong> 10 October 2011<br /><strong>To:</strong> 11 October 2011<br /><br />Auditorium at Consiglio Nazionale delle Ricerche (CNR)  Area Tor Vergata, Rome, Italy. Biology to Drugs &amp; Therapeutics]]></description>
<guid>2398</guid>
</item>
<item>
<title>Clinical Trial Supply Asia </title>
<link>http://www.drugdiscoverytoday.com/view/2747/clinical-trial-supply-asia-/</link>
<description><![CDATA[<strong>From:</strong> 12 October 2011<br /><strong>To:</strong> 13 October 2011<br /><br />Venue to be confirmed, Singapore. With more clinical trials being held in Asia than ever before, clinical trial supply systems need to become increasingly sophisticated in order to cope with local regulations, importation and exportation guidelines, obtainment of licenses, transit, packaging and labeling requirements, temperature-controlled storage and transportation and local distribution. ]]></description>
<guid>2747</guid>
</item>
<item>
<title>3rd Annual Partnerships in Clinical Trials Asia</title>
<link>http://www.drugdiscoverytoday.com/view/2772/3rd-annual-partnerships-in-clinical-trials-asia/</link>
<description><![CDATA[<strong>From:</strong> 12 October 2011<br /><strong>To:</strong> 14 October 2011<br /><br />Grand Hyatt Shanghai, China. The largest concentration of clinical decision makers specializing in clinical development, operations and outsourcing meet to provide you the opportunity to establish benchmarks, standards and next practices in the development and commercialization of products in a global marketplace. The agenda is filled with in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market.]]></description>
<guid>2772</guid>
</item>
<item>
<title>Evolution Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2609/evolution-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 17 October 2011<br /><strong>To:</strong> 19 October 2011<br /><br />Fairmont Le Montreux Palace, Montreux, Switzerland. The Evolution Summit 2011 offers the perfect setting for sponsors to meet and interact with senior drug development executives through a number of one-to-one business meetings and many networking activities. Over the past eight years, the summit has continually succeeded in offering unparalleled content and the perfect one-stop-shopping environment for drug development solutions. For more information about the summit please contact Jana Urbanovska at summits@marcusevanscy.com]]></description>
<guid>2609</guid>
</item>
<item>
<title>Evolution Summit 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2617/evolution-summit-2011/</link>
<description><![CDATA[<strong>From:</strong> 17 October 2011<br /><strong>To:</strong> 19 October 2011<br /><br />Fairmont Le Montreux Palace, Montreux, Switzerland. The Evolution Summit 2011 offers the perfect setting for sponsors to meet and interact with senior drug development executives through a number of one-to-one business meetings and many networking activities. Over the past eight years, the summit has continually succeeded in offering unparalleled content and the perfect one-stop-shopping environment for drug development solutions. For more information about the summit please contact Jana Urbanovska at summits@marcusevanscy.com

]]></description>
<guid>2617</guid>
</item>
<item>
<title>World Pharma Innovation Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2528/world-pharma-innovation-congress/</link>
<description><![CDATA[<strong>From:</strong> 18 October 2011<br /><strong>To:</strong> 20 October 2011<br /><br />London, UK. World Pharma Innovation Congress 2011 is Europe's leading conference delivering innovative, fully integrated and collaborative approaches to next generation drug discovery and development.
]]></description>
<guid>2528</guid>
</item>
<item>
<title>5th Biomarker Discovery &amp; Development</title>
<link>http://www.drugdiscoverytoday.com/view/2839/5th-biomarker-discovery-development/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2011<br /><strong>To:</strong> 21 October 2011<br /><br />Paradise Point Resort &amp; Spa, San Diego, CA, USA. GTC’s 5th Annual Biomarker Discovery and Development Conference held on October 19-21, 2011 at the Paradise Point Resort &amp; Spa in San Diego, CA will present you a host of distinguished speakers, who will address topics that span the past, present and future of biomarker research. By taking a comprehensive look at the progress that has already been made, we will be able to make projections into the future regarding the ultimate development of personalized medicine. The discussions will begin with an overview of novel technologies used in biomarker discovery, followed by how these approaches are being utilized to streamline the development process by reducing time and costs, as well as minimizing drug attrition associated with safety concerns. The discussions will then culminate with topics including biomarker utility and clinical trials as companion diagnostics in the clinics.]]></description>
<guid>2839</guid>
</item>
<item>
<title>5th Advances in Stem Cell Discovery and Development</title>
<link>http://www.drugdiscoverytoday.com/view/2840/5th-advances-in-stem-cell-discovery-and-development/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2011<br /><strong>To:</strong> 21 October 2011<br /><br />San Diego, CA, Paradise Point Resort &amp; Spa, USA. GTC's 2011 5th Advances in Stem Cell Discovery &amp; Development Conference on October 19-21, 2011 in San Diego, CA presents its attendants with information regarding cutting-edge developments in all areas of stem cell research including the biology, medicine, applications, regulations, and business of stem cells. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, regulatory policies regarding stem cell research will be addressed.

]]></description>
<guid>2840</guid>
</item>
<item>
<title>Asia Biosimilars Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2786/asia-biosimilars-summit/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2011<br /><strong>To:</strong> 20 October 2011<br /><br />Radisson Hotel Pudong Century Park, Shanghai, China. ]]></description>
<guid>2786</guid>
</item>
<item>
<title>European Pharmaceutical Pricing and Reimbursement</title>
<link>http://www.drugdiscoverytoday.com/view/2833/european-pharmaceutical-pricing-and-reimbursement/</link>
<description><![CDATA[<strong>From:</strong> 31 October 2011<br /><strong>To:</strong> 01 November 2011<br /><br />Radisson Blu Hotel Basel, Basel, Switzerland. Following on from the success of our previous Pricing and Reimbursement events SMi’s is pleased to announce their 17th annual European Pharmaceutical Pricing and Reimbursement conference. ]]></description>
<guid>2833</guid>
</item>
<item>
<title>BIO-Europe&#174; 2011—17th Annual International Partnering Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2494/bioeurope-201117th-annual-international-partnering-conference/</link>
<description><![CDATA[<strong>From:</strong> 31 October 2011<br /><strong>To:</strong> 02 November 2011<br /><br />Duesseldorf, Germany. The 17th annual BIO-Europe&#174; event will be the largest biotechnology partnering conference held in Europe. Close to 3,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.]]></description>
<guid>2494</guid>
</item>
<item>
<title>MicroRNAs &amp; Single Molecule Biology Europe - 2011 Symposium</title>
<link>http://www.drugdiscoverytoday.com/view/2399/micrornas-single-molecule-biology-europe-2011-symposium/</link>
<description><![CDATA[<strong>From:</strong> 01 November 2011<br /><strong>To:</strong> 02 November 2011<br /><br />Peterhouse, University of Cambridge, Cambridge, UK. MicroRNAs: Biology to Development and Disease

Molecular Imaging to Single Molecule Analysis
]]></description>
<guid>2399</guid>
</item>
<item>
<title>Twelfth Pharmaceutical Regulatory Compliance Congress and Best Practices Forum</title>
<link>http://www.drugdiscoverytoday.com/view/2791/twelfth-pharmaceutical-regulatory-compliance-congress-and-best-practices-forum/</link>
<description><![CDATA[<strong>From:</strong> 02 November 2011<br /><strong>To:</strong> 04 November 2011<br /><br />Mandarin Oriental, Washington, DC, USA . ]]></description>
<guid>2791</guid>
</item>
<item>
<title>ABPI Mid-Year Conference 2011 - Innovation in Healthcare</title>
<link>http://www.drugdiscoverytoday.com/view/2978/abpi-midyear-conference-2011-innovation-in-healthcare/</link>
<description><![CDATA[<strong>From:</strong> 03 November 2011<br /><strong>To:</strong> 03 November 2011<br /><br />The Royal Society, London SW1Y 5AG, UK. What do we mean by innovation?
• Introducing new partnership between ABPI and NHS Confederation, exciting new development
• New medicines are vital for physicians, patients as well as our own industry, but this is only part of the story
• The healthcare system has to reinvent itself to an innovative and effective system, that embraces innovation in working practices as well as
medicines, and embraces best practices to ensure patients benefit 
• How do industry and NHS need to change their joint working practices, what will the culture shift look like, how can we embrace innovation in
both ways of working as well as effective adoption of new medicines for the benefit of patients 
]]></description>
<guid>2978</guid>
</item>
<item>
<title>International Conference on Meningitis And Septicaemia In Children &amp; Adults</title>
<link>http://www.drugdiscoverytoday.com/view/2800/international-conference-on-meningitis-and-septicaemia-in-children-adults/</link>
<description><![CDATA[<strong>From:</strong> 08 November 2011<br /><strong>To:</strong> 09 November 2011<br /><br />Royal Society of Medicine, London, UK. Leading international experts will present the latest advances in prevention of these diseases, and issues in clinical management of bacterial meningitis and sepsis. The conference will bring together renowned scientists and clinicians from a range of specialities within both the paediatric and adult settings. These include infectious diseases, epidemiology, immunology, vaccinology, tropical medicine, microbiology, molecular medicine, emergency and crticial care and rehabilitation medicine.]]></description>
<guid>2800</guid>
</item>
<item>
<title>Blue pill pink pill? Does gender matter?</title>
<link>http://www.drugdiscoverytoday.com/view/2780/blue-pill-pink-pill-does-gender-matter/</link>
<description><![CDATA[<strong>From:</strong> 10 November 2011<br /><strong>To:</strong> 01 January 1800<br /><br />Royal Pharmaceutical Society, 1 Lambeth High Street, London SE1 7JN. The conference will examine the extent to which gender should be a factor in the development, regulation and use of medicines and discuss gender considerations in clinical practice. This is a joint event between the Royal Pharmaceutical Society (RPS), the Medical Women’s Federation (MWF), the National Association of Women Pharmacists (NAWP).


]]></description>
<guid>2780</guid>
</item>
<item>
<title>Cell-Based Assays</title>
<link>http://www.drugdiscoverytoday.com/view/2796/cellbased-assays/</link>
<description><![CDATA[<strong>From:</strong> 21 November 2011<br /><strong>To:</strong> 22 November 2011<br /><br />Marriot Hotel, Regents Park, London, UK. The event will consist of a two day conference and two post-conference workshops, with a focus on a range of topics relating to the challenges facing those involved in using and developing cell-based assays and their importance to the strategic future of R&amp;D in pharma.]]></description>
<guid>2796</guid>
</item>
<item>
<title>EuroEpiStem: European Epigenomics &amp; Stem Cells-2011 Meeting</title>
<link>http://www.drugdiscoverytoday.com/view/2400/euroepistem-european-epigenomics-stem-cells2011-meeting/</link>
<description><![CDATA[<strong>From:</strong> 21 November 2011<br /><strong>To:</strong> 22 November 2011<br /><br />Amphitheatre, University of Paris Diderot, France. A Unique Themed Conference &amp; Exhibition in  Epigenetics and Stem Cell Biology]]></description>
<guid>2400</guid>
</item>
<item>
<title>8th Annual bioProcessUK Conference 2011</title>
<link>http://www.drugdiscoverytoday.com/view/3010/8th-annual-bioprocessuk-conference-2011/</link>
<description><![CDATA[<strong>From:</strong> 30 November 2011<br /><strong>To:</strong> 01 December 2011<br /><br />Glasgow Science Centre, Glasgow, UK . The Annual bioProcessUK Conference has become the UK's leading technical networking meeting for professionals developing biological medicines. In addition to the conference the Biopharmaceuticals and Bioprocessing agenda within the KTN has several Technical Groups and also delivers an annual Career Opportunity Workshop for emerging professionals.

]]></description>
<guid>3010</guid>
</item>
<item>
<title>RACI Biomolecular Division Conference: Biomolecular at the Beach: Medicinal Chemistry, Chemical Biology and Drug Design</title>
<link>http://www.drugdiscoverytoday.com/view/2680/raci-biomolecular-division-conference-biomolecular-at-the-beach-medicinal-chemistry-chemical-biology-and-drug-design/</link>
<description><![CDATA[<strong>From:</strong> 04 December 2011<br /><strong>To:</strong> 08 December 2011<br /><br />Peppers The Sands Resort, Torquay, VIC, Australia. ]]></description>
<guid>2680</guid>
</item>
<item>
<title>NP2D Natural peptides to drugs - 5th International Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2954/np2d-natural-peptides-to-drugs-5th-international-congress/</link>
<description><![CDATA[<strong>From:</strong> 04 December 2011<br /><strong>To:</strong> 07 December 2011<br /><br />Seiler Mont Cervin Palace, Zermatt, Switzerland. This year's event will emphasise aspects related to biodiversity, drug targeting, formulation and innovative drug delivery systems. Topics will also include design and optimisation of lead compounds to pre-clinical and clinical development, large-scale production of synthetic or recombinant peptides. Bioethics, intellectual property rights and regulatory hurdles will also be addressed.
]]></description>
<guid>2954</guid>
</item>
<item>
<title>Potential Utility of Epigenetic Therapies in Non-Cancerous Settings</title>
<link>http://www.drugdiscoverytoday.com/view/2965/potential-utility-of-epigenetic-therapies-in-noncancerous-settings/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2011<br /><strong>To:</strong> 01 January 1800<br /><br />Holiday Inn Bloomsbury, London, UK. With epigenetic techniques becoming increasingly popular as a key part of efficient and effective therapies, this masterclass comes at the perfect time to provide attendees with an advanced review of current therapies as well as the future development of biomarkers and diagnostics.]]></description>
<guid>2965</guid>
</item>
<item>
<title>Late phase drug development world 2011</title>
<link>http://www.drugdiscoverytoday.com/view/2919/late-phase-drug-development-world-2011/</link>
<description><![CDATA[<strong>From:</strong> 06 December 2011<br /><strong>To:</strong> 08 December 2011<br /><br />Earl's Court Conference Centre, London, UK. ]]></description>
<guid>2919</guid>
</item>
<item>
<title>Dissolution testing for the pharmaceutical industry</title>
<link>http://www.drugdiscoverytoday.com/view/2783/dissolution-testing-for-the-pharmaceutical-industry/</link>
<description><![CDATA[<strong>From:</strong> 12 December 2011<br /><strong>To:</strong> 14 December 2011<br /><br />The Moller Centre, Cambridge, UK. What you will achieve from this course:

Receive an intensive course of study on the relevance of dissolution testing to the assessment of dosage forms [in particular oral dosage forms], dissolution method development, validation and solving day to day issues. 

Learn about the current state of knowledge of the subject, both in terms of theoretical basis and practical experience. 

Acquire skills and knowledge you will be able to apply to day-to-day problems in dissolution testing, linked to a sound theoretical knowledge of the principles involved. 

Form lasting contacts with colleagues in the field, as well as the expert course tutors. 
]]></description>
<guid>2783</guid>
</item>
<item>
<title>Drug discovery: a job too complex for academia or industry alone?</title>
<link>http://www.drugdiscoverytoday.com/view/3005/drug-discovery-a-job-too-complex-for-academia-or-industry-alone/</link>
<description><![CDATA[<strong>From:</strong> 05 January 2012<br /><strong>To:</strong> 06 January 2012<br /><br />Medical Sciences Teaching Centre - University of Oxford, UK. A group of renowned scientists, policy- and decision-makers will be joining us in a series of six provocative discussion panels to honestly and openly debate the bottlenecks hindering innovation and real tangible results in drug discovery:
 
•         How do we better select targets for Drug Discovery?
•         What are the limitations of single molecule targets?
•         How useful are animal models in Drug Discovery?
•         What is limiting Drug Discovery in Academia?
•         Is there any evidence that IP in early discovery is slowing down the development of new medicines?
•         What are the consequences of pharma downsizing in UK? How does UK maintain its position in Drug Discovery?
]]></description>
<guid>3005</guid>
</item>
<item>
<title>4th Risk Evaluation and Mitigation Strategies Conference</title>
<link>http://www.drugdiscoverytoday.com/view/2929/4th-risk-evaluation-and-mitigation-strategies-conference/</link>
<description><![CDATA[<strong>From:</strong> 19 January 2012<br /><strong>To:</strong> 20 January 2012<br /><br />The Westin, Arlington, VA, USA. The 4th Annual REMS Summit is a forum for senior level executives to gather and prepare for the changing landscape of REMS and FDA legislation. REMS and drug safety is a marathon race and the industry must stay ahead of the curve to ensure their drugs are staying compliant while ensuring accessibility and success in market. By attending this year’s event, the audience will benefit from one of the only conferences focused specifically on REMS and strategies to navigate the uncertainty, build a successful REMS program and streamline your clinical, safety, regulatory, and marketing sectors to successfully market your product.]]></description>
<guid>2929</guid>
</item>
<item>
<title>Novel Immunotherapeutics Summit </title>
<link>http://www.drugdiscoverytoday.com/view/3032/novel-immunotherapeutics-summit-/</link>
<description><![CDATA[<strong>From:</strong> 30 January 2012<br /><strong>To:</strong> 31 January 2012<br /><br />Paradise Point Resort &amp; Spa, 1404 Vacation Road, San Diego, CA, USA. The Novel Immunotherapeutics Summit brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, allergy and asthma will be discussed at the summit. Receive updates on government policy, recent regulations, important investments and partnering strategies. ]]></description>
<guid>3032</guid>
</item>
<item>
<title>10th Cytokines and Inflammation Conference</title>
<link>http://www.drugdiscoverytoday.com/view/3002/10th-cytokines-and-inflammation-conference/</link>
<description><![CDATA[<strong>From:</strong> 30 January 2012<br /><strong>To:</strong> 31 January 2012<br /><br />Paradise Point Resort &amp; Spa, San Diego, CA, USA. In 2012, the conference will cover ever-important topics such as the TNF family, the inflammasome, chemokines, costimulation and innate immunity. In addition, timely coverage will be devoted to areas of current rapid expansion, such as the IL-17 and Th17 fields and JAK/STAT kinases, at a time when phase 2 and even phase 3 studies are being conducted and reported in these areas. Intriguing recently discovered cytokines, such as IL-25, novel alarmins and novel IL-1 family members will also be covered.]]></description>
<guid>3002</guid>
</item>
<item>
<title>SLAS 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3148/slas-2012/</link>
<description><![CDATA[<strong>From:</strong> 04 February 2012<br /><strong>To:</strong> 08 February 2012<br /><br />San Diego Convention Center, San Diego, CA, USA. At SLAS2012: Collaborate | Innovate | Dominate

Collaborate with 5,000+ innovative scientists, engineers, researchers and technologists from academic, government and commercial laboratories around the globe to inaugurate the First Annual SLAS Conference and Exhibition — uniting the best of the former LabAutomation and SBS conferences — in San Diego, CA, February 4-8, 2012.

Stimulate your scientific creativity through 130+ outstanding podium presentations and 300+ posters. Investigate new and emerging technologies from 275+ exhibitors. Calibrate your personal goals, punctuate your professional success and dominate the field of laboratory science and technology.
]]></description>
<guid>3148</guid>
</item>
<item>
<title>4th International Conference on Drug Discovery and Therapy</title>
<link>http://www.drugdiscoverytoday.com/view/2897/4th-international-conference-on-drug-discovery-and-therapy/</link>
<description><![CDATA[<strong>From:</strong> 12 February 2012<br /><strong>To:</strong> 15 February 2012<br /><br />Dubai Women's College, Dubai, UAE. This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.

]]></description>
<guid>2897</guid>
</item>
<item>
<title>Clinical Outsourcing Asia Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3135/clinical-outsourcing-asia-congress/</link>
<description><![CDATA[<strong>From:</strong> 13 February 2012<br /><strong>To:</strong> 14 February 2012<br /><br />Intercontinental Hotel Shanghai Pudong, China. The Clinical Trials and Outsourcing Asia Congress will be held in Shanghai, China on the 13th and 14th February. Over two days,  the event will attract over 150 senior-level decision makers working in clinical development, clinical trials and clinical outsourcing from multinational and local pharma and biopharma companies and healthcare institutes from China, Singapore, Australia, Japan, Korea, Thailand, Malaysia. Prominent key leaders from Europe and US will also be represented.

]]></description>
<guid>3135</guid>
</item>
<item>
<title>2nd Pharma R&amp;D Asia Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2957/2nd-pharma-rd-asia-congress/</link>
<description><![CDATA[<strong>From:</strong> 13 February 2012<br /><strong>To:</strong> 14 February 2012<br /><br />Pudong, Shanghai, China. The congress is the single most senior-level and focused event in Asia Pacific dedicated to the Drug Discovery &amp; Development of pharmaceutical drugs including Generic, Patented drugs, Vaccines, Biologics, Biogenerics and Antibodies, R&amp;D Strategies, Alliances and Partnerships as well as regulatory developments. It looks at key strategies in forging R&amp;D partnerships &amp; strategic alliances for pharma companies, local biopharma companies and research institutions in the Asia market.
]]></description>
<guid>2957</guid>
</item>
<item>
<title>Metabolomics-2012</title>
<link>http://www.drugdiscoverytoday.com/view/2876/metabolomics2012/</link>
<description><![CDATA[<strong>From:</strong> 20 February 2012<br /><strong>To:</strong> 22 February 2012<br /><br />San Francisco Airport Marriott, San Francisco, CA, USA . Metabolomics-2012 is a specially designed cluster conference, which covers a wide range of critically important sessions from basic research in Metabolomics to advances its research.]]></description>
<guid>2876</guid>
</item>
<item>
<title>7th Annual Biomarkers Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2958/7th-annual-biomarkers-congress/</link>
<description><![CDATA[<strong>From:</strong> 21 February 2012<br /><strong>To:</strong> 22 February 2012<br /><br />Hilton Deansgate, Manchester, UK . The 7th Annual Biomarkers Congress is an exclusive event consisting of world-class keynote addresses, roundtable and panel discussions designed specifically for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies.

]]></description>
<guid>2958</guid>
</item>
<item>
<title>Oncology Partnering &amp; Deal-Making Conference</title>
<link>http://www.drugdiscoverytoday.com/view/3001/oncology-partnering-dealmaking-conference/</link>
<description><![CDATA[<strong>From:</strong> 27 February 2012<br /><strong>To:</strong> 28 February 2012<br /><br />Red Rock Casino, Resort &amp; Spa, Las Vegas, Nevada, USA. The Oncology Partnering &amp; Deal Making Conference is a partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant issues in Oncology and partnerships that will affect the industry. This event also provides a unique venue for attendees to learn about Oncology business development trends, market, and novel technologies that shape up the industry]]></description>
<guid>3001</guid>
</item>
<item>
<title>Targets and Strategies in Drug Discovery Summit</title>
<link>http://www.drugdiscoverytoday.com/view/3033/targets-and-strategies-in-drug-discovery-summit/</link>
<description><![CDATA[<strong>From:</strong> 27 February 2012<br /><strong>To:</strong> 28 February 2012<br /><br />Red Rock Casino, Resort &amp; Spa, Las Vegas, NV, USA. The Targets and Strategies in Drug Discovery Summit brings together experts from academia and industry to discuss the emerging targets, therapeutics and strategies against cancer, showcase ubiquitins' huge potential in the development of therapeutics and display novel discovery in developing ocular disease therapies. Attendees will also receive updates on government policy, recent regulations, important investments and partnering strategies. ]]></description>
<guid>3033</guid>
</item>
<item>
<title>3rd Cancer Targets and Therapeutics</title>
<link>http://www.drugdiscoverytoday.com/view/3012/3rd-cancer-targets-and-therapeutics/</link>
<description><![CDATA[<strong>From:</strong> 27 February 2012<br /><strong>To:</strong> 28 February 2012<br /><br />Red Rock Casino, Resort &amp; Spa, Las Vegas, NV, USA . With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets &amp; therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 2012 3rd Cancer Targets &amp; Therapeutics Conference on February 27-28, 2012 in Las Vegas, NV examines new and emerging targets and therapeutics in the area of cancer research. Speakers at the event provide case studies of emerging targets in order to address some of the issues surrounding target-based drug discovery and development.

]]></description>
<guid>3012</guid>
</item>
<item>
<title>2nd Ubiquitin Research and Drug Discovery Conference</title>
<link>http://www.drugdiscoverytoday.com/view/3165/2nd-ubiquitin-research-and-drug-discovery-conference/</link>
<description><![CDATA[<strong>From:</strong> 27 February 2012<br /><strong>To:</strong> 28 February 2012<br /><br />Red Rock Casino, Resort &amp; Spa, Las Vegas, NV, USA. The field of ubiquitin research has been growing as most big pharma companies have shown interest enough to develop ubiquitin research in their pipeline. The industry has determined that there is a huge potential in the development of therapeutics. Though ubiquitin research may be considered a small community, many have seen the growth and diversity of the field to project that the field is ready to blow up in the next few years. To stay ahead of the curve, it will require you to stay on top of recent technological advancements and development trends. ]]></description>
<guid>3165</guid>
</item>
<item>
<title>Polymorphism and Crystallisation 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3003/polymorphism-and-crystallisation-2012/</link>
<description><![CDATA[<strong>From:</strong> 28 February 2012<br /><strong>To:</strong> 29 February 2012<br /><br />Venue tbc, Amsterdam, Netherlands. Hear from the hottest new pharmaceutical researchers in the field, assess how to extend your product's life cycle and learn of new pharmaceutical techniques for polymorphism and crystallisation whilst always ensuring long term product quality. Expert speakers will present the latest scientific advances made in key solid state areas ]]></description>
<guid>3003</guid>
</item>
<item>
<title>3rd Annual Clinical Trial Supply China</title>
<link>http://www.drugdiscoverytoday.com/view/2999/3rd-annual-clinical-trial-supply-china/</link>
<description><![CDATA[<strong>From:</strong> 28 February 2012<br /><strong>To:</strong> 29 February 2012<br /><br />Venue tbc, Beijing, China. 3rd Annual Clinical Trial Supply China 2012 is the only gathering of its kind globally and has been developed through extensive research with over 100 clinical trials supply chain professionals involved with the China market. 3rd Annual Clinical Trial Supply China 2012 will address the most urgent concerns and challenges faced by these professionals in the importation, forecasting, storage and distribution of temperature sensitive clinical trials supplies and samples. ]]></description>
<guid>2999</guid>
</item>
<item>
<title>2nd Annual Bio/Pharma Cold Chain China 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3000/2nd-annual-biopharma-cold-chain-china-2012/</link>
<description><![CDATA[<strong>From:</strong> 28 February 2012<br /><strong>To:</strong> 29 February 2012<br /><br />Venue tbc, Beijing, China. The 2nd Annual Bio/Pharmaceutical Cold Chain China 2012 is THE ONLY gathering of its kind in China providing the largest and most comprehensive forum for pharmaceutical, biotech and medical device professionals in China involved in the temperature-controlled supply chain. Attendees will be able to network with and learn from other organisations who face similar challenges in monitoring, controlling, and maintaining temperatures of products throughout the supply chain – from manufacturing, warehousing, wholesalers, pharmacies, hospitals, and ultimately to the end users.]]></description>
<guid>3000</guid>
</item>
<item>
<title>Scientific Considerations for Complex Drugs in Light of Established Regulatory Guidance</title>
<link>http://www.drugdiscoverytoday.com/view/3244/scientific-considerations-for-complex-drugs-in-light-of-established-regulatory-guidance/</link>
<description><![CDATA[<strong>From:</strong> 09 March 2012<br /><strong>To:</strong> 01 January 1800<br /><br />New York Academy of Science, NY, USA. The U.S. Food and Drug Administration (FDA) is currently working toward implementing the Biologics Price Competition and Innovation Act (BPCI) of 2009, which establishes an abbreviated approval pathway for biological products that are demonstrated to be &quot;highly similar&quot; to or &quot;interchangeable&quot; with a drug regulated under the Public Health Service Act. The yet-to-be finalized pathway raises questions that are far more complicated than those posed by traditional, small molecule generics including what type of pre-clinical/clinical data, safety, purity, immunogenicity and potency testing will be required by the FDA in the marketing application. Additionally, while current regulations do not make scientific distinctions between small-molecule drugs and non-biological complex drugs (NBCDs), NBCDs present many of the same scientific challenges to reproduce as biologics, and future regulations will likely be guided by lessons learned from the development of policy for biosimilars in the U.S. and abroad.

]]></description>
<guid>3244</guid>
</item>
<item>
<title>Vaccine World Summit</title>
<link>http://www.drugdiscoverytoday.com/view/3151/vaccine-world-summit/</link>
<description><![CDATA[<strong>From:</strong> 12 March 2012<br /><strong>To:</strong> 16 March 2012<br /><br />Hyderabad, India. Vaccine World Summit India 2012 will be THE DEFINITIVE meeting place for vaccine industry's leaders from India and the rest of the world. Riding on the momentum generated by the successful 2011 event, which attracted over 130 delegates and 42 renowned speakers, Vaccine World Summit India 2012 promises to be an even greater experience. Set the stage for the next wave of innovation and discovery in vaccines today. ]]></description>
<guid>3151</guid>
</item>
<item>
<title>Biomarker Summit 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3043/biomarker-summit-2012/</link>
<description><![CDATA[<strong>From:</strong> 15 March 2012<br /><strong>To:</strong> 16 March 2012<br /><br />Paradise Point Resort &amp; Spa, 1404 Vacation Road, San Diego, CA USA. ]]></description>
<guid>3043</guid>
</item>
<item>
<title>Biomarker Partnering and Deal-Making Conference</title>
<link>http://www.drugdiscoverytoday.com/view/3044/biomarker-partnering-and-dealmaking-conference/</link>
<description><![CDATA[<strong>From:</strong> 15 March 2012<br /><strong>To:</strong> 16 March 2012<br /><br />Paradise Point Resort &amp; Spa,  San Diego, CA USA. Offering a unique opportunity, the Biomarker Partnering and Deal-Making Conference assembles leading players to discuss what needs to be accomplished to lead the industry into its next phase.  The business of biomarkers has reached an exciting and critical stage and intelligence and strategic relationship building is more important than ever.  Attendees will be able to set the stage for both at this leading event.
]]></description>
<guid>3044</guid>
</item>
<item>
<title>National Cancer Institute Second Symposium on Translational Genomics</title>
<link>http://www.drugdiscoverytoday.com/view/3170/national-cancer-institute-second-symposium-on-translational-genomics/</link>
<description><![CDATA[<strong>From:</strong> 15 March 2012<br /><strong>To:</strong> 16 March 2012<br /><br />Natcher Auditorium, NIH Bethesda, MD, USA. This symposium will provide a dedicated forum for the advancement, implementation and exchange of information on noncoding RNAs, next generation sequencing, and epigenomics and genetic variation for translation into clinical practice with the ultimate goal to improve the health of patients with cancer. ]]></description>
<guid>3170</guid>
</item>
<item>
<title>8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology</title>
<link>http://www.drugdiscoverytoday.com/view/3011/8th-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology/</link>
<description><![CDATA[<strong>From:</strong> 19 March 2012<br /><strong>To:</strong> 22 March 2011<br /><br />Istanbul, Turkey. ]]></description>
<guid>3011</guid>
</item>
<item>
<title>New Paradigms in Drug Discovery: How Genomic Data is Being Used to Revolutionize the Drug Discovery and Development Process</title>
<link>http://www.drugdiscoverytoday.com/view/3230/new-paradigms-in-drug-discovery-how-genomic-data-is-being-used-to-revolutionize-the-drug-discovery-and-development-process/</link>
<description><![CDATA[<strong>From:</strong> 21 March 2012<br /><strong>To:</strong> 01 January 1800<br /><br />20 F Street Conference Center (A &amp; B) • 20 F Street, N.W., Washington, DC 20001. ]]></description>
<guid>3230</guid>
</item>
<item>
<title>The iMedicine &amp; Mobile Life Sciences World Summit</title>
<link>http://www.drugdiscoverytoday.com/view/2924/the-imedicine-mobile-life-sciences-world-summit/</link>
<description><![CDATA[<strong>From:</strong> 21 March 2012<br /><strong>To:</strong> 22 March 2012<br /><br />tbc, Boston, MA, USA. The iMedicine &amp; Mobile Life Sciences World Summit provides a unique opportunity for mHealth developers to showcase and present their new technologies to a global eHealth audience; and for healthcare practitioners and pharmaceutical executives to present case studies on clinical or medical educational needs or outcomes of App implementation to highlight progress, challenges, and opportunities in the highly dynamic digital age.]]></description>
<guid>2924</guid>
</item>
<item>
<title>PepCon - 2012</title>
<link>http://www.drugdiscoverytoday.com/view/2950/pepcon-2012/</link>
<description><![CDATA[<strong>From:</strong> 23 March 2012<br /><strong>To:</strong> 25 March 2012<br /><br />China National Convention Center, 7 Tianchen East Road, Chaoyang District, Beijing 100105 China. PepCon-2012 is an event for protein and peptide professionals. The success of PepCon in previous years has helped it to become an influential conference for protein and peptide professionals to discuss the latest breakthroughs in the field as well as potential business opportunities. During PepCon-2011 more than 800 participants from 48 countries and 80 exhibitors joined the conference. This year we will try to provide an even better platform to exchange information and foster collaborations.

]]></description>
<guid>2950</guid>
</item>
<item>
<title>Target Selection through Application of Chemical and Systems Biology and Attrition </title>
<link>http://www.drugdiscoverytoday.com/view/3228/target-selection-through-application-of-chemical-and-systems-biology-and-attrition-/</link>
<description><![CDATA[<strong>From:</strong> 01 April 2012<br /><strong>To:</strong> 04 April 2012<br /><br />Castle &quot;Oud Poelgeest&quot;, Oegstgeest, near Leiden, The Netherlands. This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants will be limited to 35, to favour in depth discussion. ]]></description>
<guid>3228</guid>
</item>
<item>
<title>2nd Annual Vaccines Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3136/2nd-annual-vaccines-congress/</link>
<description><![CDATA[<strong>From:</strong> 02 April 2012<br /><strong>To:</strong> 03 April 2012<br /><br />Radisson Blu Portman Hotel, London, UK. Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in preclinical development, clinical design and process enhancement. Delegates will hear from those working at the forefront of vaccine innovation in areas such as oncology and universal vaccines, while internationally recognised experts present sustainable strategies for long-term success in vaccines development, delivery, manufacturing and partnering.
]]></description>
<guid>3136</guid>
</item>
<item>
<title>5th Annual Proteins Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2959/5th-annual-proteins-congress/</link>
<description><![CDATA[<strong>From:</strong> 02 April 2012<br /><strong>To:</strong> 03 April 2012<br /><br />The Radisson Blu Portman Hotel, London, UK. The 5th Annual Proteins Congress is an exclusive event consisting of world-class keynote addresses and panel discussions designed specifically for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies. ]]></description>
<guid>2959</guid>
</item>
<item>
<title>Biologics World Korea</title>
<link>http://www.drugdiscoverytoday.com/view/3152/biologics-world-korea/</link>
<description><![CDATA[<strong>From:</strong> 16 April 2012<br /><strong>To:</strong> 19 April 2012<br /><br />Seoul, Korea. Biologics World Korea provides the ONLY biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.]]></description>
<guid>3152</guid>
</item>
<item>
<title>GTC’s 5th Diabetes Drug Discovery and Development Conference </title>
<link>http://www.drugdiscoverytoday.com/view/3153/gtcs-5th-diabetes-drug-discovery-and-development-conference-/</link>
<description><![CDATA[<strong>From:</strong> 19 April 2012<br /><strong>To:</strong> 20 April 2012<br /><br />Hyatt Harborside, Boston, MA, USA. This important meeting will be held on April 19-20, 2012 in Boston, MA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss novel targets for diabetes, lessons to learn from current and clinical drug development.
]]></description>
<guid>3153</guid>
</item>
<item>
<title>Stem Cell Commercialization &amp; Partnering Conference</title>
<link>http://www.drugdiscoverytoday.com/view/3171/stem-cell-commercialization-partnering-conference/</link>
<description><![CDATA[<strong>From:</strong> 19 April 2012<br /><strong>To:</strong> 20 April 2012<br /><br />Hyatt Harborside, Boston, MA, USA. ]]></description>
<guid>3171</guid>
</item>
<item>
<title>8th Stem Cell Summit</title>
<link>http://www.drugdiscoverytoday.com/view/3166/8th-stem-cell-summit/</link>
<description><![CDATA[<strong>From:</strong> 19 April 2012<br /><strong>To:</strong> 20 April 2012<br /><br />Hyatt Harborside, Boston, MA, USA. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed. In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?]]></description>
<guid>3166</guid>
</item>
<item>
<title>Pharma Outsourcing and Procurement Summit 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3031/pharma-outsourcing-and-procurement-summit-2012/</link>
<description><![CDATA[<strong>From:</strong> 03 May 2012<br /><strong>To:</strong> 04 May 2012<br /><br />tbc. Berlin, Germany. The Pharma Outsourcing and Procurement Summit 2012 addresses the urgent need for pharma to identify and locate the best outsourcing partnerships and solutions to stay competitive in an uncertain climate whilst addressing heightened regulatory pressures and need to maintain high quality standards]]></description>
<guid>3031</guid>
</item>
<item>
<title>Retina Ciliopathies: From Genes to Mechanisms and Treatment </title>
<link>http://www.drugdiscoverytoday.com/view/3240/retina-ciliopathies-from-genes-to-mechanisms-and-treatment-/</link>
<description><![CDATA[<strong>From:</strong> 04 May 2012<br /><strong>To:</strong> 05 May 2012<br /><br />Greater Fort Lauderdale/Broward County Convention Center, 1950 Eisenhower Boulevard, Fort Lauderdale, FL 33316, USA  . The Fourteenth Vision Research Conference is a two-day satellite meeting prior to ARVO 2012. It is co-sponsored by Vision Research, an International Journal for Functional Aspects of Vision, Elsevier and ARVO, the Association for Research in Vision and Ophthalmology]]></description>
<guid>3240</guid>
</item>
<item>
<title>30th Noordwijkerhout-Camerino-Cyprus Conference. Trends in Drug Research   </title>
<link>http://www.drugdiscoverytoday.com/view/3234/30th-noordwijkerhoutcamerinocyprus-conference-trends-in-drug-research--/</link>
<description><![CDATA[<strong>From:</strong> 13 May 2012<br /><strong>To:</strong> 17 May 2012<br /><br />Royal Tropical Institute, Amsterdam, The Netherlands    . ]]></description>
<guid>3234</guid>
</item>
<item>
<title>30th Noordwijkerhout-Camerino-Cyprus Conference. Trends in Drug Research. </title>
<link>http://www.drugdiscoverytoday.com/view/3203/30th-noordwijkerhoutcamerinocyprus-conference-trends-in-drug-research-/</link>
<description><![CDATA[<strong>From:</strong> 13 May 2012<br /><strong>To:</strong> 17 May 2012<br /><br />Royal Tropical Institute, Amsterdam, The Netherlands. The Noordwijkerhout-Camerino Symposium “Trends in Drug Research” series focuses on the interplay of biological activity and chemical structures. This is an highly intriguing problem to all scientists in the study of bioactve compounds.

]]></description>
<guid>3203</guid>
</item>
<item>
<title>Pharmacokinetic - Pharmacodynamic data analysis: A hands-on residential course using Phoenix WinNonlin </title>
<link>http://www.drugdiscoverytoday.com/view/2987/pharmacokinetic-pharmacodynamic-data-analysis-a-handson-residential-course-using-phoenix-winnonlin-/</link>
<description><![CDATA[<strong>From:</strong> 13 May 2012<br /><strong>To:</strong> 17 May 2012<br /><br />The Moller Centre, Cambridge, UK. This advanced and well established four-day residential course is designed to provide an interface between the computer analysis of PK and PD data and physiological concepts. The participants will practice pkpd concepts by means
of the MAXSIM2 simulation software
]]></description>
<guid>2987</guid>
</item>
<item>
<title>World Stem Cells &amp; Regenerative Medicine Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3246/world-stem-cells-regenerative-medicine-congress/</link>
<description><![CDATA[<strong>From:</strong> 21 May 2012<br /><strong>To:</strong> 23 May 2012<br /><br />Victoria Park Plaza, London, UK . The stem cell and regenerative medicine industry is burgeoning to a critical mass and pioneering to
transform the future of healthcare.

Engage in a global forum with senior level decision makers at Europe’s largest executive level stem cell conference and make sure you learn from the recent successes and failures experienced during cell therapy development.

]]></description>
<guid>3246</guid>
</item>
<item>
<title>World Gene Therapy Congress Europe 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3247/world-gene-therapy-congress-europe-2012/</link>
<description><![CDATA[<strong>From:</strong> 21 May 2012<br /><strong>To:</strong> 23 May 2012<br /><br />Victoria Park Plaza, London, UK . The 2012 World Gene Therapy Congress Europe is the senior director-level conference that tackles all the key scientific and technical issues facing the gene therapy industry and where decision-makers from the complete Gene Therapy value chain meet to learn and plan for the future.

It’s an exclusive gathering of the cutting edge companies and leading solution providers in the Gene Therapy industry.It is a place where innovation is showcased, solutions are found and learning is done.
]]></description>
<guid>3247</guid>
</item>
<item>
<title>European Lab Automation 2012</title>
<link>http://www.drugdiscoverytoday.com/view/3144/european-lab-automation-2012/</link>
<description><![CDATA[<strong>From:</strong> 30 May 2012<br /><strong>To:</strong> 31 May 2012<br /><br />CCH - Congress Center Hamburg, Germany. ]]></description>
<guid>3144</guid>
</item>
<item>
<title>Drug Delivery and Targeting</title>
<link>http://www.drugdiscoverytoday.com/view/3229/drug-delivery-and-targeting/</link>
<description><![CDATA[<strong>From:</strong> 03 June 2012<br /><strong>To:</strong> 05 June 2012<br /><br />Icelandair Hotel Reykjavik Natura. The conference is dedicated to the drug solubility, solubilization, nanoparticles and drug targeting.  The three-day conference will consist of four plenary lectures, a number of shorter oral presentations as well as poster presentations.  There will be a preconference workshop on June 2nd where toxicological and regulatory issues of new pharmaceutical excipients will be discussed by representatives from both the industry and government agencies.  In this workshop the emphasis will be on cyclodextrins and cyclodextrin derivatives.]]></description>
<guid>3229</guid>
</item>
<item>
<title>Clinical Trials Leaders Summit</title>
<link>http://www.drugdiscoverytoday.com/view/3137/clinical-trials-leaders-summit/</link>
<description><![CDATA[<strong>From:</strong> 11 June 2012<br /><strong>To:</strong> 12 June 2012<br /><br />Renaissance Tower Hotel Zurich, Switzerland. ]]></description>
<guid>3137</guid>
</item>
<item>
<title>13th Annual Drug Discovery Leaders Summit </title>
<link>http://www.drugdiscoverytoday.com/view/2960/13th-annual-drug-discovery-leaders-summit-/</link>
<description><![CDATA[<strong>From:</strong> 11 June 2012<br /><strong>To:</strong> 12 June 2012<br /><br />Renaissance Tower Hotel Zurich, Switzerland . Oxford Global Conferences are pleased to announce the 13th Annual Drug Discovery Leaders Summit being held in June 2012 in Switzerland. The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery &amp; Development Value Chain. The event is also co-located with 4th Annual Drug Development Summit.

]]></description>
<guid>2960</guid>
</item>
<item>
<title>Proteins &amp; Biopharma World Asia Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3161/proteins-biopharma-world-asia-congress/</link>
<description><![CDATA[<strong>From:</strong> 10 September 2012<br /><strong>To:</strong> 11 September 2012<br /><br />tbc Singapore. Over two days, this event will attract over 175 senior-level decision makers working in upstream and downstream production from Asia Pacific. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

]]></description>
<guid>3161</guid>
</item>
<item>
<title>10th Annual Pharmaceutical IT Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2961/10th-annual-pharmaceutical-it-congress/</link>
<description><![CDATA[<strong>From:</strong> 17 September 2012<br /><strong>To:</strong> 18 September 2012<br /><br />Radisson Edwardian Hotel, London Heathrow, London, UK. The 9th Annual Pharma IT meeting will attract over 150 senior-level decision makers working in R&amp;D IT and pharmaceutical technology from leading pharmaceutical, biotech companies, academic and research institutions.  This prestigious event covers topic areas such as effective tools and solutions in data management, knowledge management, informatics and data sharing for collaborative research in preclinical and clinical drug development, as well as successful strategies in managing IT Infrastructure and architecture using tools such as cloud computing, semantic web for data, content management and collaborative networking in life science.]]></description>
<guid>2961</guid>
</item>
<item>
<title>2nd Annual Next Generation Sequencing Congress Asia</title>
<link>http://www.drugdiscoverytoday.com/view/2962/2nd-annual-next-generation-sequencing-congress-asia/</link>
<description><![CDATA[<strong>From:</strong> 01 October 2012<br /><strong>To:</strong> 02 October 2012<br /><br />Concorde Hotel Singapore. Next Generation Sequencing Asia Congress is to be held on the 3rd and 4th of October in Singapore. Over the 2 days, the conference will provide an overview of the current options of next-generation sequencing platforms, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data and analytical genomics as well as overcoming data management problems.]]></description>
<guid>2962</guid>
</item>
<item>
<title>2nd Oncology Biomarkers Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2963/2nd-oncology-biomarkers-congress/</link>
<description><![CDATA[<strong>From:</strong> 10 October 2012<br /><strong>To:</strong> 11 October 2012<br /><br />Hilton Deansgate Hotel, Manchester, UK. Oxford Global is proud to present the 2nd Oncology Biomarkers Congress to be held on the 10th -11th October 2012, Manchester.  It is to be co-located with our Oncology Clinical Development Congress.]]></description>
<guid>2963</guid>
</item>
<item>
<title>Oncology Clinical Development</title>
<link>http://www.drugdiscoverytoday.com/view/3138/oncology-clinical-development/</link>
<description><![CDATA[<strong>From:</strong> 10 October 2012<br /><strong>To:</strong> 11 October 2012<br /><br />tbc Manchester, UK. ]]></description>
<guid>3138</guid>
</item>
<item>
<title>4th Annual Next Generation Sequencing Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3139/4th-annual-next-generation-sequencing-congress/</link>
<description><![CDATA[<strong>From:</strong> 19 October 2012<br /><strong>To:</strong> 20 October 2012<br /><br />Radisson Edwardian, London, Heathrow, UK. Over two days, the 4th Annual Next Generation Sequencing Congress will attract over 250 experts from both academia and pharma senior practitioners, working in all aspects of next generation sequencing including analytical genomics, computational biology, oncology, RNA profiling, molecular genomics, microbiology, nutrition, biomarkers, bioinformatics, data management and clinical &amp; diagnostics development from Europe and America.

]]></description>
<guid>3139</guid>
</item>
<item>
<title>Label-Free Technologies – Advances and Applications</title>
<link>http://www.drugdiscoverytoday.com/view/3150/labelfree-technologies-advances-and-applications/</link>
<description><![CDATA[<strong>From:</strong> 01 November 2012<br /><strong>To:</strong> 03 November 2012<br /><br />NH Grand Hotel Krasnapolsky, Amsterdam, The Netherlands    . Label-Free Technologies will be a two-day conference entirely dedicated to bringing together the latest research on the advances and application of label-free technology in pharmacology and drug discovery. Specifically aimed at providing unrivalled exposure of the most emerging practical applications, this is a chance for label-free users everywhere to glimpse the future of label-free applications and help shape the future of research in their field.]]></description>
<guid>3150</guid>
</item>
<item>
<title>4th Annual Next Generation Sequencing Congress</title>
<link>http://www.drugdiscoverytoday.com/view/2964/4th-annual-next-generation-sequencing-congress/</link>
<description><![CDATA[<strong>From:</strong> 15 November 2012<br /><strong>To:</strong> 16 November 2012<br /><br />Radisson Edwardian Heathrow, London, UK. Over two days, the 3rd Annual Next Generation Sequencing Congress will attract over 250 experts from both academia and pharma senior practitioners, working in all aspects of next generation sequencing including analytical genomics, computational biology, oncology, RNA profiling, molecular genomics, microbiology, nutrition, biomarkers, bioinformatics, data management and clinical &amp; diagnostics development from Europe and America.]]></description>
<guid>2964</guid>
</item>
<item>
<title>4th Annual Next Generation Sequencing Congress</title>
<link>http://www.drugdiscoverytoday.com/view/3162/4th-annual-next-generation-sequencing-congress/</link>
<description><![CDATA[<strong>From:</strong> 19 November 2012<br /><strong>To:</strong> 20 November 2012<br /><br />Radisson Edwardian Hotel, London Heathrow, UK. Over two days, the 4th Annual Next Generation Sequencing Congress will attract over 250 experts from both academia and pharma senior practitioners, working in all aspects of next generation sequencing including analytical genomics, computational biology, oncology, RNA profiling, molecular genomics, microbiology, nutrition, biomarkers, bioinformatics, data management and clinical &amp; diagnostics development from Europe and America.

]]></description>
<guid>3162</guid>
</item>
</channel>
</rss>

